Phytochemical and biological investigation of the bark of Garcinia fusca Pierre by Nguyen, Tri Hieu
Phytochemical and biological investigation of the 
bark of Garcinia fusca Pierre. 
 
 
 
 
 
 
 
A dissertation submitted to the  
Faculty of Chemistry and Pharmacy, University of Regensburg 
for the degree of 
Doctor of Natural Sciences (Dr. rer. nat.) 
 
 
 
Presented by 
TRI HIEU NGUYEN 
from Ho Chi Minh City University of Science, Vietnam 
 
 
2015 
The present work was carried out from 07/2011 until 01/2015 under the supervision of 
Prof. Dr. Jörg Heilmann at the institute of Pharmacy, Faculty of Chemistry and 
Pharmacy, University of Regensburg. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This dissertation was submitted on 1st June 2015 
The Ph.D. defense was on 23rd June 2015 
 
 
Board of examiners: PD Dr. Sabine Amslinger (Chairwoman) 
  Prof. Dr. Jörg Heilmann (First-examniner) 
  Prof. Dr. Thomas Schmidt (Second-examiner) 
  Prof. Dr. Gerhard Franz (Third-examiner)  
ACKNOWLEDGEMENTS 
 
I would like to express my sincere gratitude to my supervisor Prof. Dr. Jörg 
Heilmann, for accepting me as a member of his group, for providing me helpful 
working facilities, for his interest in my work as well as his willingness to proofread 
my thesis.  
I offer my deepest gratitude to Assoc. Prof. Dr. Nguyen Dieu Lien Hoa for showing 
me patience and enthusiasm, for guiding me throughout many years in the field of 
natural products, as well as being a great source of knowledge. 
I would like to thank Assoc. Prof. Dr. Pham Dinh Hung for his willingness to help 
me when necessary. 
I am greatly indebted to my parish-priest Joseph Nguyen Hien Thanh, Dr. Vu 
Quang Tuyen and M.Ed. Le Minh Ha for supporting and giving me an opportunity to 
apply the Ph.D. scholarship of KAAD (Bonn, Germany). 
My sincere thanks also go to: 
- Dr. Guido Jürgenliemk for his kind help in CPC separation. 
- Dr. Birgit Kraus for her useful advice in cell culture. 
- Dr. Daniel Bücherl for helping me enthusiastically in use of HPLC and 
connection with the network of the university. 
- Dr. Marcel Flemming for his instruction in anti-oxidant assay on RAW cells. 
- Dr. Sebastian Schmidt for showing me how to carry out proliferation assay on 
HMEC-1 cells, as well as for his fruitful discussions in isolation and structural 
elucidation of natural compounds. 
- Gabi Brunner for instructing me in detail about cytotoxicity assay on HeLa cells. 
She might be very patient with me. 
- My labmate, Stefan Wiesneth for his help in rescue of my user account at the 
university every time I forgot my passwords, as well as for his tolerance to my 
clumsiness. 
- My colleague, Edna Makule for her help in use of polarimeter and for honest 
confidences which we exchanged. 
I am grateful to Annette Schramm, Georgine Stühler, Fritz Kastner, Josef Kiermaier 
and Wolfgang Söllner for measurement of NMR and MS spectra. 
I am thankful to the secretary Hedwig Ohli for her kindness and enthusiasm. I wish 
her all the best in her life. 
Thanks go to all my colleagues, staff and students in Dr. Heilamnn’s group for their 
helps and for the pleasant working atmosphere and enjoyable time we had together. I 
will never forget our nice memories.  
I am very grateful to Katholischer Akademisher Ausländer-Dienst (KAAD, 
Germany) for providing me a scholarship to complete my Ph.D. project in Regensburg 
University. I would especially like to thank Dr. Heinrich Geiger and Mrs. Karin Bialas 
for their kind help to Vietnamese candidates.  
I would like to convey my deepest thanks to my family, relatives and friends for 
understanding, encouraging and supporting me spiritually throughout my life. 
Finally, I would like to say with all my faith that I did not obtain all precious helps 
and supports as mentioned above accidentally but they must have been the blessings of 
Lord. I could not have completed my Ph.D. project without those valuable helps and 
supports. With all my heart and soul, I would like to express my greatest gratitude to 
the Lord for all the blessings I got from Him. 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For my father and my late mother, 
  my sisters and brothers 
TABLE OF CONTENTS 
 
ACKNOWLEDGMENTS 
ABBREVIATIONS .....................................................................................................i 
SUMMARY ............................................................................................................... iv 
1. INTRODUCTION ........................................................................................... 1 
2. THE GENUS GARCINIA ............................................................................... 3 
2.1. General characters ..................................................................................... 3 
2.2. Chemical constituents of Garcinia ............................................................ 3 
2.2.1. Xanthones ....................................................................................... 12 
2.2.1.1. Simple oxygenated xanthones ................................................ 12 
2.2.1.2. Prenylated xanthones ............................................................. 12 
2.2.1.3. Caged xanthones .................................................................... 16 
2.2.1.4. Bisxanthones .......................................................................... 16 
2.2.2. Biflavonoids .................................................................................... 18 
2.2.3. Benzophenones ............................................................................... 19 
2.2.4. Phloroglucinols ............................................................................... 22 
2.2.5. Depsidones ...................................................................................... 23 
2.2.6. Tocotrienols .................................................................................... 24 
2.2.7. Biphenyls ........................................................................................ 25 
2.2.8. Triterpenoids ................................................................................... 25 
2.2.9. Other compounds ............................................................................ 26 
2.3. Pharmacological and biological properties of Garcinia ......................... 30 
2.3.1. Anti-oxidant activity ....................................................................... 31 
2.3.2. Antifungal activity .......................................................................... 31 
2.3.3. Antimicrobial activity ..................................................................... 33 
2.3.4. Anti-inflammatory activity .............................................................. 35 
2.3.5. Anticancer activity .......................................................................... 36 
2.3.6. Antiviral activity ............................................................................. 36 
2.3.7. Other properties .............................................................................. 37 
2.4. Study of the genus Garcinia in Vietnam ................................................. 40 
2.5. Garcinia fusca Pierre .............................................................................. 45 
2.5.1. Botanical features and uses in traditional medicine ......................... 45 
2.5.2. Previous chemical and biological investigations .............................. 45 
3. BIOSYNTHESYS OF XANTHONES AND BIFLAVONOIDS .................. 47 
3.1. Biosynthetic pathway of xanthones ....................................................... 47 
3.2. Biosynthetic pathway of bioflavonoids ................................................. 59 
4. MATERIAL AND METHODS .................................................................... 68 
4.1. General experimental procedures .......................................................... 68 
4.2. Extraction, fractionation and isolation................................................... 69 
4.2.1. Material of plant .............................................................................. 69 
4.2.2. Extraction of plant material ............................................................. 69 
4.2.3. Fractionation of crude extracts ........................................................ 70 
4.2.4. Isolation of substances from fractions ............................................. 70 
4.2.4.1. Thin layer chromatography (TLC) ........................................ 71 
4.2.4.2. Preparative TLC ..................................................................... 73 
4.2.4.3. Open column chromatography ............................................... 73 
4.2.4.4. Flash chromatography ............................................................ 74 
4.2.4.5. Size-exclusion chromatography.............................................. 74 
4.2.4.6. Centrifugal partition chromatography ..................................... 75 
4.2.4.7. Semi-preparative HPLC ......................................................... 76 
4.3. Structural elucidation of isolated compounds .......................................... 78 
4.3.1. Ultraviolet-visible spectroscopy ...................................................... 78 
4.3.2. Mass spectrometry .......................................................................... 79 
4.3.3. Nuclear magnetic resonance spectroscopy (NMR) .......................... 81 
4.3.3.1. One dimensional (1D) NMR spectra ...................................... 82 
4.3.3.1.1. 1H NMR spectra .............................................................. 82 
4.3.3.1.2. Proton-decoupled 13C NMR spectra ................................ 83 
4.3.3.2. Two dimensional (2D) NMR spectra ...................................... 83 
4.3.3.2.1. COSY spectra ................................................................ 83 
4.3.3.2.2. HSQC spectra ................................................................. 84 
4.3.3.2.3. HMBC spectra ................................................................ 84 
4.3.3.2.4. NOESY and ROESY spectra ........................................... 84 
4.3.4. Optical rotation ............................................................................... 85 
4.4. Biological assays .................................................................................. 86 
4.4.1. Preparation of samples .................................................................... 86 
4.4.2. Cytotoxicity assay on HeLa cells..................................................... 86 
4.4.2.1. Cell culture ............................................................................ 86 
4.4.2.2. Cell counting .......................................................................... 87 
4.4.2.3. MTT assay ............................................................................. 87 
4.4.3. Proliferation assay on HMEC-1 ....................................................... 88 
4.4.3.1. Cell culture ............................................................................ 88 
4.4.3.2. Proliferation assay .................................................................. 89 
5. RESULTS AND DISCUSSION .................................................................... 90 
5.1. Experiments ............................................................................................ 90 
5.1.1. Fractionation and isolation of the n-hexane extract (GFH) ............. 90 
5.1.1.1. Isolation from fraction GFH-2 ................................................ 94 
5.1.1.2. Isolation of xanthones from fraction GFH-4 ........................... 94 
5.1.1.3. Isolation of compounds from fraction GFH-6 ......................... 95 
5.1.1.4. Isolation of xanthones from fraction GFH-7 ........................... 97 
5.1.2. Fractionation of the ethyl acetate extract and further isolation ........ 99 
5.1.2.1. Isolation of xanthones from fraction GFE-4 ......................... 103 
5.1.2.2. Isolation of compounds from fraction GFE-6 ....................... 104 
5.2. Structural elucidation of isolated substances ......................................... 105 
5.2.1. Structural identification of substances from the n-hexane extract .. 105 
5.2.1.1. Compound 21 (fuscaxanthone J) .......................................... 111 
5.2.1.2. Compound 20 (fuscaxanthone K) ......................................... 114 
5.2.1.3. Compound 19 ((+)-fuscaxanthone I) .................................... 118 
5.2.1.4. Compound 18 (fuscaxanthone L) ......................................... 123 
5.2.1.5. Compound 22 (fuscaxanthone M) ........................................ 128 
5.2.2. Structural identification of substances from the EtOAc extract ...... 133 
5.2.2.1. Compound 24 (fuscaxanthone N) ......................................... 136 
5.2.2.2. Compound 25 (fuscaxanthone O) ......................................... 140 
5.2.2.3. Compound 26 (fuscaxanthone P) .......................................... 144 
5.3. Cytotoxicity of new substances ............................................................. 148 
5.4. Proposed biosynthesis of the new xanthones in G. fusca Pierre ............. 150 
6. CONCLUSION............................................................................................ 153 
REFERENCES ................................................................................................. 154 
LIST OF SCHEMES ........................................................................................ 194 
LIST OF TABLES ............................................................................................ 195 
APPENDICES .................................................................................................. 196 
 
 
 
 
 
 
 
 
 
 
Abbreviations   i 
 
ABBREVIATIONS 
 
AflO 
 
AflY 
 
[]D 
Gene encoding the SAM-dependent O-methyltransferase in the 
Aspergillus species 
Gene encoding an enzyme catalyzing the Baeyer-Villiger oxidation 
in the Aspergillus species 
Specific optical rotation 
brs 
BHT 
Broad singlet 
Butylated hydroxytoluene 
CC Column chromatography 
CDCl3 Deuterated chloroform 
C2D6CO 
CHS 
Deuterated acetone 
Chalcone synthase 
cm Centimetre  
COSY Correlated spectroscopy 
CPC Centrifugal partition chromatography 
 Chemical shift 
d Doublet 
1D One-dimensional  
2D Two-dimensional 
DCM Dichloromethane 
dd Doublet of doublet 
DMAPP Dimethylallylpyrophosphate 
DMSO 
DPPH 
Dimethylsulphoxide 
2,2-Dipheny-1-(2,4,6-trinitrophenyl)hydrazyl 
EDTA Ethylenediaminetetraacetic acid 
EtOAc Ethyl acetate 
EtOH Ethanol  
FC Flash chromatography 
fr. Fraction  
FCS 
FAD 
Fetal calf serum 
Flavin adenine dinucleotide  
ii   Abbreviations 
 
GPC Gel permeation chromatography 
GPP Geranyldiphosphate 
HMBC Heteronuclear multiple bond correlation 
HMEC-1 Human microvascular endothelial cell line-1 
HPLC High performance liquid chromatography 
HRESI High resolution electrospray ionization 
HSQC Heteronuclear single quantum coherence 
IC50 50% Inhibition concentration 
J Coupling constant 
m 
MdpB 
MdpC 
MdpD 
MdpJ 
MdpK 
MdpL 
Multiplet 
Gene encoding dehydratase in Aspergillus spp. 
Gene encoding phenol reductase in Aspergillus spp. 
Gene encoding mono-oxygenase in Aspergillus spp. 
Gene encoding glutathione-S-transferase in Aspergillus spp. 
Gene encoding oxidoreductase in Aspergillus spp. 
Gene encoding Baeyer-Villiger oxidase in Aspergillus spp. 
MeCN Acetonitrile  
MeOH Methanol 
mg Milligram  
min Minute 
mm Millimetre  
µM Micromolar 
µl Microliter 
MEM Minimum essential medium  
MHz 
MIC 
Megahertz 
Minimum inhibitory concentration 
MS Mass spectrometry 
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
m/z Mass-to-charge ratio 
n Number  
NADPH Nicotinamide adenine dinucleotide phosphate 
NMR Nuclear magnetic resonance 
NOESY Nuclear overhauser enhancement spectroscopy 
Abbreviations   iii 
 
p.a. 
PAL 
Pro analysis 
Phenylalanine ammonia lyase 
PE Petroleum ether 
ppm Part per million 
PBS Phosphate buffered saline 
Rf Retardation factor 
ROESY Rotating-frame nuclear overhauser effect correlation spectroscopy 
RP18 Reversed phase C-18 
s Singlet 
SAM S-Adenosyl methionine 
SDS Sodium dodecyl sulphate 
t Triplet 
TLC Thin layer chromatography 
UV 
Ver-A 
Ver-1 
XtpA 
XtpB 
XtpC  
Ultraviolet 
A cytochrome  P450 monooxygenase in Aspergillus species 
An NADH-dependent deoxygenase in Aspergillus species 
Gene encoding prenyl transferase in Aspergillus spp. 
Gene encoding prenyl transferase in Aspergillus spp. 
Gene encoding oxidoreductase in Aspergillus spp. 
 
iv   Summary 
 
SUMMARY 
The Garcinia is a large genus of the family Guttiferae or Clusiaceae, nearly 
consisting of 450 species. This genus has been of interest due to its therapeutic value 
in the folk medicine for the treatment of various kinds of diseases such as vomiting, 
swelling, tapeworms, dysentery, chronic diarrhoea, piles, pains and heart complaints, 
as well as due to the successive finding of both chemically and biologically interesting 
compounds (Vo et al., 2012). In Vietnam, around thirty one Garcinia species were 
found, some of which were phytochemically and biologically investigated (Pham, 
1999). For further phytochemical and biological study of the genus Garcinia in 
Vietnam, Garcinia fusca Pierre was chosen for the investigation. 
In this work, the air-dried and powdered bark of G. fusca Pierre (1.95 kg) was 
successively extracted with n-hexane and ethyl acetate. The NMR-guided fractionation 
of both the n-hexane and ethyl acetate extracts led to the isolation of thirty one 
phenolic compounds by means of various chromatographic methods such as TLC, FC, 
GPC, CPC and semi-preparative HPLC. The structural elucidation was carried out 
based on data of UV, MS, 1D and 2D NMR spectra together with the optical rotation. 
The compounds isolated from the n-hexane extract comprise a tocotrienol, a 
benzaldehyde derivative and twenty xanthones, five of which (18 – 22) are new and 
given trivial names fuscaxanthones (+) I, J – M. Meanwhile four biflavonoids and five 
xanthones were obtained from the ethyl acetate extract, three of which (24 – 26) are 
new and given trivial names fuscaxanthones N – P, respectively. All the xanthones are 
prenylated 1,3,6,7-tetrahydroxyxanthone derivatives. Eight new xanthones possess the 
basic structure of cowanol, which was previously reported from G. cowa (Na Pattalung 
et al., 1994). However the different features were observed. Fuscaxanthone J (21) 
might have been O-methylated at 7-OH to form cowanol. In fuscaxanthone (+) I (19), 
the double-bond at C-17/C-18 of the geranyl group is hydroxylated, whereas the 
double-bond of the 4-hydroxy-3-methylbut-2-enyl group is epoxylated in 
fuscaxanthone K (20). In fuscaxanthones N and O (24 and 25), the double-bond at C-
22/C-23 of the geranyl group is hydroxylated and relocated to C-21/C-22 or C-23/C-
24. Meanwhile in fuscaxanthone L and P (18 and 26), the geranyl group is cyclized to 
give a monoterpenoid substitute with a C6 ring. To the best of our knowledge, 
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parvixanthone I, which was reported from G. parvifolia, was the only xanthone with 
such a substitute (Xu et al., 2001). Fuscaxanthone M (22) is a dimer of cowanol, which 
is combined by an unusual C-O-C linkage.   
The new xanthones and cowanol were tested for cytotoxicity on HeLa cells to 
establish a preliminary basis of a structure – activity relationship. The results showed 
that these xanthones had cytotoxic effect with the IC50 values in the range of 19.1 – 
45.9 µM, except that compounds 20 and 22 were inactive. The modification of the 
geranyl group or the 4-hydroxy-3-methylbut-2-enyl group brought about a decrease or 
loss of activity compared with cowanol. Moreover griffipavixanthone, which was 
previously isolated from G. griffithii, G. pavifolia and G.oblongifolia (Xu et al., 1998; 
Shi et al., 2014), exhibited a high cytotoxicity against HeLa cells with an IC50 value of 
7.9  0.7 µM. This bixanthone was further evaluated for anti-angiogenic activity by in 
vitro proliferation assay on HMEC-1 cell line and it showed a greatly strong anti-
proliferative effect with an IC50 value of 0.15  0.0085 µM after 72 h incubation, 
which indicated that griffipavixanthone is a potential anti-angiogenic agent which 
should be further demonstrated in vivo and in further molecular assays. 
The results of this work together with those previously reported (Ito et al., 2003; 
Nontakham et al., 2014) revealed that Garcinia fusca Pierre is a rich source of 
tetraoxygenated xanthones and biflavonoids. The cytotoxicity of those xanthones 
suggested that the bark of this plant may have an anti-tumor effect, which should be 
further studied for use in medicine. 
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1. INTRODUCTION 
 
Vietnam is situated along the eastern coast of the Indochina Peninsula in Southeast 
Asia and covers an area of 329,500 square kilometres. The country is bordered to the 
north by China, to the west by Laos and Cambodia and to the east by South China Sea 
(known in Vietnam as the East Sea). As a result of the warm and humid tropical 
climate, approximately 39% of Vietnam territory is under forest cover with around 
13,000 species of vascular plants, over 8,000 of which have been identified to date 
(Sterling and Hurley, 2005; Queiroz et al., 2013). Early on Vietnamese people 
discovered pharmaceutical properties of some plants and used them as medical 
remedies to prevent or treat some diseases such as eating ginger to treat cold and flu, 
drinking the water extract of Artemisia as an anti-malaria agent and chewing betel to 
prevent tooth decay. These formed the basis of Vietnamese traditional medicine. 
During the thousand years of Chinese domination, Vietnamese traditional medicine 
was deeply influenced by Chinese traditional medicine. In the nineteenth century, 
Western medical practices were introduced to Vietnam with the arrival of the French 
(Ladinsky et al., 1987). Nowadays Vietnamese medicine is a harmonious merging of 
Chinese, Vietnamese and Western medicinal system, in which traditional medicine has 
an important role in promoting the health of Vietnamese people, especially in primary 
health care at the commune level and the treatment of chronic illnesses such as AIDS 
and cancer which seem to be increasing. The statistics of the Vietnam Ministry of 
Health showed that about 30% of patients annually received the treatment with 
traditional medicines (WHO, 2005). Vietnamese traditional medical remedies are 
mainly based on medicinal plants. According to a report of the Vietnam Ministry of 
Health in 2014, 3,948 of 10,386 identified species have been known as medicinal 
plants, a large number of which have not been phytochemically investigated to 
improve use value. Moreover pharmaceutical properties of the remaining species have 
not determined yet. The report also showed that many valuable and rare medicinal 
plants are in the risk of extinction because of deforestation and uncontrolled 
exploitation of medicinal sources (The Vietnam Ministry of Health, 2014).  
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The Guttiferae or Clusiaceae is a family of plants including about 37 genera and 
1610 species of trees and shrubs. This family is mainly tropical (Gustafsson et al., 
2002). In Vietnam, there are around sixty five species of six genera comprising 
Calophyllum, Cratoxylum, Garcinia, Mammea, Mesua and Ochrocapus. Some species 
are used in folk medicine to treat various diseases such as dysentery, diarrhoea, 
coughs, fever, scabies, burns, menstrual disturbances and ulcer; whilst pharmaceutical 
properties of the remaining species have not been known (Vo, 1997; Pham, 1999). 
Though many species of the family Guttiferae have been phytochemically and 
biologically investigated all over the world, approximately twenty species collected in 
Vietnam have been reported so far. In order to contribute to phytochemical and 
biological study of the family Guttiferae in Vietnam, we have investigated the species 
Garcinia fusca Pierre collected in south Vietnam. The aim of this work was the 
isolation of natural compounds to characterize the phytochemical profile in detail and 
to provide possible new structures for drug discovery whereby that helps to improve 
use value of this species in the traditional medicine. Moreover, that also supplies 
phytochemical database of this species for classification and conservation of medicinal 
plants in Vietnam. The results of the phytochemical and biological investigation on the 
n-hexane and ethyl acetate extracts of G. fusca Pierre are presented in this thesis. 
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2. THE GENUS GARCINIA 
 
2.1. General characters 
The Garcinia is a large genus of the family Guttiferae (Clusiaceae), comprising 
around 450 species of tropical trees and shrubs with yellow resin or latex, mostly 
native to the Old World (tropical and South Africa, Madagascar, south-eastern Asia, 
north-eastern Australia and western Polynesia), with a few species in the tropical 
regions of the Americas. Various Asiatic species are used as a cathartic or stimulant, 
dye or artist’s pigment. Many species are important timber resources used for 
construction and furniture. In Vietnam there are about thirty one species (Pham, 1999).  
The members of the genus are various considerably in size and form but generally 
have opposite leaves (occasionally whorled), entire (untoothed or lobed), which are 
often evergreen, often thick and leathery but occasionally papery, with prominent 
secondary veins. The flowers, often fragrant, commonly have four or five parts, and 
occur in singly or in clusters of up to 5, which may be terminal (at branch tips) or 
axillary (where leaf meets stem). The fruit is a berry with a thin to leathery skin and 
one to five seeds (or more) embedded in a fleshy or pulpy, often edible, aril. The 
delicious mangosteen which is produced by G. mangostana, has been called “Queen of 
fruits” (Bailey and Bailey, 1976; Xiwen et al., 2007).  
 
2.2. Chemical constituents of Garcinia 
The genus Garcinia consists of many medicinal plants containing potential 
therapeutic agents which have been globally used in folk medicine. Those have 
attracted researchers to pharmaceutical and phytochemical investigations of species 
from the genus. To the best of our knowledge, approximately one hundred and seven 
species of the genus have been phytochemically investigated so far. A variety of plant 
parts were studied such as latex, resin, leaves, bark, root, stems, twigs, heartwood, 
branches, fruits, pericarps, seeds and flowers, see Table 1. These investigations 
revealed that the genus Garcinia produces different types of secondary metabolites 
including xanthones, biflavonoids, benzophenones, acylphloroglucinols, triterpenoids, 
depsidones, tocotrienols and biphenyls. 
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Table 1. Garcinia species which have been phytochemically investigated to date 
Species Parts  
G. achachairu Seeds Dal Molin et al., 2012 
G. afzelii Stem bark 
Seeds 
Kamdem et al., 2006 
Lannang et al., 2010 
G. amplexicaulis Stem bark Lavaud et al., 2013 and 2015 
G. aristata Fruits Cuesta-Rubio et al., 2001 
G. assigu Stem bark Ito et al., 1997 and 2003 
G. atroviridis Stem bark 
Root 
Fruits 
Kosin et al., 1998; Tan et al., 2014 
Permana et al., 2001 and 2005 
Mackeen et al., 2002; Tan et al., 2013 
G. bakeriana Leaves Al-Shagdari et al., 2013 
G. bancana Twigs 
Leaves 
Rukachaisirikul et al., 2005 
 
G. benthami Stem bark 
Bark 
Leaves 
Elya et al., 2006 
Nguyen et al., 2011 
 
G. bracteata Leaves 
Twigs 
Stem bark 
Stems 
Fruits  
Thoison et al., 2000 and 2005 
Na et al., 2010; Li et al., 2015 
Niu et al., 2012 
Hu et al., 2013 and 2014 
Na et al., 2013 
G. brasiliensis Seeds 
Pericarps  
Martins et al., 2007; Naldoni et al., 2009 
Martins et al., 2008; Gontijo et al., 2012 
G. brevipedicellata Stem bark Ngoupayo et al., 2008 
G. buchananii Heartwood 
Stem bark 
Jackson et al., 1971 
Stark et al., 2012 and 2013 
G. cambogia Latex 
Root 
Fruits 
Rama et al., 1980 
Iinuma et al., 1998 
Masullo et al., 2010 
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Table 1. (continued) 
G. cantleyana Trunk bark 
Twigs 
Shadid et al., 2007 
Jantan et al., 2012 
G. celebica Leaves Elfita et al., 2009 
G. chapelieri Bark Rambeloson et al., 2014 
G. cochinchinensis Bark Nguyen et al., 2011; Trinh et al., 2013 
G. conrauana Bark 
Heartwood 
Seeds 
Leaves 
Hussain and Waterman, 1982 
G. cornea Stem bark Elfita et al., 2009 
G. cowa Latex  
Fruits 
Stems 
Stem bark 
Na Pattalung et al., 1994; Mahabusarakam et al., 2005 
Panthong et al., 2006; Sriyatep et al., 2014 
Shen et al., 2007; Siridechakorn et al., 2012 
G. cuneifolia Stem bark Ea et al., 2003 
G. cymosa Stem bark Elfita et al., 2009 
G. densivenia Stem bark Waterman and Crichton, 1980 
G. dioica Bark Iinuma et al., 1996 
G. dulcis Branches 
Root  
Bark 
Leaves 
Fruits 
Flowers 
Seeds 
Harrison et al., 1994 
Iinuma et al., 1996 
Ito et al., 1997 
Kosela et al., 2000 
Deachathai et al., 2005 
Deachathai et al., 2006 
Deachathai et al., 2008 
G. echinocarpa Bark Bandaranayake et al., 1975 
G. edulis 
G. esculenta 
Root bark 
Twigs  
Magadula, 2010 
Zhu, et al., 2014 
G. eugeniifolia Heartwood  Jackson et al., 1971 
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Table 1. (continued)   
 
G. ferrea 
Stem bark 
Bark 
Hartati et al., 2008 
Bui et al., 2014 
G. forbesii Branches 
Twigs 
Harrison et al., 1992 
 
G. fusca Stem bark 
Root 
Ito et al., 2003 
Nontakham et al., 2014 
G. gardneriana Leaves 
Bark 
Seeds  
Castardo et al., 2008 
Otuki et al., 2011 
G. gaudichaudii Leaves 
Bark  
Cao et al., 1998 
Xu et al., 2000 
G. gerrardii Root bark Sordat-Diserens et al., 1989 
G. griffithii Stem bark 
Leaves 
Bark 
Elfita et al., 2009; Nilar et al., 2005 
Alkadi et al., 2013 
Xu et al., 1998 
G. hanburyi Latex 
Fruits 
Leaves 
Twigs  
Asano et al., 1996; Tao et al., 2009 
Reutrakul et al., 2007 
Reutrakul, 2010 
 
G. hombroniana Pericarps 
Leaves 
Twigs 
Bark 
Rukachaisirikul et al., 2000 
Rukachaisirikul et al., 2005 
Klaiklay et al., 2013 
Jamila et al., 2014 
G. huillensis Stem bark Bakana et al., 1987; Dibwe et al., 2012 
G. humilis Bark  Herath et al., 2005; Haase, 2011 
G. indica Seeds 
Leaves 
Badami and Desai, 1968 
Badami and Razdan, 1972 
 Heartwood 
Fruits 
Cotterill et al., 1977 
Krishnamurthy et al., 1981 and 1982 
The genus Garcinia   7 
 
Table 1. (continued)   
 
G. intermedia 
Stem bark 
Leaves 
Lakshmi et al., 2002 
Abe et al., 2004 
G. kola Fruits 
Seeds 
Bark  
Root 
Stems 
Mesocarp 
Hussain et al., 1982 
Iwu, 1985 
Kabangu et al., 1987 
Iwu et al., 1990; Niwa et al., 1994 
Terashima et al., 1999a and 1999b 
Morabandza et al., 2013 
G. lateriflora Stem bark Kosela et al., 1999; Ren et al., 2010 
G. lancilimba Stem bark Yang et al., 2007; Han et al., 2008 
G. latissima Bark Ito et al., 1997 
G. linii Root Chen et al., 2004 and 2006 
G. livingstonei Heartwood 
Root bark 
Leaves 
Fruits 
Pelter et al., 1971 
Sordat-Diserens et al., 1990 and 1992 
Kaikabo et al., 2009 
Yang et al., 2010 
G. lucida Bark 
Stem bark 
Nyemba et al., 1990 
Fotie et al., 2007 
G. macrophylla Leaves 
Flowers 
Twigs 
Andrade et al., 2007 
 
Williams et al., 2003 
G. madruno Aerial  Osorio et al., 2013 
G. maingayii Stem bark Hartati et al., 2007 
G. malaccensis Stem bark Taher et al., 2012; Alkadi et al., 2013 
G. mangostana Fruits 
Leaves 
Pericarps 
Heartwood 
Root bark 
Govindachari et al. 1971; Suksamrarn et al., 2006 
Parveen et al., 1990 and 1991 
Sen et al., 1982; Suksamrarn et al., 2002  
Nilar and Harrison, 2002 
Ea et al., 2006 
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Table 1. (continued)   
 
G. mannii 
Stem bark 
Bark 
Heartwood 
Seeds 
Leaves  
Ea et al, 2008; Han et al., 2009 
Crichton and Water, 1979 
Hussain and Waterman, 1982 
G. merguensis Bark 
Wood 
Twigs 
Nguyen et al., 2003 
Kijjoa et al., 2008 
Trisuwan et al., 2013 
G. multiflora Heartwood 
Stems  
Fruits 
Twigs 
Stem bark 
Leaves 
Chen et al., 1975 
Chiang et al., 2003 
Chen et al., 2008 
Liu et al., 2010 
Jing et al., 2013 
Jiang et al., 2014 
G. myrtifolia Bark  Spino et al., 1995 
G. neglecta Leaves Ito et al., 2001 
G. nervosa Stem bark 
Leaves 
Ampofo and Waterman, 1986 
Babu et al., 1988; Ilyas et al., 1994 
G. nigrolineata Bark  
Leaves 
Twigs  
Rukachaisirikul et al., 2003 
Rukachaisirikul et al., 2003 
Rukachaisirikul et al., 2005 
G. nobilis 
 
G. nujiangensis 
Stem bark 
Twigs 
Twigs  
Fouotsa et al., 2012 
Fouotsa et al., 2014 
Tang et al., 2015 
G. oblongifolia Bark  
Stems 
Leaves 
Bark 
Hamed et al., 2006 
Wu et al., 2008 
Zhang et al., 2014 
Feng et al., 2014 
G. oligantha Stems Gao et al., 2013; Wu et al., 2013 
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Table 1. (continued)   
G. oliveri 
G. opaca 
Bark 
Leaves 
Bark 
Ha et al., 2009 and 2012 
Goh et al., 1992 
Mori et al., 2014 
G. ovalifolia Stem bark 
Leaves 
Waterman and Crichton, 1980; Lannang et al., 2013 
Gustafson et al., 1992 
G. parvifolia Leaves 
Bark  
Stem bark 
Twigs  
Xu et al., 2000 
Xu et al., 2001 
Kardono et al., 2006; Syamsudin et al., 2013 
Rukachaisirikul et al., 2006 
G. paucinervis Leaves  
Stem bark 
Stems 
Gao et al., 2010; Wu et al., 2013 
Fan et al., 2012 
Hu et al., 2014 
G. penangiana Leaves Jabit et al., 2007 
G. penduculata Heartwood  
Pericarps 
Bark  
Rao et al., 1974 
Sahu et al., 1989 
Vo et al., 2012 
G. polyantha Stem bark 
Wood 
Root bark 
Leaves 
Lannang et al., 2005 
Louh et al., 2008 
Lannang et al., 2008 
Lannang et al., 2014 
G. porrecta Stem bark Kardono et al., 2006 
G. prainiana Leaves 
Twigs 
Klaiklay et al., 2011; Mawa and Said, 2012 
Susanti et al., 2013  
G. preussii Leaves Messi et al., 2012 
G. propinqua Twigs Tantapakul et al., 2012 
G. pseudoguttifera Heartwood Ali et al., 2000 
G. puat Leaves Ito et al., 2001 
G. punctata Stem bark Ngameni et al., 2014 
G. purpurea Pericarp Iinuma et al., 1996 
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Table 1. (continued)   
G. pyrifera Stem bark 
Fruits 
Ampofo and Waterman, 1986 
Roux et al., 2000 
G. quadrifaria Stem bark Waterman and Hussain, 1982 
G. quaesita Bark  Gunatilaka et al., 1984 
G. rigida Leaves Elya et al., 2006 and 2011 
G. scortechinii Twigs 
Latex 
Stem bark 
Fruits 
Rukachaisirikul et al., 2000 
Rukachaisirikul et al., 2003 
Rukachaisirikul et al., 2005 
Sukpondma et al., 2005 
G. semseii Stem bark 
Pericarps   
Magadula et al., 2008 
Magadula et al., 2012 
G. shomburgkiana Bark 
Wood 
Stems 
Vo et al., 2012 
Mungmee et al., 2013 
Ito et al., 2013 
G. smeathmannii Stem bark 
Root bark 
Komguem et al., 2005; Kuete et al., 2007 
Lannang et al., 2006 
G. solomonensis Stem bark Carroll et al., 2009 
G. speciosa Bark 
Trunk bark 
Vieira et al., 2004 
Rukachaisirikul et al., 2003  
G. spicata Bark 
Fruit  
Leaves 
Konoshima et al., 1970 
Lyles et al., 2014 
Gunatilaka et al., 1984 
G. subelliptica Heartwood 
Root bark 
Wood 
Seeds 
Stem bark 
Fruits 
Leaves 
Fukuyama et al., 1991 
Iinuma et al., 1995 
Fukuayama et al., 1998 
Weng et al., 2003 and 2004 
Abe et al., 2003 
Zhang et al., 2010 
Ito et al., 2013 
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Table 1. (continued)   
G. succifolia Wood Duangsrisai et al., 2014 
G. staudtii Stem bark Waterman and Hussain, 1982 
G. talboti Root Joshi et al., 1970 
G. terpnophylla Bark  
Wood  
Bandaranayake et al., 1975 
 
G. tetralata Stem bark 
Branches 
Leaves 
Wang et al., 2008; Guo et al., 2011 
Na and Xu, 2010 
 
G. tetranda Wood Purwaningsih and Ersam, 2007 
G. thwaitesii Bark 
Timber  
Gunatilaka et al., 1983 
 
G. vieillardii Stem bark Hay et al., 2004 and 2008 
G. vilersiana Bark Nguyen et al., 1999; Bui et al., 2012 
G. virgata Stem bark Merza et al., 2004 and 2006 
G. volkensii Heartwood  
Bark 
Herbin et al., 1970 
Magadula et al., 2014 
G. xanthochymus Fruits 
Bark 
Stem bark 
Twigs 
Karanjgoakar et al., 1973; Baggett et al., 2005 
Chen et al., 2008 and 2010 
Ji et al., 2012 
Trisuwan et al., 2014 
G. xipshuanbannaensis Fruits  
Leaves  
Twigs  
Shen et al., 2006 
Na and Xu, 2010 
Han et al., 2008; Na and Xu, 2009 
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2.2.1. Xanthones 
The latex or resin of Garcinia species is commonly yellow because of the presence 
of xanthone derivatives. Xanthones have been widely found in all species of this genus 
including simple oxygenated xanthones, prenylated xanthones, caged xanthones and 
bisxanthones.   
 
2.2.1.1. Simple oxygenated xanthones 
These compounds can be di-, tri-, tetra- or penta-oxygenated xanthones with simple 
substituents such as hydroxyl, methoxyl and methyl groups (see Figure 1). Two 
xanthones, 1,5- and 1,7-dihydroxyxanthones are simple di-oxygenated xanthones 
found extensively in many species (Bennett and Lee, 1989). Simple tri-oxygenated 
compounds as 1,3,5-trihydroxyxanthone and 1,5-dihydroxy-2-methoxyxanthone were 
isolated from G. xanthochymus (Baslas, 1979). Three xanthones, 1,3,5,7-, 1,3,6,7-
tetrahydroxyxanthones and 1,2-dihyroxy-5,6-dimethoxyxanthone, which were reported 
from G. penduculata and G. subelliptica, are examples for simple tetra-oxygenated 
xanthones (Rao et al., 1974; Minami et al., 1995). Simple penta-oxygenated xanthones 
are rarely found in the genus, whereas some were isolated from the genus Calophyllum 
(Guttiferae). Three xanthones, 1,3,4,5,8-pentahydroxyxanthone,  1,3,8-trihydroxy-4,6-
dimethoxyxanthone and 1,3,7-trihydroxy-4,6-dimethoxyxanthone, are simple penta-
hydroxyxanthones identified from two species G. tetranda and G. hombroniana 
(Purwaningsih and Ersam, 2007; Klaiklay et al., 2013). 
 
2.2.1.2. Prenylated xanthones 
Prenylated xanthones are di-, tri-, tetra- and penta-oxigenated xanthones, whose the 
aromatic ring system is substituted by prenyl groups such as isoprenyl, 1,1-
dimethylprop-2-enyl, geranyl and farnesyl (see Figure 2). These groups can be 
cyclized with adjacent hydroxyl groups at the ortho-position to give tetra- or penta-
cyclic xanthones with furano- or pyrano rings, respectively. A xanthone can be 
substituted by one, two or three prenyl groups. Natural xanthones with more than three 
prenyl groups have not yet been found up to date. A large number of prenylated tri- 
and tetra-oxygenated xanthones have been reported from the genus. Prenylated penta-
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oxygenated xanthones are rare. 1,7-Dihydroxy-3-methoxy-2-(3-methylbut-2-
enyl)xanthone, isocowanol and dulciol C, three xanthones from G. mangostana, G. 
pyrifera and G. dulcis, are three xanthones substituted by one, two and three prenyl 
groups (Mahabusarakam et al., 1987; Ampofo and Waterman, 1986; Iinuma et al., 
1996). Garcigerrin A, a tri-oxygenated xanthone with a pyrano ring from G. gerrardii 
and rheediaxanthone B, a tetra-oxygenated xanthone with a furano ring from G. 
polyantha, are two examples of tetracyclic xanthones (Ampofo and Waterman, 1986; 
Sordat-Diserens et al., 1989). Subelliptenone C from G. subelliptica is a tetra-cyclic 
xanthone with a furo ring (Iinuma et al., 1995). BR-xanthone A, a xanthone from G. 
mangostana and 1,5-dihydroxy-6,6-dimethylpyrano(2,3:6,7)-4,4,5-
trimethylfurano(2,3:3,4)-2-(3-methylbut-2-enyl)xanthone, a xanthone from G. 
opaca, are representative of penta-cyclic xanthones (Balasubramanian and 
Rajagopalan, 1988; Goh et al., 1992). 5-Farnesyltoxyloxanthone, a tetraoxygenated 
xanthone isolated from G. merguensis, is a rare xanthone with a farnesyl group (Kijjoa 
et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14   The genus Garcinia 
 
 
O
O OH
OH
O
O OH
HO
O
O OH
OH
OH
1,5-Dihydroxyxanthone 1,7-Dihydroxyxanthone 1,3,5-Trihydroxyxanthone
O
O OH
OH
OH
HO
O
O OH
OHHO
HO
O
O OH
OH
OHOH
OH
1,3,6,7-Tetrahydroxyxanthone 1,3,5,7-Tetrahydroxyxanthone 1,3,4,5,8-Pentahydroxyxanthone
O
O OH
OMe
OH
O
O OH
OH
MeO
OMe
1,5-Dihydroxy-2-methoxyxanthone1,2-Dihydroxy-5,6-dimethoxyxanthone
O
O OH
OH
OMe
MeO
OH
O
O OH
OH
OMe
HO
MeO
1,3,7-Trihydroxy-4,6-dimethoxyxanthone 1,3,8-Trihydroxy-4,6-dimethoxyxanthone
 
Figure 1. Simple xanthones from some Garcinia species 
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Figure 2. Prenylated xanthones from some Garcinia species 
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2.2.1.3. Caged xanthones 
These compounds are polyprenylated xanthones, in which the ring B is converted 
into an unusual ring, 4-oxa-tricyclo[4.3.1.03,7]dec-2-one (caged) scaffold (Ollis et al., 
1965). This motif can be further modified with various substituents on the aromatic 
ring A and can also be oxidized to form a wide range of compounds with interesting 
structures, see Figure 3. Caged xanthones have been restrictively found in some 
species of the genus Garcinia, especially G. hanburyi. Over one hundred compounds 
have been identified from the genus. Morellin, a caged xanthone from G. morella, was 
first reported in 1937 (Rao, 1937). Gambogellic acid, one of caged xanthones isolated 
from G. hanburyi, has a polycyclic structure (Asano et al., 1996). Although the 
majority of caged xanthones possess the general motif, a few compounds have 
alternative structures. For example, 6-O-methylneobractatin identified from G. 
bracteata, contains the neo-motif (Thoison et al., 2000). Lateriflorone isolated from G. 
lateriflora, has a spiroxalactone core by oxidation of the ring C (Kosela et al., 1999), 
whilst the ring B in the structure of scortechinone K, one of caged xanthones from G. 
scortechinii, undergoes ring-opening oxidation (Rukachaisirikul et al., 2003). 
 
2.2.1.4. Bisxanthones 
Bisxanthones are dimeric xanthones, which have been found in some species of the 
family Guttiferae. They are formed from prenylated monomeric xanthones by ring-
closure coupling through side-chains, see Figure 4. Garcilivins A-C, which was 
isolated from the bark of the of roots G. livingstonei, have been reported for the first 
time from the genus. These compounds are dimerics linked via a 6-membered ring, 
which is formally derived from a Diels-Alder-type reaction between two isoprenyl 
units. (Sordat-Diserens et al., 1992). Bigarcinenone A from the bark of G. 
xanthochymus is a dimer linked via a 5-membered ring like cratoxyxanthone. A 
biosynthetic pathway of the latter one was proposed to involve the coupling of two 
xanthone radicals, see Scheme 11 (Zhong et al., 2008). Bigarcinenone B, which was 
also obtained from G. xanthochymus, is a bisxanthone that is connected via a 6- and 6-
membered ring system (Chen et al., 2011). 
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Figure 3. Caged xanthones from some Garcinia species
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Figure 4. Bisxanthones from some Garcinia species 
 
2.2.2. Biflavonoids 
The genus Garcinia is shown to be a source of biflavonoids. To the best of our 
knowledge, about one hundred biflavonoids have been identified from this genus to 
date. The majority of these compounds are dimers of two flavanones, two flavones, 
between a flavanone and a flavone or a flavanonol, which are linked at the positions C-
3 and C-8 or C-3 and C-8. There are four main groups of Garcinia biflavonoids: 
GB-1 type with a flavanone-(3-8)-flavanonol system, GB-1a type with a flavanone-
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(3-8)-flavanone system, morelloflavone type with a flavanone-(3-8)-flavone system 
and amentoflavone type with a flavone-(3-8)-flavone system (Ferreira et al., 2012; 
Ito et al., 2013). Beside these four types, some biflavonoids have alternative structures. 
For instance, lateriflavone with the 6-8 linkage has been isolated from G. lateriflora, 
whereas (22)-biflavonol from G. nervosa has a rare linkage between C-2 and C-
2, see Figure 5 (Parveen et al., 1994; Ren et al., 2010).   
 
2.2.3. Benzophenones 
Benzophenones from Garcinia comprise simple benzophenones and polyprenylated 
benzophenones, in which the aromatic ring A can undergo oxidation, prenylation and 
cyclization to form polycyclic benzophenones with a bicyclo[3.3.1]nonane-2,4,9-
trione skeleton (Zhang et al., 2010). These polycyclic benzophenones are divided into 
three types corresponding to the position of the benzoyl group. Type A includes 
compounds with the benzoyl group at C-1, for example garcimultiflorone A from G. 
multiflora (Chen et al., 2009). Type B, with the benzoyl group at C-3 such as 
pedunculol from G. pendunculata, was widely found in the genus (Sahu et al., 1989). 
Garcinielliptone K, which was obtained from G. subelliptica, is representative of type 
C with the benzoyl group at C-5 (Weng et al., 2004). Cyclization involving the β-
diketone and olefinic groups in polyprenylated compounds led to formation of 
interesting adamantanyl benzophenones such as garciniagifolone A from G. 
oblongifolia (Shan et al., 2012).. Additionally in some cases, the ring B can be 
modified into a bicyclo[3.3.2]decane-2,4,10-trione skeleton such as gambogenone 
reported from G. xanthochymus or can undergo intramolecular oxidative coupling 
between the enol and the aromatic ring B to form corresponding polycyclic xanthone 
derivatives, for examples garcinialone obtained from G. multiflora (Baggett et al., 
2005; Chien et al., 2008). Doitunggarcinone B, which was isolated from G. propinqua, 
is an unusually rearranged benzophenone, see Figure 6 (Tantapakul et al., 2012). 
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Figure 5. Biflavonoids from some Garcinia species 
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Figure 6. Benzophenones from some Garcinia species 
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2.2.4. Phloroglucinols 
Phloroglucinol derivatives reported in the genus include simple phloroglucinols and 
complex compounds with an oxidized and polyprenylated nucleus or a 
bicyclo[3.3.1]nonane-1,3,9-trione skeleton. Parvifoliol A is one of simple 
phloroglucinols isolated from G. parvifolia (Rukachaisirikul et al., 2006). 
Garcinielliptone HB is one of seven polyprenylated phloroglucinols identified from G. 
subelliptica, whilst garcicowin A from G. cowa is a phloroglucinol derivative with the 
bicycle[3.3.1]nonane-1,3,9-trione core (Lu et al., 2008; Xu et al., 2010). 
Garcinielliptone HF, which was also obtained from G. subelliptica, is a phloroglucinol 
with an unprecedented skeleton, see Figure 7 (Wu et al., 2008).  
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Figure 7. Phloroglucinol derivatives from some Garcinia species 
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2.2.5. Depsidones 
Depsidones are polyphenolic compounds containing the 11H-dibenzo[b,e][1,4]-
dioxepin-11-one system. These compounds were mainly found in lichens, which 
usually provide polyketide-derived natural products. However a substantial number of 
depsidones were reported from the genus Garcinia, which is well known as a rich 
source of shikimate-derived aromatic compounds. Depsidones from the genus are 
commonly substituted with hydroxyl, methoxyl, isoprenyl and geranyl groups. For 
instance, garcidepsidone A, one of four prenylated depsidones, was isolated from G. 
parvifolia (Xu et al., 2000). Prenyl side-chains can be cyclized with hydroxyl groups at 
the position ortho to give tetra- and penta-cyclic compounds such as garcinisidone B 
and C, a tetracyclic depsidone and a penta-cyclic depsidone, respectively, were 
identified from G. neglecta, see Figure 8 (Ito et al., 2001). 
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Figure 8. Depsidones from some Garcinia species 
 
24   The genus Garcinia 
 
2.2.6. Tocotrienols 
Tocotrienol derivatives were isolated from some Garcinia species. They have a 6-
chromanol skeleton substituted by a farnesyl group at the position C-2, which can be 
oxidized at two terminal methyl groups. These compounds can be mono- or dimeric 
derivatives. For instance, 5-formyl--tocotrienol is a mono derivative identified from 
G. virgate (Merza et al., 2004), whilst δ,γ-bi-O-amplexichromanol, δ,γ-
biamplexichromanol and ,-biamplexichromanoate are dimeric tocotrienols reported 
from G. amplexicaulis, see Figure 9 (Lavaud et al., 2015). 
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Figure 9. Tocotrienols from some Garcinia species 
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2.2.7. Biphenyls 
A series of biphenyl derivatives were identified from the genus. These compounds 
possess a biphenyl core substituted by hydroxyl, methoxyl and isoprenyl groups such 
as garcibiphenyls B and C from the root of G. linii (Chen et al., 2006). 
Oblongifoliagarcinines A and C, which were reported from G. oblongifolia, are tri- 
and tetracyclic biphenyls, see Figure 10 (Wu et al., 2008). 
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Figure 10. Biphenyl derivatives from some Garcinia species 
 
2.2.8. Triterpenoids 
Triterpenoids from this genus consist of lanostanes, friedolanostanes, 
abeolanostanes, cycloartanes, friedocycloartanes, friedelanes, protostanes, triterpenes 
with lup-20(29)-en-type and oleanolic acid skeletons. Garcihombronane A and D are a 
friedolanostane and a lanostane of ten triterpenes isolated from the leaves of G. 
hombroniana (Rukachaisirikul et al., 2000 and 2005). 14β,15β-Epoxy-3β-hydroxy-9-
oxo-11[10-8]-abeolanostan-22-cis,24-trans-dien-28-oic acid is one of four 11(10-8)-
abeolanostanes reported from G. speciosa (Vieira et al., 2004), whereas 
garciosaterpene A is one of three protostanes also isolated from this species 
(Rukachaisirikul et al., 2003). 2α-Hydroxy-3β-O-acetyllup-20(29)-en-28-oic acid, a 
lup-20(29)-en-type triterpene and an oleane, 3-O-(4′-O-acetyl)-α-L-
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arabinopyranosyloleanolic acid, have been reported from the resin of G. hanburyi 
(Wang et al., 2008). (22Z,24E)-3-Hydroxy-17,13-friedocycloarta-12,22,24-trien-26-
oic acid is a friedocycloartane obtained from the bark of G. benthami, whilst 
ovalifolone A is a friedelane derivative from G. ovalifolia, see Figure 11 (Nguyen et 
al., 2011; Lannang et al., 2013). 
 
2.2.9. Other compounds 
Hydroxycitric acid and its derivatives were isolated from the fruits of three species, 
G. cambogia, G. indica and G. atroviridis (Lewis, 1969). (-)-Hydroxycitric acid has 
drawn all worldwide attention because of its anti-obesity property (Krishnamurthy and 
Sapna, 2008). Some sesquiterpenes were identified from the genus, for instance, 
scortechterpenes A and B from the fruit of G. scortechinii (Sukpondma et al., 2005). 
Garcinielliptones N and O are two novel terpenoids isolated from the seed of G. 
subelliptica (Weng et al., 2004). Some unusual compounds were reported from the 
genus such as three benzophenone-xanthone dimers from the root of G. dulcis, 
garciduols A-C have been first identified in nature (Iinuma et al., 1996). Two 
flavanone-chromone dimers, preussianone and I-4,I-5,II-5,I-7,II-7-
pentahydroxyflavanone[I-3,II-8]-chromone were isolated from the leaves of G. 
preussii and G. dulcis (Messi et al., 2012; Ansari and Rahman, 1975). The 
unsubstituted chromone moiety is supposed to be derived by elimination of a phenyl 
ring from a biflavone. Garcinianins A and B, two new proanthocyanidins from the 
leaves of G. multiflora, have been first reported from the genus (Jiang et al., 2014). In 
addition, the essential oil of some species contains volatile compounds, see Figure 12 
and 13 (Macleod and Pieris, 1982). 
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Figure 11. Triterpenoids from some Garcinia species
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Figure 12. Some rare phenolic compounds in the genus Garcinia 
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Figure 13. (-)-Hydroxycitric acid and terpenoids from some Garcinia species 
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2.3. Pharmacological and biological properties of Garcinia 
Many species of the genus are used in traditional medicine around the world, 
particularly in Asia and Africa. The pericarp of G. mangostana is used in Southeast 
Asia for the treatment of skin infections, wounds, dysentery, diarrhoea, fever, arthritis 
and inflammation (Pedraza-Chaverri, 2008). The leaves and seeds of G. dulcis are 
used in Indonesian folk medicine to treat lymphatitis, parotitis and struma, whereas its 
stem bark is used in Thailand as an antiseptic and the fruit juice as an anti-scurvy and 
expectorant. In addition, its root extract is also used as an antipyretic and antitoxin 
(Kalahari and Hemi, 1986; Wuttidhammavej, 1997). The bark of G. cowa is used in 
Thai folk medicine as an antipyretic and antimicrobial agent. Its latex is also used as 
anti-fever agent (Na Pattalung et al., 1994). In India, the fruit of G. indica is 
anthelmintic and useful for piles, dysentery, tumours, pain and heart complaints (Jena 
et al., 2002). G. cambogia extract has been used in Indian traditional medicine to treat 
tumours, ulcers, haemorrhoids, diarrhoea, dysentery, fever, open sores and parasites 
(Duke, 2002). The gum of G. hanburyii is used internally in Thailand as a purgative, 
vermifuge and for treatment of infected wounds. It is also applied for treatment of 
chronic dermatitis, haemorrhoids and bedsore. In China, it was developed as an 
antitumor medicine (Saralamp et al., 1996; Han et al., 2006). G. xanthochymus is 
widely used in Chinese traditional medicine for dispelling worms and removing food 
toxin (Lin et al., 2003). G. hombroniana, a seashore mangosteen in Malaysia, is used 
as protective medicine after child birth and to cure skin allergies (Jamila, 2014). In 
Africa, G. preussii is traditionally used to treat stomach aches and its leaves are 
prepared as a decoction to relieve toothache (Bouquet, 1969; Visser, 1975). Extracts of 
G. kola are used in Nigerian ethnic medicine against laryngitis, cough and liver 
diseases. Its seeds are used in Africa as an antidote (Iwu et al., 1985 and 1987). The 
leaves and flowers of G. afzelii are used in Cameroon and Ghana for antibacterial 
properties (Waffo et al., 2006). In Fiji, an extract of the leaves of G. pseudoguttifera is 
mixed with coconut oil and used to relieve pain in the limbs (Cambie and Ash, 1994). 
Pharmacological and biological investigations of natural products from the genus 
showed that some of them possess a wide range of various properties such as anti-
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oxidant, antifungal, antimicrobial, anti-inflammatory, anticancer and antiviral 
activities (Hemshekhar et al, 2011). 
 
2.3.1. Anti-oxidant activity 
1,8-Dihydroxy-6-methoxyxanthone, a tri-oxygenated xanthone from the wood G. 
subelliptica exhibited inhibitory activities in three in vitro assays viz., anti-
lipidperoxidation in rat brain homogenates, DPPH free radical scavenging and 
superoxide anion scavenging assays at 5 µg/ml (Minami et al., 1994). -Mangostin 
from the pericarp of G. mangostana inhibited 7,12-dimethylbenz[]anthracene-
induced preneoplastic lesions in a mouse mammary organ culture assay with an IC50 of 
1.0 µg/ml (Jung et al., 2006).  Garcidepsidone B, a depsidone from the twigs of G. 
parvifolia, gave an IC50 of 0.13 µM equal to that of BHT in the DPPH free radical 
scavenging assay (Rukachaisirikul et al., 2006). The antioxidant activity of 
bigarcinenone A, a bisxanthone from the bark of G. xanthochymus, is even stronger 
than that of BHT in a DPPH radical scavenging test. Bigarcinenone A gave an IC50 of 
9.2 µM, compared to the positive control, BHT with an IC50 of 20 µM, see Figure 14 
(Zhong et al., 2008).  
 
2.3.2. Antifungal activity 
Beside the anti-oxidant activity, -mangostin also exhibited the inhibition towards 
the fungi Alternaria solani, Cunninghamella echinulata and Candida albicans that 
causes candidiasis with a MIC of 1 mg/ml. It was shown to be more efficient than the 
existing antifungal drugs such as clotrimazole and nystatin (Sundaram et al., 1983; 
Kaomonkolgit et al., 2009). Two isoprenylated tri-oxygenated xanthones, 1,4,5-
trihydroxy-3-(3-methylbut-2-enyl)xanthone and 4-(3,7-dimethylocta-2,6-dienyl)-
1,3,5-trihydroxyxanthone of G. livingstonei showed an activity against the plant 
pathogenic fungus Cladosporium cucumerinum at 0.5 and 0.2 µg, respectively, see 
Figure 14 (Sordat-Diserens et al., 1992).   
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Figure 14. Some anti-oxidant and antifungal compounds from the genus Garcinia 
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2.3.3. Antimicrobial activity 
Rubraxanthone isolated from G. dioica displayed higher activity against 
Staphylococcal strains (MIC = 0.31-1.25 µg/ml) than that of the antibiotic, 
vancomycin with MIC values of 3.13-6.25 µg/ml (Iinuma et al., 1996). Garcilivin A, a 
bisxanthone from G. livingstonei, showed a high anti-parasitic activity against two 
trypanosomes, T. brucei brucei and T. cruzi that cause the fata human diseases, 
sleeping sickness and chagas disease with IC50 values of 0.4 µM and 4.0 µM, 
respectively. Moreover, this compound also exhibited antiplasmodial property against 
Plasmodium falciparum with an IC50 of 6.7 µM (Mbwambo et al., 2006). 
Xanthochymol, a polyprenylated benzophenone from G. xanthochymus and G. 
subelliptica, was evaluated for the antibacterial property against methicillin-resistant 
Staphylococcus aureus with the lowest minimum inhibitory concentration at 3.1-12.5 
µg/ml, nearly equal to that of vancomycin (Iinuma et al., 1995). Guttiferone A, a 
polyisoprenylated benzophenone from the fresh fruits of G. aristata, showed a potent 
antiplasmodial effect against Plasmodium falciparum with an IC50 of 0.5 µM, nearly 
similar to that of chloroquine (IC50 = 0.3 µM), a 4-aminoquinoline drug used in the 
treatment or prevention of malaria (Monzote et al., 2011). Amentoflavone, a biflavone 
from some Garcinia species, was reported to be more active against Mycobacterium 
smegmatis than the drug isoniazid used in the clinical treatment of tuberculosis. This 
compound gave a MIC of 0.6 µg/ml compared to isoniazid with a MIC of 1.3 µg/ml 
(Kaikabo and Eloff et al., 2011).  Kolaviron, a biflavonoid complex from the seeds of 
G. kola containing GB-1, GB-2 and kolaflavanone, exhibited potent antiplasmodial 
activity against Plasmodium berghei infection in Swiss albino mice, see Figure 15 
(Oluwatosin et al., 2014). 
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Figure 15. Some anti-microbial compounds from the genus Garcinia 
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2.3.4. Anti-inflammatory activity 
Garcinielliptones L and M, two polyisoprenylated phloroglucinols from the seeds of 
G. subelliptica, showed potent inhibitory effects on the release of β-glucuronidase and 
on histamine from peritoneal mast cell stimulated with p-methoxy-N-
methyphenethylamine in a concentration-dependent manner. They also exhibited 
potent activities on NO production in culture media of RAW 264.7 cells in response to 
lipopolysaccharide (LPS) and in culture media of N9 cells in response to 
LPS/interferon- (IFN-) (Weng et al., 2004). Two xanthones, - and -mangostin 
from the pericarps of G. mangostana, showed significant properties in the expression 
decrease of TNF-, IL-1β, IL-6, IL-8, MCP-1 (monocyte chemoattractant protein) and 
TLR-2 (toll-like receptor). They also potently inhibited the LPS induced NO and PEG2 
activity in RAW264.7 macrophages with IC50 concentration of 3.1 and 6.0 µM 
(Bumrungpert et al., 2009; Chen et al., 2008). In the study of the effects on neutrophil 
pro-inflammatory responses of benzophenones from G. multiflora, garcimultiflorone D 
potently inhibited fMLP/CB-induced superoxide anion generation and elastase release 
with IC50 values of 7.21 and 6.0 µg/ml, respectively, see Figure 16 (Ting et al., 2012).  
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Figure 16. Some anti-inflammatory compounds from the genus Garcinia 
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2.3.5. Anticancer activity 
Gambogic acid and epigambogic acid, two caged xanthones from the gamboges of 
G. hanburyi, were examined for their cytotoxicity against human leukaemia K562/S 
and doxorubicin-resistant K562/R cell lines. They were shown to be potent agents 
against both cell lines with IC50 values of 1.32 and 0.89 µM for gambogic acid, 1.11 
and 0.86 µM for epigambogic acid, respectively (Han et al., 2005). 7-
Hydroxyforbesione, a caged xanthone from the leaves of G. cantleyana, exhibited 
significant cytotoxicity against MDA-MB-231, CaOV-3, MCF-7 and HeLa cancer cell 
lines with IC50 values ranging from 0.22 - 2.17 µg/ml (Shadid et al., 2007). For 3-O-
(4′-O-acetyl)-α-L-arabinopyranosyloleanolic acid, a triterpene from the resin of G. 
hanburyi, the anti-proliferative effects and the apoptosis induction abilities in four 
human leukaemia cell lines consisting of HL-60, NB4, U937 and K562 were 
determined with IC50 values of 2.45, 2.69, 2.42 and 4.15 µM, respectively (Wang et 
al., 2008). Guttiferone A, an anti-oxidant benzophenone from some Garcinia species, 
displayed strong activity against HTC-116 and HT29 cell lines with the same IC50 
values of 5.0 µM (Yang et al. 2010). GB1, a biflavone reported from some Garcinia 
species, inhibited -glucosidase and aromatase with IC50 values of 0.9 and 11.3 µM, 
respectively. It was discussed to be a potential dietary supplement or phytomedicine 
for the prevention of breast cancer and type II diabetes mellitus. Morelloflavone, 
another Garcinia biflavone, was found to inhibit proteasome at an IC50 concentration 
of 1.3 µM, see Figure 17 (Antia et al., 2010; Ren et al., 2010). 
 
2.3.6. Antiviral activity 
Morelloflavone demonstrated potent activity against HIV-1 (strain LAV-1) in 
phytohemagglutinin-stimulated primary human peripheral blood mononuclear cells at 
an EC50 value of 6.9 µM and a selectivity index value of approximately 10, whilst 
amentoflavone exhibited significant antiviral activity against two strains of influenza 
A, H1N1 and H3N2 with EC50 values of 3.1 and 4.3 µg/ml, respectively (Lin et al., 
1999). Morellic acid, gambogic acid and dihydroisomorellin, three caged xanthones 
from G. hanburyi, showed potent HIV-1 RT inhibitory property with IC50 values < 50 
µg/ml (Reutrakul et al., 2007). Garciosaterpenes A and C, two pronostanes from the 
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bark of G. speciosa, were determined to have strong inhibitory activities against HIV-1 
RT with IC50 values of 15.5 and 12.2 µg/ml, respectively, see Figure 17 and 18  
(Rukachaisirikul et al., 2003). 
 
2.3.7. Other properties 
(-)-Hydroxycitric acid, which was found in the fruits of three species G. cambogia, 
G. indica and G. atroviridis, exhibited the in vitro inhibitory effect on the conversion 
of lactate, acetate and glucose to fatty acids in bovine and rat adipose tissues (Hood et 
al., 1985). Furthermore, anti-inflammatory, anti-oxidative stress and insulin resistance 
properties of this acid were evaluated using obese male Zucker rats with type II 
diabetes associated with inflammation of the IL-6 and plasma C-reactive protein and 
oxidative stress makers of malondialdehyde, protein carbonyl and protein tyrosine 
nitration. The results showed that (-)-hydroxycitric acid reduced food-intake, body 
weight gain as well as decreased the inflammation, oxidative stress and insulin 
resistance (Asgar et al., 2007). Two biflavonoids of G. kola seeds (GB1 and GB2) 
were tested for anti-hepatotoxic activities using four experimental toxins, namely 
carbon tetrachloride, galactosamine, -amanitin and phalloidin. These compounds 
significantly modified the action of all these hepatoxins. At 100 mg/kg orally, they 
reduced thiopental-induced sleep in CCl4-poisoned rats, see Figure 19 (Iwu et al., 
1987). 
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Figure 17. Some compounds from the genus Garcinia with cytotoxic activity 
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Figure 18. Some antiviral compounds from the genus Garcinia 
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Figure 19. Compounds with other biological activities from the genus Garcinia 
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2.4. Study of the genus Garcinia in Vietnam 
There are around thirty one species of the genus in Vietnam, see Table 2. They are 
distributed in different areas of the country, particularly in the forests. Fruits of some 
species are edible such as G. harmandii, G. merguensis, G. multiflora, G. fusca and 
especially G. mangostana, which is cultivated as a fruit-tree. Young leaves of some 
species are used as vegetables, for example, G. cowa and G. oliveri. Some species are 
used in traditional medicine for the treatment of various diseases. The bark of G. 
cochincinensis is used to cure allergy, itches and skin diseases, whereas the buds are 
useful for threatened abortion. The ground bark of G. oliveri is mixed with that of G. 
vilersiana to make a powder used as medicinal agent against sprains. G. pendunculata 
is used to treat constipation and digestive problems. G. schomburgkiana is used for the 
treatment of coughs and menstrual disturbances. The pericarp of G. mangostana is 
used as antibacterial and antibiotic agent as well as for the treatment of dysentery, 
fever and inflammation (Vo, 1997; Pham, 1999).  
Twelve species, which were collected in Vietnam, have phytochemically been 
investigated so far, as shown in Table 2 with bold types. New compounds including 
prenylated xanthones, caged xanthones, prenylated benzophenones, phloroglucinol 
derivatives, triterpenoids and depsidones, were reported from these species.  Some of 
them possess biological properties such as cytotoxic, antitumor and anti-oxidant 
activities. Neoisobractatins A and B, two caged xanthones from the leaves of G. 
bracteata, exhibited a significant cytotoxic activity on KB cells with IC50 values of 
0.14 and 0.16 µg/ml, respectively (Thoison, 2005).  (+)-Guttiferone G, which was 
identified from the bark of G. cochinchinensis, was tested as an inhibitor of human 
sirtuins SIRT1 and SIRT2 (Gey et al., 2007). Guttiferone Q, a polyisoprenylated 
benzophenone from the pericarp of G. cochinchinensis, showed potent cytotoxicity 
against cell lines, MCF-7, HeLa and NCI-H460 with IC50 values in the range of 2.74-
4.04 µg/ml (Nguyen et al., 2011). Oliveridepsidones A-D, four depsidones from the 
bark of G. oliveri, exhibited DPPH radical scavenging activity, see Figure 20 (Ha et 
al., 2011). 
Some of the remaning species collected in other countries have been 
phytochemically and biologically studied such as G. cowa (Na Pattalung et al., 1994; 
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Panthong et al., 2006; Mahabusarakam et al., 2005), G. gaudichaudii (Xu et al., 2000; 
Cao et al., 1998a and 1998b), G. multiflora (Chen et al., 1975; Chiang et al., 2003; 
Chen et al., 2009, Liu et al., 2010), G. nigrolineata (Rukachaisirikul et al., 2003a, 
2003b and 2005), G. oligantha (Gao et al., 2013; Wu et al., 2013; Yang et al., 2014) 
and G. xanthochymus (Karanjoakar et al, 1973; Baggett et al., 2005; Chen et al., 2010; 
Trisuwan et al., 2014). However these species have not yet been collected in Vietnam 
to date. Nowadays collection and identification of Garcinia species in Vietnam are 
indeed very difficult because the majority of species was not easily found in nature any 
more. They are merely distributed in the thick forests throughout the country. Some 
species are seemingly extinct such as G. fagraeoides (Vietnam’s Red Data Book). 
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Table 2. Garcinia species distributed in Vietnam 
Species name Plant part New compounds 
G. bassacensis Pierre   
G. benthami Pierre Bark 
 
 
Leaves   
Two triterpenoids, a friedolanostane and a 
friedocycloartane, along with a benzophenone, 
benthaphenone  
Two friedolanostanes (Nguyen et al., 2011) 
G. bracteata Wu ex Li Bark  
 
 
Leaves  
Two prenylated xanthones, garcibracteatone 
and 5-O-methylxanthone V1, together with a 
benzophenone, xerophenone C 
Ten prenylated xanthones including eight 
caged xanthones, bractatin, isobractatin, 1-O-
methylbractatin, 1-O-methylisobractatin, 1-O-
methyl-8-methoxy-8,8a-dihydrobractatin, 1-O-
methylneobractatin, neoisobractatins A and B, 
bracteaxanthone I and II.  
(Thoison et al., 2000 and 2005)  
G. cochinchinensis Lour Pericarp 
 
Bark 
Three polyisoprenylated benzophenones, 
guttiferones Q-S (Nguyen et al., 2011) 
Two prenylated benzophenones, guttiferone T 
and (+)-guttiferone G (Trinh et al., 2013; Gey 
et al., 2007) 
G. cowa Roxb   
G. delpyana Pierre Bark In study 
G. ferrea Pierre Bark  Three triterpenoids, a protostane and two 
lanostanes (Bui et al., 2014) 
G. fagraeoides   
G. fusca Pierre   
G. gaudichaudii Planch   
G. gracilis Pierre   
G. hainanensis Merrill   
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Table 2. (continued)   
G. hanburyii Hook. f.   
G. harmandii Pierre   
G. lanessanii Pierre   
G. mackeaniana Craib   
G. mangostana L. Pericarp  (Nguyen et al., 2009; Ha et al., 2009) 
G. multiflora Champ. Ex   
G. merguensis Wight Bark  A xanthone, merguenone (Nguyen et al., 2003; 
Vo et al., 2008) 
G. nigrolineata Pl. ex T.    
G. oblongifolia Champ. ex Bark  Four polyprenylated benzophenones, 
oblongifolins A-D (Hamed et al., 2006) 
G. oligantha Merr   
G. oliveri Pierre Bark  Four depsidones, oliverixanthones A-D, 
together with two prenylated xanthones 6-O-
methylcowanin and oliverixanthone (Ha, 2009 
and 2012) 
G. pendunculata Roxb Bark  Three isoprenylated xanthones, 
pendunxanthones A-C (Vo et al., 2012) 
G. planchonii Pierre   
G. poilanei Gagn   
G. schefferi  Pierre   
G. schomburgkiana Pierre Bark  Two tetraoxygenated xanthones, 6-O-
demethyloliverixanthone and 
schomburgxanthone (Vo et al., 2012) 
G. tinctoria (DC.)   
G. vilersiana Pierre Bark A xanthone, 1-O-methylglobuxanthone 
(Nguyen and Harrison, 2000; Nguyen et al., 
2009; Bui et al., 2012) 
G. xanthochymus Hook. f.   
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Figure 20. Compounds with different bioactivities from some Garcinia species 
collected in Vietnam 
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2.5. Garcinia fusca Pierre 
 
2.5.1. Botanical features and uses in traditional medicine 
Garcinia fusca Pierre is belonged to the genus Garcinia of the family Guttiferae 
(Clusiaceae). The trivial name of this plant in Vietnamese is Bứa lửa. It is a ca. 8 m 
high tree with reddish wood and dark brown bark. The leaf blade is relatively narrow 
and elliptic-lanceolate. Leaves are blackish on dry. Male flowers are three in cymules 
with four petals. Fruits are pointed and edible with segments. Seeds are 12-15 cm long. 
This species is distributed in table forests from the middle to the South East of 
Vietnam (Pham, 1999). It can be also found in some Asian countries with the tropical 
climate such as Thailand, Malaysia, Indonesia and India. Green fruits and leaves are 
commonly used in food preparation as a spice or favouring. The root, stem, leaf and 
fruit of this plant are ethno-medically used for improvement of blood circulation, 
expectorant, treatment of coughs and indigestion, laxative, and the relief of fever 
(Poomipamorn and Kumkong, 1997).  
 
2.5.2. Previous chemical and biological investigations 
In 2003, Ito et al. investigated the stem bark of this species collected in Thailand. 
The investigation resulted in the identification of eight new prenylated xanthones, 
fuscaxanthones A-H, along with eight known xanthones, which exhibited the 
inhibitory effects on 12-O-tetradecanoylphorbol-13-acetate induced Espstein-Barr 
virus early antigen activation in Raji cells, see Figure 21 (Ito et al., 2003). In 2014, 
Nontakham et al. carried out a chemical investigation on the roots of this genus as part 
of the on-going project to search for new bioactive compounds from Garcinia species 
in Thailand. A new oxygenated xanthone, fuscaxanthone I, along with thirteen known 
compounds consisting of nine xanthone, a biphenyl and three biflavonoids were 
isolated. Anti-Helicobacter pylori activity of these compounds was evaluated 
(Nontakham et al., 2014). 
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Figure 21. New xanthones, fuscaxanthones A-I, from G. fusca Pierre 
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3. BIOSYNTHESIS OF XANTHONES AND BIFLAVONOIDS 
 
3.1. Biosynthetic pathway of xanthones 
Xanthones are natural polyphenolic compounds commonly occurring in higher 
plants, fungi and lichens. These compounds have the symmetrical basic skeleton, 9H-
xanthen-9-one as shown in Figure 22 (Cardona et al., 1990; Peres and Nagem, 1996). 
The families Gentianaceae, Guttiferae and Polygalaceae are rich sources of xanthones 
(Negi et al., 2013). Natural xanthones can be subdivided based on the nature of 
substituents into six main groups: simple oxygenated xanthones, prenylated xanthones, 
xanthone glycosides, bisxanthone, xanthonolignoids and miscellaneous xanthones 
(Mandal et al., 1992). 
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Figure 22. Basic skeleton of xanthones. 
 
The biosynthesis of xanthones has been thoroughly investigated in vivo and in vitro 
for fourty years via radiolabeled experiments (El-Seedi et al., 2010). It has been known 
that compounds may be formed from polyhydroxybenzophenone intermediates 
through two different processes involved:  
- The acetate polymalonic pathway in lower plants and fungi. 
- The mixed shikimate – acetate pathway in higher plants. 
In the latter one, L-phenylalanine, which is formed from shikimate, is oxidized to 
form m-hydroxybenzoic acid by losing two carbon atoms from the side chain. This 
acid combines with three units of malonyl coenzyme A via a series of Claisen 
condensations to yield the intermediate as shown in Scheme 1. The shikimate-acetate 
intermediate undergoes subsequent folding and ring-closure of a Dieckmann 
condensation and enolization to give a substituted benzophenone, which generates the 
central ring of the xanthone moiety via an oxidative phenol coupling catalysed by 
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xanthone synthase. This reaction can take place in two ways depending on the folding 
of the bezophenone either in the ortho or the para position to the 3-hydroxyl group to 
give 1,3,5- or 1,3,7-trihydroxyxanthone. These two xanthones are precursors for most 
xanthones in higher plants. This pathway has been proved by experiments, in which 
Gentiana lutea plant was supplied with 14C-labeled phenylalanine or 14C-labeled 
acetate (Gupta and Lewis, 1971; Fujita and Inoue, 1980; Beerhues et al., 1999). 
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Scheme 1. Formation of trihydroxyxanthone from shikimic acid. 
 
The reaction mechanism of the regioselective intermolecular cyclization of the 
2,3,4,6-tetrahydroxybenzophenone is likely to involve two one-electron oxidation 
steps. The first one-electron transfer and a deprotonation yield a phenoxy radical in the 
B-ring, which cyclizes the benzophenone by an electrophilic attack to give a hydroxyl-
CoA
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cyclohexadienyl radical. This radical loses an electron and a proton to form a 
xanthone, as shown in Scheme 2 (Peters et al., 1998). 
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Scheme 2. The reaction mechanism of the regioselective intermolecular cyclization 
of the 2,3,4,6-tetrahydroxybenzophenone. 
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An alternative biosynthesis of xanthone in cell cultures of Hypericum androsaemum 
has been determined. The condensation of benzoyl-CoA with three molecules of 
malonyl-CoA gives 2,4,6-trihydroxybenzophenone, which is hydroxylated at C-3 by 
the presence of benzophenone-3-hydroxylase to yield 2,3,4,6-
tetrahydroxybenzophenone. The 3-hydroxy group is essential for the oxidative 
phenolic coupling reaction catalysed by xanthone synthase, as shown in Scheme 3 
(Schmidt and Beerhues, 1997). 
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Scheme 3. Biosynthesis of 1,3,7-trihydroxyxanthone in cell cultures of H. androsaemum. 
 
Another demonstrated biosynthetic pathway in the formation of plant xanthones 
involves intermediate glucosidation at an early stage of benzophenone biosynthesis 
before cyclization of the two rings. This pathway has been found in the herb 
Hypericum annulatum, in which 2,3,4,6-tetrahydroxybenzophenone-2-O-glucoside 
has been confirmed to be a precursor of 1,3,7-trihydroxyxanthone. The glucoside 
undergoes acidic or enzymatic hydrolysis and subsequent dehydration of the hydroxyl 
groups from phloroglucinol rings A and B in the ortho position to the carbonyl group 
to give the xanthone. This would confirm the hypothesis that some xanthones are 
formed in plants by dehydration of 2,2-dihydroxybenzophenone, see Scheme 4 
(Kitanov and Nedialkov, 2001). 
SCoA
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Scheme 4. Formation of plant xanthones involves intermediate glucosidation. 
 
Xanthones occurring in fungi, such as Aspergillus strains, have a complex 
biosynthesis. They are proposed to be formed via an anthrone or anthraquinone 
intermediate derived from eight acetate units as shown in Scheme 5 (Holker et al., 
1974). In 1975, Birch et al. has proved that polyketides are the biosynthetic precursors 
of xanthones for fungi by feeding experiments with radiolabeled acetate. 
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Scheme 5. Formation of xanthones from fungi. 
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In 2005, Henry and Townsend reported the generation of sterigmatocystin through 
an enzyme-catalysed sequence of epoxidation, rearrangement, deoxygenation, Bayer-
Villiger oxidation and further decarboxylation of versicolorin A, an anthraquinone 
derivative from Aspergillus strains, see Scheme 6 (Henry and Townsend, 2005). In 
2012, Simpson has described the biosynthetic pathway of shamixanthone via key steps 
of oxidative ring-scission, ring-closure and reduction of emodin, which are catalysed 
by synthase enzymes in Aspergillus nidulans, see Scheme 7 (Simpson, 2012). 
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Scheme 6. Biosynthetic pathway of sterigmatocystin in Aspergillus strains.  
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Scheme 7. Biosynthetic pathway of shamixanthone in Aspergillus nidulans.  
 
As displayed above, xanthones in both plants and fungi are formed from 
benzophenone intermediates, which are generated from two distinct pathways. 
Therefore, the pattern of oxidation between them also differs. Fungal xanthones almost 
have hydroxylation at C-1 and C-8, whereas those in plants frequently display 1,3,5- or 
1,3,7-hydroxylation (Wezeman et al, 2014). The aromatic ring system of xanthones 
may be substituted with a variety of prenyl, hydroxyl and methoxyl groups that form a 
large number of possible structures. Prenyl groups can be modified by hydroxylation, 
oxidation or cyclization with adjacent hydroxyl groups via nucleophilic attack to give 
tetra- or penta-cyclic xanthones, see Scheme 8 (Dewick, 2009). 
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Scheme 8. Cyclization of prenyl groups with adjacent hydroxyl groups.  
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Different hypotheses have been proposed for the biosynthetic conversation of 
simpler xanthones into the more complex caged structures (Dakanali and Theosorakis, 
2011). In the first one, a xanthone is prenylated at an early stage at C-5 and C-7 
positions. An oxidation-reduction-oxidation sequence of the prenylated xanthone gives 
an intermediate, which can be cyclized by a nucleophilic attack of the hydroxyl group 
at C-5 on the prenyl group at C-7 to form the caged structure (Kartha et al, 1963) as 
showed in Scheme 9 (A). The second one has been proposed for the generation of the 
caged motif via a Claisen rearrangement followed by a Diel-Alder reaction on the 
intermediate dienone as illustrated in Scheme 9 (B, Quillinan and Scheinmann, 1971). 
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Scheme 9. Two hypotheses regarding the formation of caged xanthones.  
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Mono xanthones can be linked to generate dimeric or trimeric types by a variety of 
ways: a rotatable or atropisomeric biaryl C-C bond, a biaryl ether C-O-C linkage, aryl-
O-alkyl linkages and prenyl derivative-prenyl derivative linkages. Although the 
biosynthesis of dimeric xanthones has been studied for some compounds, until now it 
is still unclear, particularly regarding the involvement of enzymes. The common way 
of xanthone dimerization found in plants, bacteria, lichens and fungi is the biaryl 
linkage as proposed in Scheme 10. First, a hydroxy group deprotonates to give an 
electron-negative intermediate. This can be easily oxidized by single-electron-transfer 
to a xanthonyl radical, which then forms aryl radicals by resonant effects. Radicals can 
couple to electron-donors at the ortho and para positions to give dimers (Wezeman et 
al, 2014).  
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Scheme 10. Common formation of dimeric xanthones. 
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Bisxanthones which have been found in some plants of the family Gutttiferae 
(Clusiaceae) are mostly generated by aryl-O-alkyl or prenyl derivative-prenyl 
derivative linkages, for example cratoxyxanthone from Cratoxylum cochinchinese and 
griffipavixanthone from Garcinia griffithii (Sia et al., 1995; Xu et al., 1998). A 
possible biosynthetic pathway of cratoxyxanthone was proposed via the coupling of 
two mangostin-derived radicals, see Scheme 11. Meanwhile the biosynthesis of 
griffipavixanthone was suggested to involve an initial Diels-Alder reaction of two 
prenyl groups of the two xanthones to provide a cyclohexene derivative and this one is 
followed by another ionic or radical cyclization to give a fused 5-membered ring as 
shown in Scheme 12. 
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Scheme 11. Proposed biosynthesis of cratoxyxanthone. 
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Scheme 12. Proposed biosynthesis of griffipavixanthone. 
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3.2. Biosynthetic pathway of biflavonoids 
Biflavonoids are dimers of flavonoids linked by a C-C or C-O-C bond at different 
positions in flavonoid skeletons to give a large number of possible structures. 
Monomers can be flavans, flavones, flavonols, flavanones, flavanonols, chalcones, 
aurones, isoflavonoids or even neoflavonoids. Biflavonoids can be formed by two 
identical or non-identical units of flavonoids in a symmetrical or asymmetrical type 
(Mercader and Pomilio, 2012). Ginkgetin was the first biflavonoid found in nature. 
This compound was isolated from the leaves of Ginkgo biloba by Furukawa in 1929 
(Baker and Simmonds, 1940). Nowadays, the number of biflavonoids continually 
increases. Though the biosynthetic pathway of flavonoids has been well established, 
the formation of natural biflavonoids has not been thoroughly identified. It was 
proposed to concern a radical dimerization (Geiger and Quinn, 1975). Up to date the 
enzymatic dimerization of the monomeric units has not been observed yet. Chalcones 
derived from the shikimate pathway are showed to be precursors of different classes of 
flavonoids, see Scheme 13. L-Phenylalanine, which is generated from shikimate, is 
deaminated by phenylalanine deaminase to yield (E)-cinnamic acid. This acid is 
subsequently transformed into 4-coumaroyl-CoA by enzyme-catalysed hydroxylation 
and reduction of HSCoA. The chain extension of 4-coumaroyl-CoA with three 
malonyl-CoA via Claisen condensation forms a polyketide intermediate which can be 
folded to give naringenin chalcone (chalcones). This chalcone can undergo oxidation 
and nucleophilic attack to afford aureusidin (aurones). An internal Michael-type 
nucleophilic attack of naringenin chalcone also produces naringenin (flavanones). This 
key flavanone may undergo radical oxidation, rearrangement and dehydration to give 
daidzein (isoflavonoids). Moreover naringenin may be transformed into apigenin 
(flavones) by oxidation (hydroxylation) and dehydration at C-2/C-3 or hydroxylated at 
C-3 to yield aromadendrin (flavanonols) and further oxidized to form kaempferol 
(flavonols) as shown in Scheme 14. Leucopelargonidin (flavandiols) can be generated 
by ketone-elimination of aromadendrin. This flavandiol may be transformed into 
afzelechin (flavanols) by dehydroxylation at C-4 or undergo a series of oxidation and 
dehydration to yield pelargonidin (anthocyanidins) (Harborne, 1998; Velisek et al., 
2008; Dewick, 2009).  
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Biflavonoids was proposed to be formed from the radical dimerization of 
monomeric flavonoids. Because flavonoids are phenolic compounds, they are 
susceptible to one-electron oxidation to generate radicals. Theoretically, one-electron 
oxidation can occur in any type of flavonoids. Geiger and Quinn suggested that 
chalcones, the precursors of flavonoids, undergo one-electron oxidation to afford a 
series of appropriate radicals which may couple to form biflavonoids as illustrated in 
Scheme 15 (Geiger and Quinn, 1975). The removal of a phenol proton brings about an 
oxygen free radical, which can be stabilized by delocalization. This key radical in turn 
generates radicals (a-e). In principle, those radicals can freely couple to produce 
biflavonoids. However not all dimers have been found to exist in nature so far. There 
are around twenty four types of simple biflavonoids identified to date, see Table 3 and 
Figures 23-26 (Mercader and Pomilio, 2012). 
62  Bisosynthesis of xanthones and biflavonoids 
 
 
OOH
HO OH OH
OOH
O OH OH
OOH
O OH OH
OOH
HO OH O
Naringenin chalcone a
bc
OOH
HO OH O
d e
OOH
HO OH O
OOH
HO O
OH
OH
Eriodyctiol
OOH
HO O
O
OH
OOH
HO O
O
OHOH
OOH
HO O
O
gh
f
 
 
Scheme 15. Formation of flavonoid radicals.  
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Table 3. Combination of flavonoid radicals to form simple biflavonoids 
Combination 
of radicals 
Type of 
linkage 
Example 
e + e I-3, II-3 Chamaejasmenin derivatives from the roots of 
Stellera chamaejasme (Yang et al, 2005) 
e + b I-3, II-6 Stephaflavones from Stephania tetrandra and 
Ridiculaflavones from Aristolochia ridicula (Si et al., 
2001; Machado and Lopes, 2005) 
I-3, II-8 Garcinia biflavones (Jackson et al., 1971) 
e + d I-3, II-3 Taiwaniaflavones from the leaves of Taiwania 
cryptomeriodides (Gadek and Quinn, 1985) 
b + b I-6, II-6 Succedaneaflavones from the drupes of Rhus 
succedea (Lin et al., 1997)  
I-6, II-8 Agathisflavones from the genus Agathis (Ofman et 
al., 1995) 
I-8, II-8 Cupressusflavones from the genus Cupressus (Gardek 
and Quinn, 1985) 
g + b I-2, II-6 Dicranolomins from the gametophytes of 
Dicranoloma robustum (Markham et al., 1988) 
I-2, II-8 Philonotisflavones from the gametophytes of 
Philonotis fontana (Geiger and Bokel, 1989) 
h + h (g + g) I-2, II-2 (22)-Biapigenin from Garcinia nervosa (Parveen 
et al., 2004) 
d + b I-3, II-6 Robustaflavones from the genus Selaginella (Lin and 
Chou, 2000) 
I-3, II-8 Amentoflavones from the family Guttiferae (Abe et 
al., 2004) 
 I-3, II-7 Lophirone M from the leaves of Lophira alata 
(Murakami et al., 1992) 
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Table 3. (continued) 
h + b I-6, II-6 Hegoflavones from the fronds of Alsophila spinulosa 
(Wada et al., 1985) 
h + h I-5, II-5 (I-5,II-5)-Bisdihydroquercetin from the bark of 
Pseudotsuga menziesii (Lai et al., 1992) 
e + c I-3 ,O, II-4 Delicaflavone from the aerial parts of the Selaginella 
delicatula (Lin and Chou, 2000) 
b + a I-6 ,O, II-7 Masazinoflavanone from the leaves of Rhus tripartitum 
(Mahjoub et al., 2005) 
 I-6 ,O, II-8 (I-6,O,II-8)-Biapigenin from the leaves of Viburnum 
cotinifolium (Muhaisen et al., 2002) 
d + c I-3, O, II-4 Ochnaflavones from the genus Ochna (Reddy et al., 
2008) 
d + a I-3, O, II-7 Lophirone L from the leaves of Lophira alata (Tih et 
al., 1992) 
c + b I-4 ,O, II-6 Hinokiflavone from Thuja javanica (Roy et al., 1985) 
I-4, O, II-8 Lanaroflavone from the whole plant of Lanaria lanata 
(Dora and Edwards, 1991) 
 I-4, O, II-4 Loniflavone from Lonicera japonica (Kang, 2005) 
 I-8,CH2, II-8 Pentagrammetin from Pentagramma triangularis 
(Roitman et al., 1993) 
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Figure 23. Examples of different types of simple biflavonoids. 
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Figure 24. Examples of different types of simple biflavonoids (continued) 
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 Figure 25. Examples of different types of simple biflavonoids (continued)  
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Figure 26. Examples of different types of simple biflavonoids (continued)  
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4. MATERIAL AND METHODS 
 
4.1. General experimental procedures 
Extraction was carried out using a sohxlet system of 1000 ml (Ducan). Thin layer 
chromatography (TLC) was performed using silica gel 60 F254 and RP18 F254 pre-
coated aluminium sheets (Merck, 0.2 and 2.0 mm). TLC plates were visualized by UV 
light (CAMAG) at 254 nm and 366 nm after sprayed with anisaldehyde/sulphuric acid 
reagent (anisaldehyde, 2 ml; H2SO4 98%, 10 ml, AcOH, 16 ml and MeOH, 170 ml) 
and heated on a thermoplate (Desaga). The solution of FeCl3 in methanol was used for 
detecting phenolic compounds. Open column chromatography (CC) was carried out on 
silica gel (Merck, 63 – 200 µm) using glass columns of various dimensions. Gel 
permeation chromatography (GPC) was performed on Sephadex LH-20 (GE 
Healthcare) with MeOH or MeOH – CHCl3 3:7 as eluent. Flash chromatography (FC) 
was performed on an Armen Instrument Spot System with columns: SVF D26 (26 x 
110 mm) and SVP D40 (4- x 160 mm) on silica gel 60 (Merck, 63 – 200 µm). 
Centrifugal partition chromatography (CPC) was carried out using an Armen Spot 
Centrifugal Partition Chromatography SCPC-250 with the solvent system HEMWat 
(n-hexane/ethyl acetate/methanol/water) as eluent. All solvents used for TLC, CC, 
GPC, FC and CPC were p.a. (pro analysis, Merck). Semi-preparative HPLC 
separations were performed on a Varian ProStar 210 solvent delivery module equipped 
with a Varian Prostar 335 photodiode array detector. Two prepacked columns, Varian 
Dynamax Pursuit XRs C18 of 21.4 x 250 mm and Eclipse XDB-C18 of 9.4 x 250 mm 
(HP), were used for RP18 HPLC. All solvents used were HPLC grade (Merck).  
1D and 2D NMR spectra were measured using a Bruker ADVANCE 600 
spectrometer (600 MHz for 1H and 150 MHz for 13C) or 400 spectrometer (400 MHz 
for 1H and 115 MHz for 13C) with tetramethylsilane (TMS) as an internal standard and 
CDCl3 or acetone-d6 (Deutero GmbH) as the solvent. The spectra were processed 
using the NMR softwares: MestReNOva 6.0.2-5475 (Mestrelab Research) and 
Topspin 3.1 (Brucker). High-resolution mass spectra were measured on a Finnigan 
MAT SSQ 710 A spectrometer at 70 eV (HRESIMS, positive mode) or recorded on an 
Agilent 6540 UHD (HRESIMS, positive and negative mode). UV spectra were 
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obtained by the Varian Prostar 335 photodiode array detector of the HPLC system. 
Optical rotation was recorded using an UniPol L1000 polarimeter (Schmidt & 
Haensch). 
The MEM-Earle (0.85 g/l NaHCO3, Biochrom) supplemented with 1% of L-
glutamine (200 mM), 10% of fetal bovine serum and 1 % of non-essential amino 
(Biochrom) were used for culture of HeLa cells (ATCC CCL17). The medium ECGM 
(Porvitro GmbH) with supplement mix and antibiotics (Porvitro GmbH) were used for 
HMEC-1 cells (CDC). The incubation was carried out in a NU-5500E incubator 
(NUAIRE). Cell-counting was performed using a neubauer improved haemocytometer 
(Brand) and a CK X 41 SF microscope (Olympus). A Megafuge 1.0 centrifugal 
(Heraeus Sepatech) was used for centrifugation. Autoclaving was carried out using an 
Autoklav 23 (Melag) or a Varioklav 500 (H+P). All the pipettes used were from 
Eppendorf. Tris(4-dimethylaminophenyl)methyliumchlorid (crystal violet) was 
obtained from Merck. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide 
(MTT) and 3,3′-Dimethyl-4,4′-bis(5-amino-4-hydroxy-2,7-disulfonaphtyl-3-azo)-[1,1′-
biphenyl] dye were from Sigma-Aldrich. The optical density was measured at 560 nm 
using a SpectraFlour Plus microplate reader (Tecan). Cytotoxicity and proliferation 
assays were performed in 96 well plates (TPP). 
 
4.2. Extraction, fractionation and isolation 
 
4.2.1. Material of plant 
The bark of Garcinia fusca Pierre was collected in Binh Phuoc Province, south 
Vietnam in January 2011 and was identified by Mr Dang Van Son, Institute of 
Tropical Biology, Ho Chi Minh City. A voucher specimen (Hieu-GF-01/2011) is 
deposited in the Natural Product and Medicinal Chemistry Lab, Ho Chi Minh City 
University of Sciences. The bark was air-dried and ground into powder. 
 
4.2.2. Extraction of plant material 
The powder of the bark of G. fusca Pierre (1.95 kg) was first exhaustively extracted 
with 3.0 L of n-hexane by using a soxhlet system (1000 ml), a form of solid-liquid 
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extraction. The solvent was heated to reflux and successively percolated the material. 
The extraction of n-hexane was done until the liquid passing through the material was 
colourless. The residue of material was subsequently extracted with the same volume 
of ethyl acetate. After extraction the solvents were removed by a rotary evaporator to 
yield the crude extracts of n-hexane and ethyl acetate, which were shortly named as 
GFH (G. fusca n-hexane extract) and GFE (G. fusca ethyl acetate extract), 
respectively. 
 
4.2.3. Fractionation of crude extracts 
The n-hexane extract (GFH, 90.5 g) was divided into two portions. Each portion 
was subjected to an open CC using a column of 10 x 40 cm dimension, 800 g of silica 
gel as stationary phase and a solvent system of acetone and petroleum ether (0-100%) 
as mobile phase to give 30 fractions (500 ml of each). On the basis of TLC, identical 
fractions were combined to afford 8 main fractions which were shortly named GFH-1 - 
8. The ethyl acetate extract (GFE, 112.3 g) was also split into two portions which were 
in turn applied to CC with the same column and amount of silica gel using a gradient 
elution of acetone and petroleum ether (0-100%) to produce 35 fractions (500 ml of 
each). The combination of similar fractions was also based on TLC to give 8 main 
fractions (GFE-1 - 8). 
 
4.2.4. Isolation of substances from fractions 
Chromatography is one of the powerful methods for the separation and purification 
of natural products. It is based on the distribution of a component between two phases 
- a moving one (mobile phase) that is passed over an immobile phase (stationary 
phase). Components will be released by the mobile phase at various rates because of 
their different affinities with the stationary phase. A variety of chromatography 
methods are widely used for the isolation of natural products such as adsorption, 
partition, ion-exchange and permeation chromatography. Mobile phase can be either 
gas or liquid. For the isolation of compounds from G. fusca Pierre, the adsorption, 
partition and permeation chromatography were used. The general strategy of the 
isolation and structural elucidation of substances is shown in Scheme 16.  
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Scheme 16. The general strategy of the isolation and structural elucidation of 
substances from G. fusca Pierre 
 
4.2.4.1. Thin layer chromatography (TLC) 
TLC was used to select appropriate solvent systems for the CC of fractions based on 
their Rf (retardation factor) values. The Rf value refers to the distance that a compound 
moves in chromatography relative to the solvent front. It can be calculated by the 
following formula (Braithwaite and Smith, 1996). 
 
Formula 1: Calculation of retardation factor (Rf) 
Rf = 
Distance travelled by compound
Distance travelled by solvent front  
Sub-fractions 
Flash CC on silica gel 
or GPC on Sephadex LH-20 
or CPC 
GPC Sephadex LH-20 
or CPC 
Sub-fractions 
Pure compounds 
Semi-preparative HPLC on RP18 
silica gel 
or preparative TLC on silica gel 
Sub-fractions 
Pure compounds 
Semi-preparative HPLC on RP18 
silica gel 
or preparative TLC on silica gel 
Structural elucidation using spectroscopic methods 
Cytotoxic assays 
Crude extract 
Fractionation using open CC on silica gel 
Fractions ˃ 5 g Fractions < 5 g 
Open CC on silica gel 
Sub-fractions 
Flash CC on silica gel 
72   Material and methods 
 
A suitable solvent system should give useful Rf values of between 0.3 and 0.7, i.e., a 
compound can be separated from other components without staying at or so close to 
the original point or with the solvent front. The separation between two compounds is 
possible with an Rf value (the difference between two Rf values) of at least 0.2-0.3 
(Braithwaite and Smith, 1996). TLC is also used to determine two identical 
compounds relying on their Rf values in the same solvent system or for the 
combination of similar fractions. It is even used to show the relative number of 
components existing in a given fraction or if an isolated substance was pure. Moreover 
TLC is also applied to identify types of compounds in extracts or fractions based on 
their physical and chemical properties with ultraviolet (UV) and typical reagents 
(Gibbons, 2006).  
In the present work, aluminium sheets coated by silica gel or reverse phase silica 
C18 of 0.2 mm thickness with fluorescent indicator (Merck) were used for TLC. 
Samples were applied on the plate via a micropipette with a volume of 0.5 µl and a 
concentration of 5 mg/ml. For the selection of suitable eluent of CC, the plates were 
developed with different solvent systems. After the development, the location of 
compounds was detected using UV or chemical reagents. Coloured substances are 
easily visible to naked-eyes as separate spots, whilst colourless ones require chemical 
or physical methods. Substances having an enone or a benzene ring are detectable with 
UV. Therefore they can be visualized by UV when irradiated at 254 nm. The plates 
contain a fluorescent indicator which absorbs light at 254 nm and re-emits at the green 
end of the spectrum, thus if a substance absorbs at 254 nm, it will be detectable as a 
dark spot against the green background. Methanolic ferric chloride (FeCl3/MeOH) 
reagent was used to detect phenolic compounds as dark green spots. Compounds 
which are not detectable with UV could be visualized by spraying the plate with 
anisaldehyde-H2SO4 reagent or sulphuric acid 10%. The plate was heated after 
spraying at 100-105ºC until the colours have totally occurred. Depending on the 
structure of compounds, the colours of spots changed from pink to dark brown. After 
heated, substances were also detected by UV at 366 nm as light spots against the dark 
violet background. 
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4.2.4.2. Preparative TLC 
 The practice of this technique is similar to that of qualitative analysis but differs in 
the thickness of plates. They are principally coated by 1-5 mm of adsorbent for using 
in the preparation of large sample quantities (10-100 mg). Pre-coated glass plates of 2 
mm thickness (Merck) and 20 x 20 cm dimension with fluorescence indicator were 
used for the present work. The adsorbent was silica gel 60 (63-200 µm). The sample 
was dissolved in acetone (5 mg/ml) and applied onto the plate as a streak by a pasteur 
pipette. The chromatography was carried out in a glass tank of 22 x 22 cm with 100 ml 
of a suitable solvent system. A filter paper of 20 x 20 cm was soaked with the solvent 
and put into the tank to keep the internal atmosphere saturated with solvent vapour. 
After the development was complete, the plate was dried and the bands of substances 
were detected by UV at 254 nm. The bands were then scraped off with a spatula and 
the substance was washed out of the adsorbent by acetone. The pure substance 
obtained after the removal of acetone was structurally determined by spectroscopic 
techniques. 
 
4.2.4.3. Open column chromatography 
Open CC using silica gel as an adsorbent is one of traditional forms of adsorption 
chromatography. This is a simple and low cost CC technique. Fractions were subjected 
to open CC by using simple glass columns of various dimensions depending on the 
amount of sample. The stationary phase was silica gel 60 (Merck, 63-200 µm) and the 
mobile phase was the appropriate solvent systems selected by TLC. The column was 
packed by wet-column method, in which silica gel was soaked in the solvent with the 
ratio of 0.5 mg/ml before poured into the column. The quantity of silica gel used was 
fifty times of the sample amount. The packed column was equilibrated by at least two 
bed volumes of the solvent before the sample adsorbed on silica gel was applied onto 
the top of the packed column. Afterwards the ready column was eluted by a gradient 
elution. The solvent runs through the column under the influence of gravity. The 
chromatography was carried out within 3-7 hours and the eluent containing separated 
components was collected in test tubes or conical flasks. Collected fractions were 
subsequently applied to TLC for combination.  
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4.2.4.4. Flash chromatography 
The standard method of flash chromatography (FC) is based on the report of Still in 
1978 (Still et al., 1978). This is a rapid column chromatography technique using a 
narrower packing than classical CC and a slightly increased over-pressure to achieve 
adequate flow-rates. The technique is much efficient for the separation of components 
with Rf values of less than 0.2. It is suitable for sample loads ranging from 10 mg to 
10 g depending on the difference of Rf values (Braithwaite and Smith, 1996). The flash 
chromatography system used in the present work is Spot Liquid Chromatography 
Flash (Armen Instrument). Plastic columns of 26 x 110 mm (SVF D26-Si60) or 40 x 
160 mm (SVP D40-Si60) were tightly packed with silica gel 60 (63-200 µm) without 
solvent. The packed column was subsequently eluted with solvent by a mini pressure 
of maximum 7 bar until it was homogeneous without air-bubbles. The sample 
adsorbed on silica gel was then applied onto the top of the column. The column SVF 
D26-Si60 was used for the sample quantity of 0.3-1.5 g, whilst the column SVP D40-
Si60 was suitable for 0.9-4.5 g of the sample. The elution was a gradient with the 
flow-rate of 10-30 ml/min and the eluent was automatically collected in test tubes. The 
chromatography was controlled by the built-in UV detector at 290 nm. The 
combination of collected fractions was based on the result of TLC. 
 
4.2.4.5. Size-exclusion chromatography 
Size-exclusion chromatography or gel filtration is one of the permeation 
chromatographic methods, in which gels or polymers are used as stationary phase and 
the separation of uncharged compounds is based on the relative size or mass of 
molecules, i.e., large components leave the column first followed by smaller ones in 
order of their decreasing size. This technique was first performed in 1954 by Mould 
and Synge and the systematic use of the principle was introduced in 1959 by Porath 
and Flodin (Braithwaite and Smith, 1996). In this work, Sephadex LH-20 (GE 
Healthcare) was used as the stationary phase and the mobile phase was methanol or a 
mixture of methanol and chloroform of 3:7 by volume. Sephadex LH-20 is a 
hydroxypropylated polysaccharide developed for gel filtration and CC of natural 
products in the range of 100-5000 molecular weight. In the experiment, the gel was 
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suspended in the solvent of 4.0 ml/g before poured into an appropriate glass column 
depending on the amount of sample. The packed column was stationary in at least 
three hours for full swelling of the gel and afterwards equilibrated with three bed 
volumes of the solvent. The sample was dissolved in the solvent before applied onto 
the packed column in such a way that the sample volume was 5% of the total bed 
volume. The ready column was then eluted with a flow rate of 0.5 ml/min. The solvent 
flows through the column under the influence of gravity. The eluent was manually 
collected in test tubes. The fractions were then combined into sub-fractions based on 
TLC. 
 
4.2.4.6. Centrifugal partition chromatography 
Centrifugal partition chromatography (CPC) is a liquid-liquid chromatographic 
technique originally pioneered by Ito in 1964 (Ito, 1970). The principle of this 
technique is based on the different partitions of components between two immiscible 
liquid phases. Each one has a specific partition (distribution) coefficient (Kd) defined 
by the following formula (Kumar et al., 2014). 
 
Formula 2: Calculation of partition coefficient (Kd) 
Kd = 
[X]upper
[X]lower  
 
For a given compound X, at the equilibrium of two liquid phases and for a given 
temperature:  
[X]upper
 = the concentration of X in the upper phase 
[X]lower = the concentration of X in the lower phase 
 
CPC functions with one of two liquid phases used as stationary phase and the other 
one as mobile phase. The column system consists of a series of channels linked in 
cascade by ducts and aligned in cartridges or disks in a circle around a rotor. The 
liquid stationary phase is fed into the column and held in channels by the centrifugal 
force generated by the spinning rotor. The liquid mobile phase containing the 
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components of the sample is then pumped through the column. The separation is 
achieved as a function of the specific partition coefficient (Kd) of each component. For 
the ideal separation of the components, the solvent system should result in a partition 
coefficient of 1. However based on practical experiments, 0.2 < Kd < 5 can be used 
without excessive elution and broadening band (Wilson, 2012). Many strategies for 
selection of solvent system have been reported in literature. Foucault suggested that 
there should be a solvent that is soluble in the other solvents of the solvent system and 
this solvent should completely dissolve the sample (Foucault, 1995) 
For this research, the CPC system used is Spot Centrifugal Partition 
Chromatography SCPC-250 (Armen). The solvent system of HEMWat (n-
hexane/ethyl acetate/methanol/water) was selected with an appropriate ratio so that the 
partition coefficient is between 0.2 and 5. Two modes of the CPC used for the 
separation are descending mode in which the lower phase is the mobile phase and 
ascending mode in which the upper phase is the mobile phase. For the 
chromatography, the sample amount of 1 g was dissolved in 10 ml of a mixture 
containing 50% of mobile phase and stationary phase. The speed of the rotor was 1000 
U min-1 and the flow rate of elution was 5 ml/m. The eluent containing separated 
components was automatically collected in test tubes. At first, the column was fed 
with the lower phase. The upper phase was subsequently pumped through the column 
until the equilibration was established. The sample volume of 10 ml was then ejected 
into the equilibrated column. The upper phase passes through the column and elutes 
separated components. After 60 minutes of the chromatography, the ascending mode 
was switched into descending mode, i.e., the lower phase was at that moment used as 
the mobile phase. The chromatography was carried out within at least two hours. 
Collected fractions were subsequently applied to TLC for combination. 
 
4.2.4.7. Semi-preparative high performance liquid chromatography 
High performance liquid chromatography (HPLC) is a column chromatographic 
technique using a small particle size packing and a large pressure elution in order to 
get a high performance of separation. In 1967, Horvath et al. set up one of the first 
practical HPLC systems for their research on nucleotides (Braithwaite and Smith, 
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1996). Nowadays HPLC is widely used for qualitative and quantitative analysis as 
well as preparation of natural or synthetic compounds. In the present work, semi-
preparative HPLC was used for the isolation and purification of substances is a ProStar 
system (Varian) consisting of an auto-sampler, two pumps with maximum pressure of 
400 bar, a diode array detector (DAD) and a fraction collector. Two pre-packed 
columns were used for the preparation are Dynamax Pursuit XRs C18 of 21.4 x 250 
mm and Eclipse XDB-C18 of 9.4 x 250 mm. Both columns were packed with RP18 
silica of 5 µm. The former was used for the sample amount of 10-20 mg and the flow 
rate of maximum 20 ml/m, whilst the later was used for that less than 10 mg of the 
sample and the flow rate of maximum 6 ml/min. The solvent system of water and 
acetonitrile was selected for the elution. The sample was dissolved in acetonitrile with 
the ratio of 10 mg/ml before injected into the column. The preparation time was 
around 30-40 minutes and the separation was monitored by UV. The purified 
substances were then structurally identified using spectroscopic techniques such as 1D 
and 2D NMR, UV and mass spectrometry. 
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4.3. Structural elucidation of isolated compounds 
Spectroscopic and spectrometric methods are considered as effective and useful 
tools for the structural identification of natural products. These include ultraviolet - 
visible (UV-vis), infrared (IR), nuclear magnetic resonance (NMR), X-ray, circular 
dichroism (CD) and mass spectrometry. A molecular structure including the relative 
and the absolute configurations can be completely determined by the combination of 
these methods. In this work, the structural determination of the new natural 
compounds was mainly performed by one (1D) and two dimensional (2D) NMR 
spectroscopy associated with UV and mass spectroscopy as well as optical rotation. 
The steps of the structural elucidation was executed in succession as follows 
- Identification of the class of substance based on 1H NMR and UV spectra. 
- Calculation of unsaturation degree or hydrogen deficiency index and 
establishment of the molecular formula from data of 13C NMR and mass spectra. 
- Analysis of skeletal connectivity to accomplish the covalent structure relying on 
2D NMR spectra such as HMQC, HMBC and COSY. 
- Determination of the relative stereochemistry using NOESY or ROESY 
spectroscopy and optical rotation. 
 
4.3.1. Ultraviolet-visible spectroscopy 
As the electromagnetic radiation in the ultraviolet and visible region (190-800 nm) 
passes through a transparent substance, a portion of the radiation may be absorbed in a 
form of energy which can make electrons in molecules move from a state of low 
energy (ground state) to a state of higher energy (excited state). The absorbed energy 
is exactly equal to the energy difference between these two states. Once that happens, 
the residual radiation is recorded by a detector to give a spectrum which is called an 
absorption spectrum. The possible transitions of electrons are from the  or 
nonbonding (n) orbitals to unoccupied or anti-bonding orbitals (* and *). The UV-
vis spectrum is basically recorded as a plot of absorbance (A, mAU) versus 
wavelength (, nm). The absorbance obeying the Beer-Lambert Law can be calculated 
for a given wavelength by the following formula (Pavia et al., 2009) 
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Formula 3: Calculation of absorbance (A) 
 
 
A = absorbance 
I0 = intensity of light incident upon sample cell 
I = intensity of light leaving sample cell 
c = molar concentration of solute 
l = length of sample cell (cm) 
 = molar absorptivity 
 
The appearance of several peaks of absorbed maximum wavelengths (max) in the 
UV-vis spectrum is caused by conjugated systems and electronic transitions between 
the different vibrational and rotational energy levels for each electronic state. The max 
values are useful for the structural elucidation and those of conjugated systems such as 
diens or enones can be predicted by Woodward’s rules for the * transition. Each 
type of compound gives specific absorption bands. For examples, carotenoids 
commonly show three distinct peaks between 400 and 500 nm in methanol, whilst 
biflavonoids perform two peaks at 260-290 nm and 320-340 nm. Xanthones give four 
different peaks at 230-245, 250-265, 305-330 and 340-400 nm (Harborne, 1998). In 
the present work, the UV spectra of the isolated compounds were measured in the 200-
420 nm region by the diode array spectrophotometer of Prostar HPLC system. 
 
4.3.2. Mass spectrometry (MS) 
A substance can be transformed into gas phase ions by various ionization methods. 
These ions are then accelerated by an electromagnetic field, separated by their mass-
to-charge (m/z) ratio and counted by a detector. The signal is recorded and output as a 
graph of the number of ions detected versus their m/z ratio, called a mass spectrum. 
Common ionization methods can be divided into three main groups, viz gas-phase, 
desorption and evaporative ionization. The gas-phase ionization including electron 
impact (EI) and chemical ionization (CI) methods is suitable for volatile and small 
organic molecules. The desorption ionization consists of three methods: secondary ion 
A = log(I0/I ) = .c.l 
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mass spectrometry (SIMS), fast atom bombardment (FAB) and matrix-assisted laser 
desorption ionization (MALDI). The evaporative ionization comprising thermo-spray 
(TS) and electro-spray (ES) methods, along with desorption, are appropriate for non-
volatile and large molecules, especially peptides and proteins (Pavia et al., 2009). 
There are two significant categories of mass spectrometers, low resolution and high 
resolution. High resolution mass spectrum (HRMS) can determine an extremely 
precise m/z value up to four or five decimal numbers, i.e., only one rational molecular 
formula will fit the data especially in combination with 1H and 13C NMR data. In the 
present work, the molecular weight and the molecular formula of new compounds 
were obtained from electrospray ionization- high resolution spectra (ESI-HRMS) 
which were measured by the instrument Q-TOF 6540 UHD (Agilent). In ESI, the 
sample in solution is sprayed out from a capillary into a heated chamber at nearly 
atmospheric pressure. The tip of the capillary is maintained a high voltage potential of 
2-5 keV to expel the sample molecules in charged droplets into the ionization 
chamber. The charged droplets are subjected to a counter-flow of a nebulizing gas that 
evaporates solvent molecules from the droplets until solvent-free sample ions are 
released in the vapour phase. These ions will then pass through the high resolution 
mass spectrometer to yield a HRESI-MS. With this ionization method [M+H]+, 
[M+Na]+ or [M+K]+ ions are produced but fragmentation is rare (Silverstein et al., 
2005). For a compound of general formula CaHbNcOdXe in which X is a halogen atom, 
the degree of unsaturation can be calculated by the following formula 
 
Formula 4: Calculation of degree of unsaturation 
Degree of unsaturation  =
(2 + 2a - b + c - e) 
2  
 
a = number of carbon atoms  b = number of hydrogen atoms 
c = number of nitrogen atoms   e = number of halogen atoms 
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4.3.3. Nuclear magnetic resonance spectroscopy  
Nuclear magnetic resonance (NMR) has been shown to be a powerful spectroscopic 
method for the structural determination of natural products, especially novel 
compounds sometimes possessing unusual or unprecedented structures. It has become 
the main choice for the establishment of chemical structures, particularly when X-ray 
crystallography is inapplicable. Nowadays modern NMR spectroscopy can be 
performed by high magnetic spectrometers of up to 900 MHz which allow to 
accomplish multi-pulsed and multidimensional experiments with a small sample 
amount of under 0.5 mg. Nuclei have an angular momentum described by a spin 
quantum number I, which gives 2I+1 of allowed spin states with integral differences 
ranging from +I to –I. Each spin state possesses a corresponding energy level when a 
nucleus with I  0 is immersed in a magnetic field of strength B0. A spectroscopic 
transition may occur between these levels by the absorption of electromagnetic 
radiation of appropriate frequency in accordance with the following equation (Pavia et 
al., 2009) 
 
Formula 5: The equation of energy difference of nuclei in a magnetic field  
 
 
 
 
E = the energy difference between the possible spin states 
 = the frequency of the absorbed electromagnetic radiation which is usually in the 
radiofrequency region of ca. 1-1000MHz 
 = magnetogyric ratio, a constant for each nucleus 
 
Natural products commonly contain nuclei having spin number I of ½ such as 1H, 
13C, 15N and 31P. Among these, 1H and 13C are the most important nuclei because they 
constitute the skeleton of substances. The proton 1H is quite sensitive with NMR 
because of its high natural abundance (99.98 %) and therefore it is first investigated 
for the structural elucidation of substances (Neri and Tringali, 2001). In the present 
work, the 1D and 2D NMR spectra of isolated compounds were obtained using NMR 
E = (h/2)B0 = h  
  = B0/2 
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spectrometers of AVANCE 300, 400 and 600 Kryo (Bruker). The sample was 
dissolved in 0.6 ml of deuterated chloroform (CDCl3) or deuterated acetone (C2D6CO) 
and the solution was then dispensed into a 5 mm diameter NMR tube. The spectra 
were measured at the room temperature or 393ºK using the Fourier transform (FT) 
technique. The NMR-active nuclei are simultaneously excited by an irradiation pulse. 
When the pulse is switched off, the excited nuclei slowly return to their original spin 
state and emit electromagnetic radiation of different frequencies. This is so-called 
relaxation process. The signal is recorded in the form of the free induction decay (FID) 
(Mitchell and Costisella, 2007).  Tetramethylsilane (TMS), (CH3)4Si, was used as the 
internal reference compound.  
 
4.3.3.1. One dimensional (1D) NMR spectra 
1D NMR spectra are typically displayed as an absorption spectra, the axes of which 
are the frequency (chemical shift) and the intensity. Many functional groups or types 
of hydrogens or carbons contained in a molecule can be identified by the characteristic 
chemical shift values in 1H and 13C NMR spectra. 
 
4.3.3.1.1. 1H NMR spectra 
Protons in a molecule have resonances at various frequencies because of their 
different chemical environment. Therefore, each type of proton gives a resonance peak 
in a limited range of chemical shifts. The peak of a nucleus can be split into a multiplet 
with (n + 1) components as a result of the spin-spin coupling between this nucleus and 
adjacent equivalent nuclei, where n is the number of neighbouring equivalent protons 
with the same coupling constant. If the nuclei are not equivalent, the peak will appear 
as a multiple-multiplet of 2n components (Neri and Tringali, 2001). The relative 
intensity ratios of components in multiplets follow entries in Pascal’s triangle. 1H 
NMR spectra reveal information about types of hydrogens and the number of each in a 
molecule based on their chemical shifts, integration values and coupling constants. For 
instance, aromatic protons have resonance in the chemical shift range of 6-8 ppm, 
whereas protons bonded with sp3 carbons have resonance in between 0 to 3 ppm. The 
proton of aldehyde group has resonance near 9 to 10 ppm and that of acid group is in 
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the 10-12 ppm region. In alkenes, protons that are cis to each other have 3J coupling 
constants of 6-12 Hz, whilst those of trans protons are between 11 and 18 Hz. In 
aromatic compounds, ortho protons (3J = 7-10 Hz) couple stronger than meta ones (3J 
= 2-3 Hz) and para ones (3J = 0-1 Hz) (Pavia et al., 2009). 
 
4.3.3.1.2. Proton-decoupled 13C NMR spectra 
Spin-spin coupling between 13C atoms are rarely observed but the spin-spin 
interaction of protons bonded directly to 13C atoms can split the carbon signal 
responding to the n + 1 Rule. However proton-coupled 13C NMR spectra of large 
molecules are too complicated to interpret because of overlap of the multiplets from 
different carbons. This is caused by the 13C-H coupling constants being often larger 
than the chemical shift differences of the carbons. In proton-decoupled 13C NMR 
spectra, overlapping multiplets are transformed into singlets and therefore, the spectra 
are easier to interpret. 13C NMR spectra show information about the number and types 
of carbons and functional groups. For example, the carbonyl carbons of ketones often 
have resonance at low field of 180-220 ppm, whereas those of aldehydes and 
carboxylic acids have resonance near 170 to 190 ppm. The chemical shifts of aromatic 
and unsaturated carbons are in the 90-170 ppm region and those of saturated carbons 
are between 10 and 90 ppm (Pavia et al., 2009). 
 
4.3.3.2. Two dimensional (2D) NMR spectra 
2D NMR spectra are obtained by recording resonance signals as a function of two 
time variables and carrying out two Fourier transformations on a matrix of data. 
Therefore both of the horizontal and vertical axes in 2D NMR spectra are two 
chemical shift (frequency) axes. The 2D spectra give cross peaks showing correlations 
between the two axes and the data are displayed as a series of contours (Mitchell and 
Costisella, 2007).  
 
4.3.3.2.1. 1H-1H COrrelation SpectroscopY (COSY) 
A COSY spectrum shows homonuclear correlations between coupling protons in a 
molecule. The 1H chemical shifts are thus plotted on both axes. The off-diagonal peaks 
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in the spectrum are the important peaks, whilst the diagonal peaks are only considered 
as reference points. The spectrum provides information on which proton couples with 
which one. It also indicates H-H connectivities, gemical, vicinal or long range 
couplings. Correlations can be observed for all protons except the hydroxylic proton, 
which is often rapidly exchanged in protonic solvents (Breitmaier, 2002). 
 
4.3.3.2.2. Heteronuclear Single Quantum Correlation (HSQC) spectra 
A HSQC spectrum displays the heteronuclear correlations of protons with 13C atoms 
to which they are directly attached. Therefore the 1H chemical shifts are plotted on an 
axe and the 13C chemical shifts on the other one.  All C-H single bonds of the molecule 
can be determined by the HSQC spectrum and hence it provides information on which 
protons are bonded to which carbons. Multiplets of protons in large molecules 
frequently overlap in 1H NMR spectra and are difficult to be identified. HSQC spectra 
can help to determine these protons (Breitmaier, 2002).  
 
4.3.3.2.3. Heteronuclear Multiple Bond Coherence (HMBC) spectra 
The HSQC spectrum shows the 1H-13C correlations through a single bond (1JCH) and 
thereby is only applied to 13C atoms which are attached by protons. The HMBC 
technique is the modification of HSQC technique. A HMBC spectrum is applicable to 
non-protonated or quaternary 13C atoms to provide 2JCH, 
3JCH and 
4JCH correlations. 
The HMBC spectrum is very useful to identify quaternary carbons which can not be 
observed in the 13C NMR spectrum in some cases because of their low signal intensity 
(Breitmaier, 2002). The combination of data of COSY, HSQC and HMBC spectra 
produces essential information of skeletal connectivity on which structural fragments 
can be determined and then reassembled to accomplish the overall covalent structure 
of the substance.  
 
4.3.3.2.4. Nuclear Overhauser Effect SpectroscopY (NOESY) and Rotating-frame 
Overhauser Effect SpectroscopY (ROESY) spectra 
  NOESY and ROESY spectra display the correlations of protons that are close to 
each other in space with the common distance of 4.5 Å or less. Spatial interactions 
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between protons can be obtained via many bonds. In these spectra, the 1H chemical 
shifts are plotted on both axes like a COSY spectrum. NOESY and ROESY spectra are 
extremely helpful for the determination of relative stereochemistry in molecular 
structures (Silverstein et al., 2005).  
 
4.3.4. Optical rotation 
 Optical activity is the ability of chiral substances to rotate the plane of polarisation 
of polarised light. Optical rotation is considered to be positive (+) for dextrorotatory 
substances, i.e. those that rotate the plane of polarisation in a clockwise direction and 
negative (-) for laevorotatory substances. The specific rotation of a chiral compound 
can be calculated from the observed angle of rotation according to the expression 
(Carey, 2001). 
 
Formula 6: The calculation of specific rotation 
[

c.l
t
D
 
 
[] = specific rotation 
 = angle of rotation observed by a polarimeter 
c = concentration of the substance in g/100 ml 
l = length of the polarimeter tube in decimetres 
t = temperature of measurement (ºC) 
D = D-line of sodium ( = 589.3 nm) 
 
In the present work, the optical rotations of new substances were obtained using a 
polarimeter of UniPol L1000 (Schmidt and Bonaduz). The samples were prepared for 
a concentration of 1 mg/ml in methanol and then dispensed in a polarimeter tube of 5 
cm. The angle of rotation was observed at the wavelength of the D-line of sodium at 
22  0.5 ºC. Measurements were repeated at least five times and the final angle of 
rotations was obtained as an average value. 
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4.4. Biological assays 
The cytotoxicity of new compounds was tested on HeLa cell line using MTT assay. 
Moreover anti-angiogenic activity was carried out with a bixanthone using 
proliferation assay on human microvascular endothelial cell line-1 (HMEC-1) 
 
4.4.1. Preparation of samples 
The samples were prepared as stock solutions with a concentration of 100 mM in 
dimethyl sulfoxide (DMSO) and stored at -20 ºC. For the assays, the final 
concentration of DMSO per well was not more than 1%.  
 
4.4.2. Cytotoxicity assay on HeLa cells 
The HeLa cell line was originated by Gey et al. in 1952 from cervical cells taken 
from Henrietta Lacks, a young cancer patient. These cells were the first human cells 
continuously grown in culture and widely used for the research of anti-cancer activity 
of natural or synthesis substances (Heneen, 1976). The cytotoxicity of new compounds 
was evaluated by the MTT assay on HeLa cells as described by Mosman (1983) and 
modified according to Heilmann et. al (2001).  
 
4.4.2.1. Cell culture 
HeLa cells were cultured in Minimum Essential Medium (MEM-Earle with 0.85 g/l 
NaHCO3 of Biochrom) supplemented with 1% of L-glutamine (200 mM), 10% of fetal 
bovine serum  and 1 % of non-essential amino acids at 37 ºC in a humidified 5 % CO2 
environment. For the passage of the cells, the medium was removed through a pasteur-
pipette and the cells were washed with 5 ml of phosphate buffered saline (PBS). The 
cells were then incubated with 2 ml of trypsin/EDTA for 5 minutes to release from the 
bottom of flask. The cell suspension was centrifuged with 8 ml of the medium in a 15 
ml centrifuge tube at a speed of 700 U/min at 20 ºC for 3 minutes. The upper solution 
was removed and the cells were homogenised with 7 ml of the medium. Afterwards 
350 µl of the cell suspension was dispersed into a 50 ml culture flask containing 20 ml 
of the medium for growth. After 2-3 days, the old medium was changed by the same 
amount of fresh medium. The cells were split after 4-5 days. 
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4.4.2.2. Cell counting 
The counting of cells was carried out using a haemocytometer of nine 1 x 1 mm 
squares. The cell suspension (10 µl) was mixed with 10 µl of Trypan Blue solution and 
then a volume of 10 µl of the mixture was applied to the chamber of haemocytometer. 
Trypan Blue is used to staining dead cells. The number of unstained cells in the four 
large corner squares was counted using a microscope. The number of cells per ml can 
be calculated as the following equation. 
 
Formula 7: The calculation of the number of cells per ml 
 
 
 
In this study, the dilution factor is 2. Because the volume of each large square is 0.1 
µl, the average of cells per large square must be multiplied with 104 to give the number 
of cells per millilitre.  
 
4.4.2.3. MTT assay 
The assays were carried out in 96-well plates and the number of cells per well was 
9000 cells. Nine different concentrations of the samples were prepared in the medium 
with a volume of 75 µl per well and 75 µl of the cell suspension was then added to 
each well so that the total volume per well was 150 µl. The plates were incubated at 37 
ºC in a humidified 5 % CO2 environment for 72 hours. After incubation, 15 µl of an 
aqueous solution of methylthiazoyl tetrazolium bromide (MTT) was added into each 
well containing the cells and incubated for next 4 hours. MTT is reduced to a purple 
formazan by NADH of living cells. After incubation, the solution was removed and 
150 µl of sodium dodecylsulfate (SDS) solution (10%) was added to each well. The 
plates were subsequently placed in the dark for 24 hours at the room temperature. The 
optical density was measured at 560 nm using a microplate reader (Tecan SpectraFlour 
Plus). For the determination of the IC50 values, the optical density was plotted against 
the log scale of the concentration. Each concentration was performed in hexaplicates 
and the assays have been repeated at least three times. Maximal observed standard 
deviation was about 15% (absolute). 
Cells per ml = The average of cells per large square x Dilution factor x 104 
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4.4.3. Proliferation assay on HMEC-1 
Vascular endothelial cells line the inside of blood vessel walls throughout the 
circulatory system to compose an interface between flowing blood and the vessel wall. 
They are involved in the formation of new blood vessels called angiogenesis. 
Angiogenesis has been shown as a target for the fight against diseases characterized by 
either poor vascularisation or abnormal vasculature. Compounds that inhibit or induce 
the formation of new blood vessels (angiogenesis inhibitors) can help to combat such 
diseases (Birbrair et al., 2014). The proliferation assay on human microvascular 
endothelial cell line-1 (HMEC-1) is (among others) an in vitro method to identify the 
anti-angiogenic activity of a substance. The HMEC-1 is derived from human foreskin 
and transfected by a gene of simian virus 40. These transfected cells have been created 
by Dr. Thomas Lawley and his team including members from the University of Emory 
and the Centers for Disease Control and Prevention (CDC), USA. They possess all of 
the characteristic makers of endothelial cells and can last from 25 to 27 generations 
without losing their genetic characteristics (Ades et al., 1992). The proliferation assay 
was carried out as described by Schmidt et al. (2012). 
 
4.4.3.1. Cell culture 
HMEC-1 was cultured in Endothelial Cell Growth Medium (ECGM, Provitro) 
supplemented with 10% of FCS and antibiotics at 37 ºC in a humidified 5 % CO2 
environment. For the passage of the cells, the medium was removed through a pasteur-
pipette and the cells were washed twice with 10 ml of phosphate buffered saline 
(PBS). The cells were then released by incubation with 4 ml of trypsin/EDTA for 5 
min. The cell suspension was centrifuged with 6 ml of the medium in a 15 ml 
centrifuge tube at a speed of 1000 U/min at 20 ºC for 5 minutes. The upper solution 
was removed and the cells were homogenised with 10 ml of the medium. Afterwards 1 
ml of the cell suspension was dispersed into a 50 ml culture flask containing 20 ml of 
the medium (ECGM) for growth.  
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4.4.3.2. Proliferation assay 
The assays were carried out in 96-well plates. The HMEC-1 cells were seeded in 
the plates coated with collagen (100 µl of the cell suspension per well) and the number 
of cells in each well was 1500 cells. The plates were incubated at 37 ºC in a 5% CO2 
atmosphere with constant humidity. After 24 hours, the medium in a reference plate 
was removed and the cells in this plate were stained with a crystal violet solution for 
10 minutes in the dark at the room temperature to serve for the baseline. The cells in 
other plates were treated with 100 µl of the samples with various concentrations in the 
culture medium. After 72 h incubation, the solution was removed and the cells were 
stained with the crystal violet solution for 10 minutes in the dark at the room 
temperature. The plates were then washed with distilled water and 100 µl of 0.1 M 
sodium nitrate solution was added in each well. The optical density was measured at 
560 nm using a microplate reader (Tecan SpectraFlour Plus). For the determination of 
the IC50 values, the optical density was plotted against the log concentration. Every 
test was performed at least in hexaplicates and the assays have been repeated at least 
three times. The maximal observed standard deviation was about 15% (absolute). 
Xanthohumol was used as positive control and pure solvent (0.1 % DMSO) was used 
as negative control. 
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5. RESULTS AND DISCUSSION 
 
5.1. Experiments 
 
5.1.1. Fractionation and isolation of the n-hexane extract 
The n-hexane extract of the bark of Garcinia fusca (GFH, 90.5 g) was divided into 
two portions which were in turn applied to open column chromatography (CC) using a 
column of 10 x 40 cm dimension, 800 g of silica gel as stationary phase and a solvent 
system of acetone and petroleum ether (0-100%) as mobile phase to give 30 sub-
fractions (500 ml of each). Identical fractions were combined on the basis of TLC to 
afford 8 main fractions which were shortly named GFH-1 - 8 as shown in Scheme 17.   
 
 
 
 
 
 
 
 
Scheme 17. Fractionation of the n-hexane extract (GFH) 
 
The 1H NMR spectra of the fractions (see Figure 27 - 29) revealed that the fractions 
from GFH-3 to GFH-7 contained prenylated xanthone derivatives based on typical 
signals at 13 - 14 ppm (hydrogen-bonded hydroxyl groups), 6 – 7.5 ppm (aromatic 
protons), 5 – 5.5 ppm (olefinic protons of prenyl groups), 4 – 4.2 ppm (methylene 
protons of prenyl substitutes at the peri position, C-8), 3.7 – 4 ppm (methoxyl groups 
and protons of oxygenated sp3 carbons) and 1 – 2 ppm (vinyl methyls in prenyl 
chains). The fractions GFH-4 and GFH-5 comprised xanthones with peri prenyl 
groups because their spectra showed resonance peaks at 4 – 4.2 ppm. On the contrary, 
the absence of this signal in the spectrum of the fraction GFH-6 indicated that this 
fraction did not contain xanthones with prenyl groups at the peri position (C-8). 
- CC, silica gel (800 g) 
- Acetone-PE (0 – 100 %) 
- 30 fractions (500 ml/fr.) 
Crude extract 
GFH (90.5 g) 
GFH-1 
(3.8 g) 
GFH-2 
(3.6 g) 
GFH-3 
(2.9 g) 
GFH-5 
(6.7 g) 
GFH-6 
(37.1) 
GFH-4 
(31.4 g) 
GFH-7 
(3.4 g) 
GFH-8 
(0.72 g) 
Result and discussion  91 
 
Moreover in the spectrum of the fraction GFH-7, there was a signal at 4.3 ppm due to 
the resonance of a deshielded proton of an oxygenated sp3 carbon. On the basis of 
those spectral data and TLC, we chose fractions GFH-2, GFH-4, GFH-6 and GFH-7 
for phytochemical investigation.  
 
GFH-1 
 
 
GFH-2 
 
 
 
Figure 27. 1H NMR spectra of fractions GFH-1 and GFH-2 
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GFH-3 
 
GFH-4 
 
GFH-5 
 
Figure 28. 1H NMR spectra of fractions GFH-3 – 5 
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GFH-6 
 
GFH-7 
 
GFH-8 
 
Figure 29. 1H NMR spectra of fractions GFH-6 - 8  
94   Results and discussion 
 
5.1.1.1. Isolation from fraction GFH-2  
The fraction GFH-2 (3.6 g) was applied to FC (40 x 160 mm, 100 g of silica gel, 0 – 
100 % EtOAc-PE, 30 ml/min) to yield 82 fractions (20 ml/fraction) which were 
combined on the basis of TLC to give 5 fractions (GFH-2.1 – 5). The fraction GFH-2.2 
(145.7 mg) was then purified by GPC (2 x 70 cm, 23 g of Sephadex LH-20, 
MeOH/CHCl3 6 : 4) to give 1 (120.0 mg), see Scheme 18. 
 
 
 
 
 
 
 
 
 
Scheme 18. Isolation of compound 1  
 
5.1.1.2. Isolation of xanthones from fraction GFH-4 
The half of the fraction GFH-4 (15.3 g) was subjected to CC (5 x 50 cm, 400 g of 
silica gel, 0-100 % EtOAc-PE) to yield 28 fractions (250 ml/fraction) combined on the 
basis of TLC to give 4 fractions (GFH-4.1 - 5), see Scheme 19. An amount of 1.0 g of 
the fraction GFH-4.2 was further applied to CPC (n-hexane/EtOAc/MeOH/H2O 
8:2:8:2, 5 ml/min) to afford 330 fractions (2.5 ml/fraction) combined by relying on 
TLC to give 7 fractions (GFH-4.2.1 - 7). The fraction GFH-4.2.3 (57.3 mg) was then 
separated by preparative TLC (2 mm, silica gel, acetone/CHCl3 3 : 7) to yield 2 (15.0 
mg) and 3 (14.3 mg). The fraction GFH-4.2.5 (46.9 mg) was similarly applied to semi-
preparative HPLC to produce 4 (12.4 mg) and 5 (5.7 mg). The fraction GFH-4.4 (3.3 
g) was further chromatographed by FC (40 x 160 mm, 100 g of silica gel, 0 – 100 % 
EtOAc-PE, 30 ml/min) to afford 86 fractions (20 ml/fraction) combined on the basis of 
TLC to give 4 fractions (GFH-4.3.1 - 4). Semi-preparative HPLC (21.4 x 250 mm, RP-
- GPC, Sephadex LH-20 (56 g) 
- MeOH/CHCl3 (6 : 4) 
 
- FC, silica gel (100 g) 
- EtOAc-PE (0 – 100%) 
- 82 fractions (20 ml/fr.) 
GFH-2 (3.6 g) 
GFH-2.2 (145.7 mg) 
 
1 (120.0 mg) 
Result and discussion  95 
 
18 silica, 50 - 100% MeCN-H2O, 10 ml/min) of GFH-4.3.2 (41.8 mg) furnished 6 (6.8 
mg) and 7 (18.0 mg). 
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 19. Isolation of xanthones from fraction GFH-4 
 
5.1.1.3. Isolation from fraction GFH-6 
An amount of 10.7 g of GFH-6 was fractionated by CC (5 x 50 cm, 300 g of silica 
gel, 0-100 % acetone-PE) to produce 36 fractions (150 ml/fraction) combined on the 
basis of TLC similarities to give 6 fractions (GFH-6.1 – 6). Fraction GFH-6.2 (1.2 g) 
was purified by GPC (5 x 70 cm, 56 g of Sephadex LH-20, MeOH/CHCl3 6 : 4) and 
further subjected to semi-preparative HPLC (21.4 x 250 mm, RP18 silica, 50 - 100% 
MeCN-H2O, 10 ml/min) to give 8 (8.2 mg) and 9 (6.4 mg). Besides the fraction GFH-
6.4 (1.4 g) was chromatographed by CPC (n-hexane/EtOAc/MeOH/H2O 8:2:8:2, 5 
GFH-4 (15.3 g) 
- CC, silica gel (400 g) 
- EtOAc-PE (0 – 100%) 
- 28 fractions (200 ml/fr.) 
GFH-4.2 (1.0 g) GFH-4.4 (3.3 g) 
- CPC, 5 ml/min 
- n-Hexane/EtOAc/MeOH/H2O (8:2:8:2) 
- 330 fractions (2.5 ml/fr.) 
- FC, silica gel, 30 ml/min 
- EtOAc-PE (0 – 100%) 
- 86 fractions (20 ml/fr.) 
GFH-4.2.3 (57.3 mg) GFH-4.2.5 (46.9 mg) 
- RP18 HPLC, 5 ml/min 
- MeCN-H2O (50 – 100%) 
2 (15.0 mg) 
3 (14.3 mg) 
4 (12.4 mg) 
5 (5.7 mg) 
GFH-4.3.3 (41.8 mg) 
- RP18 HPLC, 5 ml/min 
- MeCN-H2O (50 – 100%) 
6 (6.8 mg) 
7 (18.0 mg) 
- Preparative TLC 
- Silica gel 
- Acetone-CHCl3 (3 :7) 
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- Preparative TLC 
- Silica gel 
- Aceton-CHCl3 (-
4:6)  
ml/min) to afford 330 fractions (2.5 ml/fraction) combined on the basis of TLC 
similarities to give 5 fractions (GFH-6.4.1 – 5). The separation of fraction GFH-6.4.3 
(12.4 mg) using preparative TLC (2 mm, silica gel, acetone/CHCl3 4:6) obtained 10 
(4.1 mg). The fraction GFH-6.4.2 (30.7 mg) was purified by semi-preparative HPLC 
(21.4 x 250 mm, RP18 silica, 50 - 100% MeCN-H2O, 10 ml/min) to furnish 11 (7.2 
mg) and 12 (2.7 mg). Similarly, semi-preparative HPLC of GFH-6.4.4 (52.2 mg) 
yielded 13 (20.0 mg) and 14 (4.4 mg), see Scheme 20. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 20. Isolation of compounds from fraction GFH-6  
GFH-6.4.3 (12.4 mg) 
- Preparative TLC 
- Sil ca gel 
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12 (4.1 mg) 
GFH-6.4.4 (41.8 
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5.1.1.4. Isolation of xanthones from fraction GFH-7 
FC (40 x 160 mm, 100 g of silica gel, 0 – 100% acetone-CHCl3, 30 ml/min) of the 
fraction GFH-7 (3.4 g) produced 90 fractions (20 ml/fraction) combined by relying on 
TLC to give 5 fractions (GFH-7.1 - 5). The fraction GFH-7.2 (345.0 mg) was purified 
by semi-preparative HPLC (21.4 x 250 mm, RP18 silica, 60 - 100% MeCN-H2O, 10 
ml/min) to yield 15 (10.5 mg) and 16 (20.3 mg). The fraction GFH-7.4 (1.3 g) was 
further chromatographed by CPC (n-hexane/EtOAc/MeOH/H2O 8:2:8:2, 5 ml/min) to 
afford 330 fractions (2.5 ml/fraction) combined on the basis of TLC to give 6 fractions 
(GFH-7.4.1 – 6). GPC (2 x 70 cm, 23 g of Sephadex LH-20, MeOH) of GFH-7.4.3 
(328.0 mg) produced 86 fractions (5 ml/fraction) combined by relying on TLC to give 
3 fractions (GFH-7.4.3.1 – 3). Semi-preparative HPLC (21.4 x 250 mm, RP18 silica, 60 
- 100% MeCN-H2O, 10 ml/min) of GFH-7.4.3.2 (79.6 mg) to furnish 17 (2.5 mg), 18 
(3.1 mg), 19 (6.5 mg) and 20 (7.3 mg). The fraction GFH-7.4.5 (146.0 mg) was 
separated by GPC (2 x 70 cm, 23 g of Sephadex LH-20, MeOH) to produce 74 
fractions (5 ml/fraction) combined on the basis of TLC to give 3 fractions (GFH-
7.4.5.1 - 3). The purification of GFH-7.4.5.1 (56.1 mg) using semi-preparative HPLC 
(21.4 x 250 mm, RP18 silica, 60 - 100% MeCN-H2O, 10 ml/min) yielded 21 (7.0 mg), 
whereas GFH-7.4.5.3 (17.4 mg) was similarly purified by semi-preparative HPLC to 
obtain 22 (10.7 mg), see Scheme 21. 
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Scheme 21. Isolation of xanthones from fraction GFH-7 
GFH-7 (3.4 g) 
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5.1.2. Fractionation of the ethyl acetate extract and further isolation  
The ethyl acetate extract of Garcinia fusca (GFE, 112.3 g) was split into two 
portions which was in turn applied to CC (10 x 40 cm, 800 g of silica gel, 0 – 100% 
acetone-PE) to produce 35 sub-fractions (500 ml of each). The combination of 
identical fractions was based on TLC to give 8 main fractions (GFE1 - 8) (Scheme 
22). 
 
 
 
 
 
 
 
 
Scheme 22. Fractionation of the ethyl acetate extract (GFE) 
 
The 1H NMR spectra of fractions (see Figure 30 - 31) indicated that the fractions 
GFE-3 and GFE-4 contained prenylated xanthone derivatives based on typical signals 
at 13.9 ppm (hydrogen-bonded hydroxyl groups), 6 – 7.5 ppm (aromatic protons), 5 – 
5.5 ppm (olefinic protons of prenyl groups), 4.1 ppm (methylene protons of prenyl 
substitutes at the peri position, C-8), 3.8 ppm (methoxyl groups and protons of 
oxygenated sp3 carbons) and 1 – 2 ppm (tertiary methyls in prenyl chains). On the 
other hand, the spectra of fraction GFE-4 also showed a signal at 4.3 ppm due to the 
resonance of deshielded proton of an oxygenated sp3 carbon. The spectra of the 
fractions from GFE-5 to GFE-7 showed the characteristic signals of biflavonoids at 
11.5 – 12.0 ppm and 12.5 – 14.0 ppm (hydroxyl groups in hydrogen bonds), 6 - 8 ppm 
(aromatic and olefinic protons), 5.5 – 6. ppm (deshielded protons of oxygenated sp3 
carbons) and  4.5 -5.2 (deshielded protons of tertiary carbons). On the basis of those 
spectral data and TLC, we chose fractions GFE-4 and GFE-6 for phytochemical 
investigation. 
  
- CC, silica gel (800 g) 
- Acetone-PE (0 – 100  %) 
- 35 fractions (500 ml/fr.) 
Crude extract 
GFE (112.3 g) 
GFE-1 
(2.7 g) 
GFE-2 
(11.5 g) 
GFE-3 
(6.5 g) 
GFE-5 
(24.2 g) 
 
GFE-6 
(14.2 g) 
GFE-4 
(14.1 g) 
GFE-7 
(10.4 g) 
GFE-8 
(12.4 g) 
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Figure 30. 1H NMR spectra of fractions GFE-1 – 3 
GFE-1 
GFE-2 
GFE-3 
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Figure 31. 1H NMR spectra of fractions GFE-4 – 6  
GFE-4 
GFE-5 
GFE-6 
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Figure 32. 1H NMR spectra of fractions GFE-7 and GFE-8 
 
GFE-7 
GFE-8 
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5.1.2.1. Isolation of xanthones from fraction GFE-4 
CC (5 x 50 cm, 400 g of silica gel, 0-100% acetone-PE) of the fraction GFE-4 (14.1 
g) produced 26 fractions (250 ml/fraction) combined by relying on TLC to give 6 
fractions (GFE-4.1 – 6). The fraction GFE-4.2 (1.7 g) was further applied to FC (40 x 
160 mm, 80 g of silica gel, 0 – 100% acetone-CHCl3, 20 ml/min) to afford 86 fractions 
(15 ml/fraction) combined on the basis of TLC to give 5 fractions (GFE-4.3.1 - 5). 
GPC (2 x 70 cm, 23 g of Sephadex LH-20, MeOH) of GFE-4.3.2 (398.7 mg) yielded 
92 fractions (5 ml/fraction) combined by relying on TLC to give 3 fractions (GFE-
4.3.2.1 – 3). The repeated purification of fraction GFE-4.3.2.2 (60.7 mg) using semi-
preparative HPLC (9.4 x 250 mm, RP18 silica, 60 - 100% MeCN-H2O, 3 ml/min) 
furnished 23 (2.9 mg), 24 (5.2 mg)) and 25 (2.7 mg). Moreover 26.8 mg of the fraction 
GFE-4.3.2.3 was purified by semi-preparative HPLC (9.4 x 250 mm, RP18 silica, 60 - 
100% MeCN-H2O, 3 ml/min) to obtain 26 (3.1 mg), see Scheme 23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 23. Isolation of xanthones from fraction GFE-4 
- CC, silica gel (400 g) 
- EtOAc-PE (0 – 100%) 
- 26 fractions (250 ml/fr.) 
GFE-4.3 (1.7 g) 
- FC, silica gel, 20 ml/min 
- Acetone-CHCl3 (0 – 100%) 
- 86 fractions (15 ml/fr.) 
GFE-4.3.2.2 (60.7 mg) 
GFE-4.3.2 (398.7 mg) 
- RP18 HPLC, 3 ml/min 
- MeCN-H2O (60 – 100%) 
23 (2.9 mg) 24 (5.2 mg) 
- GPC, Sephadex LH-20 
- MeOH 
- 92 fractions (5 ml/fr.) 
GFE-4.3.2.3 (26.8 mg) 
26 (3.1 mg) 
25 (2.7 mg) 
- RP18 HPLC, 3 ml/min 
- MeCN-H2O (60 – 100%) 
GFE-4 (14.1 g) 
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5.1.2.2. Isolation from fraction GFE-6 
The fraction GFE-6 (14.2) was applied to CC (5 x 50 cm, 400 g of silica gel, 0-
100% acetone-CH2Cl2) of the fraction GFE-4 (14.1 g) to afford 28 fractions (250 
ml/fraction) combined on the basis TLC to give 5 fractions (GFE-6.1 – 5). GPC (5 x 
70 cm, 56 g of Sephadex LH-20, MeOH) of the fraction GFE-6.3 (2.8 g) produced 96 
fractions (10 ml/fraction) combined by relying on TLC to give 6 fractions (GFE-6.3.1 
– 6). The fraction GFE-6.3.4 was 27 (35.7 mg). the fraction GFE-6.3.3 (841.7 mg) was 
further chromatographed by FC (40 x 160 mm, 35 g silica gel, 10 ml/min) to yield 60 
fractions (10 ml/fraction) combined on the basis of TLC to give 3 fractions (GFE-
6.3.3.1 – 3). GFE-6.3.3.1 (126.5 mg) was purified using semi-preparative HPLC to 
obtain 28 (15.8 mg). The repeated purification of the fraction GFE-6.3.3.3 (356.4 mg) 
using semi-preparative HPLC (9.4 x 250 mm, RP18 silica, 60 - 100% MeCN-H2O, 3 
ml/min) furnished 29 (20.5), 30 (15.6) and 31 (22.0), see Scheme 24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 24. Isolation of compounds from fraction GFE-6 
GFE-6 (14.2 g) 
- CC, silica gel (400 g) 
- Acetone-CH2Cl2 (0 – 100%) 
- 28 fractions (250 ml/fr.) 
GFE-6.3 (2.8 g) 
- GPC, Sephadex LH-20 
- MeOH 
- 96 fractions (10 ml/fr.) 
27 (35.7 mg) 
GFE-6.3.3.3 (356.4 mg) 
- FC, silica gel, 20 ml/min 
- Acetone-CHCl3 (0 – 100%) 
- 86 fractions (15 ml/fr.) 
GFE-6.3.3 (841.7 mg) 
- RP18 HPLC, 3 ml/min 
- MeCN-H2O (60 – 100%) 
29 (20.5 mg) 30 (15.6 mg) 31 (22.0 mg) 
GFE-6.3.3.1 (126.5 mg) 
- RP18 HPLC, 3 ml/min 
- MeCN-H2O (60 – 100%) 
28 (15.8 mg) 
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5.2. Structural elucidation of isolated substances 
 
5.2.1. Structural identification of substances from the n-hexane extract 
Thin layer and column chromatography as well as semi-preparative HPLC of the n-
hexane extract resulted in the isolation of twenty two substances. On the basis of NMR 
spectra data (see Appendices 1 – 17) and comparison with those of literatures, the 
structures of seventeen known compounds were determined as shown in Table 4. 
Compound 8 was previously reported as a semi-synthetic xanthone. Five other 
substances (18 – 22) have been first isolated and their structures were elucidated by 
relying on the data of UV, 1D and 2D NMR, mass spectrometry and optical rotation. 
In general, all the new compounds (18 - 22) gave positive test with FeCl3 in 
methanol, which revealed their phenolic nature. The UV spectra of these compounds 
displayed four maxima at 213 - 220, 242 - 244, 314 - 318 and 356 - 360 nm, which are 
similar to those of 1,3,6,7-tetraoxygenated xanthones (Iinuma et al., 1996; Nilar and 
Harrison, 2002). The 1H and 13C NMR spectra of these compounds indicated that they 
are prenylated xanthone derivatives containing a hydrogen-bonded hydroxyl group at 
H 13.72 – 14.08 with the appropriate interacting carbonyl carbon at C 181.7 – 183.0, 
two isolated aromatic protons at H 6.79 – 6.83 and 6.23 – 6.36 and a methoxyl group 
at H 3.78 – 3.83 (except for 21). Besides the 
1H and 13C NMR spectra also showed the 
presence of geranyl and isoprenyl side chains, whose benzylic methylene protons are 
deshielded by the adjacent carbonyl group. This allowed the placement of these side 
chains to the peri position (C-8) (Xu et al., 2001; Nilar and Harrison, 2002). 
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Table 4. The structure of substances isolated from the n-hexane extract 
 
Isolated 
compounds 
Structure 
1 
 
O
HO
 
-Tocotrienol (Ohnmacht et al., 2007) 
 
2 
 
O
H3CO
H3CO
O OH
OH
 
1,3-Dihydroxy-6,7-dimethoxy-2,8-diprenylxanthone 
(Pattanaprateeb et al., 2004) 
 
 
3 
 
 
O
H3CO
HO
O OH
OCH3  
-Mangostin (Mahaburarakam et al., 1987) 
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4 
 
O
H3CO
HO
O OH
OH
 
Cowanin (Na Pattalung et al., 1994) 
 
5 
 
OO
OH OH
OH
O
 
Garbogiol (Iinuma et al., 1997) 
 
6 
 
 
O
H3CO
HO
O OH
OH
 
-Mangostin (Mahaburarakam et al., 1987) 
 
 
 
 
108   Results and discussion 
 
7 
 
O
H3CO
HO
O OH
OH
 
Rubraxanthone (Ampofo and Waterman, 1986) 
8 
 
O
H3CO
H3CO
O OH
OCH3  
1-Hydroxy-3,6,7-trimethoxy-2-(3-methyl- 
but-2-enyl)-xanthone (Nilar and Harrison, 2002) 
9 
 
O
H3CO
HO
O OH
OCH3  
1,6-Dihydroxy-3,7-dimethoxy-2-(3-methyl- 
but-2-enyl)-xanthone (Nilar and Harrison, 2002) 
 
10 
 
O
O
CHO
 
Piperaldehyde  
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11 
 
OHO
O OH
OCH3
OH
 
Nigrolineaxanthone E (Rukachaisirikul et al., 2003) 
12 
 
 
O
O OH
HO
OH
 
Fuscaxanthone E (Ito et al., 2003) 
 
 
13 
 
 
O
OHO
OH
H3CO
HO
 
Cowaxanthone (Na Pattalung et al., 1994) 
14 
 
 
O
OHO
OH
OH
 
Mangostinone (Asai et al., 1995) 
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15 
 
O
H3CO
HO
O OH
OH
OH
 
Cowanol (Na Pattalung et al., 1994) 
16 
 
O
HO
HO
O OH
OH
 
Norcowanin (Na Pattalung et al., 1994) 
17 
 
O
H3CO
HO
O O
OH
 
1-Isomangostin (Mahabusarakam et al., 1987) 
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5.2.1.1. Compound 21 (fuscaxanthone J) 
 
 
 
 
 
 
 
 
 
Figure 33. Structure of fuscaxanthone J (21) 
 
Compound 21 was isolated as a yellow oil. The molecular formula was established 
as C28H32O7 by HRESIMS (m/z 481.2217 [M+H]
+). The 1H and 13C NMR spectra of 
21 (see Figure 34; Table 5 and 6)  contained signals for a hydrogen-bonded hydroxyl 
group [H 14.08 (1H, s, 1-OH)] with the interacting carbonyl carbon [C 183.0 (C-9)], 
two isolated aromatic protons [H 6.81 (1H, s, H-5) and 6.35 (1H, s, H-4); C 101.0 (C-
5) and 93.3 (C-4)], a geranyl group [H  5.34 (1H, m like t, J = 8.0 Hz, H-22), 5.06 
(1H, m like t, J = 6.8 Hz, H-17), 4.21 (2H, d, J = 6.8 Hz, H2-16), 2.05 (2H, m, H2-21), 
1.97 (2H, m, H2-20), 1.86 (3H, d, J = 0.8 Hz, H3-19), 1.57 (3H, d, J = 0.8 Hz, H3-24) 
and 1.53 (3H, s, H3-25); C 135.0 (C-18), 131.4 (C-23), 125.2 (C-22), 124.4 (C-17), 
40.6 (C-20), 27.4 (C-21), 26.2 (C-16), 25.7 (C-24), 17.6 (C-25) and 16.6 (C-19)] and 
an isoprenyl group [H 5.37 (1H, m like t, J = 8.0 Hz, H-12), 4.30 (2H, s, H2-14), 3.45 
(2H, d, J = 8.0 Hz, H2-11) and 1.73 (3H, d, J = 1.2 Hz, H3-15); C 135.7 (C-13), 125.4 
(C-12), 61.7 (C-14), 22.0 (C-15) and 21.7 (C-11)], in which one of two vinyl methyl 
groups is hydroxylated to form a 4-hydroxy-3-methylbut-2-enyl group. This was 
confirmed by the HMBC correlations of the protons of the oxygenated vinyl 
methylene group at H 4.30 with two olefinic carbons (H 135.7, C-13 and 125.4, C-
14) and the vinyl methyl carbon (C 22.0, C-15). The 
13C NMR spectra also showed 
resonances due to ten substituted aromatic carbons, six of which are oxygenated (C 
152.6 – 162.7). The 1H and 13C NMR data of 21 are the same as those of cowanol, 
O
OHO
OH
HO
HO
OH
1
2
3
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6
7
8
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which has previously reported from G. cowa (Na Pattalung et al., 1994). However 
there is a difference regarding the absence of the signal for a methoxyl group.  
In the HMBC spectrum, the chelated hydroxyl proton (H 14.08, 1-OH) correlated 
with an oxygenated aromatic carbon (C 161.2) and two substituted aromatic carbons 
(C 109.7 and 103.7). The isolated aromatic proton (H 6.35) gave cross-peaks with 
two latter carbons and two oxygenated aromatic carbons (C 162.7 and 155.9). On the 
other hand, the benzylic methylene protons (H 3.45) had correlations with a 
substituted aromatic carbon at C 109.7 and two oxygenated aromatic carbons (C 
161.2 and 162.7). These HMBC data revealed that the oxygenated aromatic carbon at 
C 161.2 is C-1, C-3 is oxygenated (C 162.7), C-4a is the carbon at C 155.9, C-4 is 
protonated (C 93.3) and the 4-hydroxy-3-methylbut-2-enyl group is attached to C-2 
(C 109.7). In the xanthone B ring, two benzylic methylene protons at H 4.21 (C 
26.2) exhibited a less shielding by the adjacent carbonyl group, i.e., the geranyl group 
is placed at C-8. Furthermore these protons gave HMBC correlations with an 
oxygenated aromatic carbon (C 141.7) and two substituted aromatic carbons (C 128.9 
and 111.9). Meanwhile, the isolated aromatic proton at H 6.81 (C 101.0) showed 
cross-peaks to a substituted aromatic carbon at C 111.9 and three oxygenated 
aromatic carbons (C 153.6, 152.6 and 141.7). Thus, the substituted aromatic carbon at 
C 128.9 is C-8, bearing the geranyl group and the other one is C-8a. Three oxygenated 
aromatic carbons are C-6, C-10a and C-7, respectively. The isolated aromatic proton is 
bonded to C-5. The NOESY correlations between H-14/H-11 and H-15/H-12 indicated 
that the double bond of the isoprenyl group has the Z-configuration. The compound 21 
was identified as 1,2,6,7-tetrahydroxy-2-(Z)-(4-hydroxy-3-methylbut-2-enyl)-8-(3,7-
dimethylocta-2,6-dienyl)xanthen-9-one and was given the trivial name fuscaxanthone 
J.  
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Figure 34. 1H and 13C NMR spectra of fuscaxanthone J (21) 
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5.2.1.2. Compound 20 (fuscaxanthone K) 
 
 
 
 
 
 
 
 
 
 
 
Figure 35. Structure of fuscaxanthone K (20) 
 
Compound 20 was obtained as a yellow oil and given the molecular formula 
C29H34O8 by HRESIMS (m/z 511.2334 [M + H]
+). In the 1H NMR spectrum (see 
Figure 38; Table 5 and 6), the presence of a chelated hydroxyl group [H 13.72 (1H, s, 
1-OH)], two isolated aromatic protons [H 6.83 (1H, s, H-5) and 6.23 (1H, s, H-4)], a 
methoxyl group [H 3.79 (3H, s, 7-OCH3)] and a geranyl group [H 5.28 (1H, m like t, 
J = 6.6 Hz, H-17), 5.04 (1H, m, H-22), 4.12 (2H, d, J = 6.6 Hz, H-16), 2.05 (2H, m, 
H2-21), 1.98 (2H, m, H2-20), 1.82 (3H, s, H3-19), 1.55 (3H, s, H3-24) and 1.51 (3H, s, 
H3-25)] were observed together with a benzylic methylene group [H 3.22 and 3.12 
(2H, dd, J = 8.1 and 15.6 Hz, H2-11)], a deshielded methine proton [H 5.03 (1H, m, 
H-12)], an oxygenated methylene group [H 3.69 and 3.57 (2H, d, J = 9.6 Hz, H2-14)] 
and a vinyl methyl group [H 1.19 (3H, s, H3-15)]. The 
13C NMR spectrum (see Figure 
38; Table 5 and 6) contained signals of twenty nine carbons including a conjugated 
carbonyl carbon (C 182.2), twelve aromatic carbons and four oxygenated sp
3 carbons 
(C 60.8 – 89.1). Of twelve aromatic carbons, six are oxygenated (C 157.5 – 167.4). 
These spectral data supported 20 to be a tetra-oxygenated xanthone derivative carrying 
a hydrogen-bonded hydroxyl group, a geranyl group, a methoxyl group and a C5 unit. 
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In the HMBC spectrum, two protons of the oxygenated methylene group (H 3.69 
and 3.57; C 67.2) correlated with an oxygenated tertiary carbon (C 73.6), an 
oxygenated secondary carbon (H 5.03; C 89.1) and the secondary carbon (H 1.19; C 
20.2). The benzylic methylene protons (H 3.22 and 3.12, C 26.1) also showed cross-
peaks to the oxygenated tertiary carbon and the oxygenated secondary carbon. 
Moreover these protons gave the COSY correlation with the deshielded methine 
proton (H 5.03). These data suggested that the C5 unit is an isoprenyl group, in which 
the double bond is oxidized and a vinyl methyl group is hydroxylated to form the 2,3-
epoxy-4-hydroxy-3-methylbutyl group. Besides the chelated hydroxyl group (H 
13.72) correlated with C-1 (C 158.0) and C-9a (C 103.7) and a substituted aromatic 
carbon (C 108.5), whereas the benzylic methylene protons of the 2,3-epoxy-4-
hydroxy-3-methylbutyl side chain also exhibited correlations with C-1, the substituted 
aromatic carbon and another oxygenated aromatic carbon (C 167.4). The side chain is 
therefore bonded to C-2 (C 108.5) and C-3 is oxygenated (C 167.4). The isolated 
aromatic proton at H 6.23 is attached to C-4 because it gave cross-peaks to C-2, C-3 
and another oxygenated aromatic carbon (C 157.4), which is C-4a. In the xanthone B 
ring, the downfield shift (H 4.12) of the benzylic methylene protons of the geranyl 
group revealed that this group is located at C-8 as in the case of compound 21. These 
methylene protons (H2-16) and the methoxyl protons (H 3.79) showed correlations to 
an oxygenated aromatic carbon (C 144.2), indicating that this carbon is C-7, which 
carries the methoxyl group. This was confirmed by the HMBC correlation between 
H2-16 with C-7, C-8a (C 111.2) and a substituted aromatic carbon (C 137.4) which 
has to be C-8. Meanwhile the remaining isolated aromatic proton (H 6.83) gave cross-
peaks to C-7, C-8a and two oxygenated aromatic carbons (H 157.4 and 155.9). This 
proton is therefore bonded to C-5 and two oxygenated aromatic carbons are C-6 and 
C-10a. 
In the ROESY spectrum (Figure 36), the protons H2-14 gave an interaction with the 
proton H-12, whereas they did not show any interaction with H2-11. This indicated 
that the oxygenated methyl group is trans to the benzylic methylene group in the 2,3-
epoxy-4-hydroxy-3-methylbutyl side chain. Therefore, the configuration of two chiral 
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carbons C-12 and C-13 was suggested as R by comparison of the optical rotation of 20 
with that of (2S-trans)-2-methyl-3-phenyloxiranemethanol, see Figure 37 (Gao et al., 
1987). Two chiral carbons of this compound possess S configuration corresponding to 
the optical rotation []25D – 16.9º, whereas that of 20 is + 76.3º (measured at 22 ºC). 
Hence 20 was determined as 12R,13R-1,3,5-trihydroxy-2-(2,3-epoxy-4-hydroxy-3-
methylbutyl)-7-methoxyxanthen-9-one and given the trivial name fuscaxanthone K. 
 
 
 
Figure 36. The ROESY interaction of H2-14 
 
 
 
 
 
 
Figure 37. (2S-trans)-2-methyl-3-phenyloxiranemethanol 
OH
O
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Figure 38. 1H and 13C NMR spectra of fuscaxanthone K (20) 
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5.2.1.3. Compound 19 ((+)-fuscaxanthone I)  
 
 
 
 
 
 
 
 
 
Figure 39. Structure of (+)-fuscaxanthone I (19) 
 
Compound 19 was isolated as a yellow amorphous powder and showed a [M+H]+ 
ion peak at m/z 513.2478 in HRESIMS, corresponding to the molecular formula 
C29H36O8. The 
1H and 13C NMR spectrum of 19 (see Figure 40; Table 5 and 6) 
showed resonances for a hydrogen-bonded hydroxyl group [H 13.89 (1H, s, 1-OH)] 
corresponding to the chelated carbonyl carbon [C 181.7 (C-9)], two isolated aromatic 
protons [H 6.79 (1H, s, H-5) and 6.34 (1H, s, H-4); C 101.6 (C-5) and 92.5 (C-4)], a 
methoxyl group [H 3.83 (3H, s, 7-OCH3), C 60.5 (CH3O-7)], a 4-hydroxy-3-
methylbut-2-enyl side chain [H 5.35 (1H, t, J = 7.4 Hz, H-12), 4.28 (2H, s, H2-14), 
3.42 (2H, d, J = 7.4 Hz, H2-11), 1.71 (3H, s, H-15); C 134.7 (C-13), 124.4 (C-12), 
60.7 (C-14), 21.0 (C-15) and 20.7 (C-11)], an isoprenyl group [H 5.17 (1H, t, J = 7.2 
Hz, H-22), 2.18 (2H, m, H2-21), 1.66 (3H, s, H3-24) and 1.63 (3H, s, H3-25); C 130.3 
(C-23), 125.2 (C-22), 24.8 (C-24), 22.4 (C-21) and 16.7 (C-25)], a benzylic methylene 
group [H 3.42 (2H, m, H2-16),  C 21.9 (C-16)], two methylene groups [H 1.75 (2H, 
m, H2-17) and 1.57 (2H, m, H2-20); C 42.5 (C-17) and 41.6 (C-20)] and a methyl 
group [H 1.28 (3H, s, H3-19); C 26.4 (C-19)]. The 
1H and 13C NMR data of 19 quite 
resembled to those of fuscaxanthone I, which was previously reported from G. fusca 
collected in Thailand (Nontakham et al., 2014). In this xanthone, the double bond at C-
17/C-18 of the geranyl group is hydroxylated to produce the 3-hydroxy-3,7-dimethyl-
oct-6-enyl group. This group was confirmed by the HMBC and COSY correlations. 
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The HMBC correlations between the shielded benzylic methylene protons (H 3.22) 
with the secondary carbon (C 42.5) and an oxygenated quaternary carbon (C 71.3), in 
addition to the COSY interaction with the methylene protons (H 1.75) showed that the 
secondary carbon is C-17 and C-18 is the oxygenated quaternary carbon. The HMBC 
cross-peaks of a methyl group (H 1.28) with C-17, C-18 and a secondary carbon (C 
41.6) indicated that this methyl group is located at C-18 and the secondary carbon is 
C-20. The COSY interaction between H-20 and the vinyl methylene protons of the 
isoprenyl group pointed out the connectivity of C-20 with the isoprenyl group. 
Moreover the HMBC correlations of the benzyl methylene protons H2-16 with two 
aromatic substituted carbons at C 138.9 (C-8) and 110.8 (C-8a) and an oxygenated 
aromatic carbon at C 143.5 (C-7) as well as the ROESY interaction with the methoxyl 
protons allowed the placement of the hydroxylated geranyl group at C-8. On the other 
hand, the benzylic methylene protons of the 4-hydroxy-3-methylbut-2-enyl side chain 
gave the HMBC correlations with C-1 (C 160.6), the substituted aromatic carbon at C 
109.7 (C-2) and C-3 (C 162.3), i.e. this side chain is obviously attached to C-2. Thus, 
19 was identified as 1,3,6-trihydroxy-2-(4-hydroxy-3-methylbut-2-enyl)-8-(3-hydroxy-
3,7-dimethyl-oct-6-enyl)-7-methoxyxanthen-9-one. However the optical rotation of 19 
([]22D + 36.0º) is different from that of fuscaxanthone I ([]
26
D – 9.5º), in which the 
configuration of the chiral carbon C-18 could not be resolved. Comparison of the 
optical rotation of 19 with that of (3’S)-4-hydroxy-3-(3’-hydroxy-3’,7’-dimethyloct-6’-
enoyl)benzaldehyde ([]25D – 12.0º) (see Figure 41) (Chakor et al., 2011) suggested 
that the chiral carbon C-18 of 19 has R configuration and the compound was given 
trivial name (+)-fuscaxanthone I. 
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Figure 40. 1H and 13H NMR spectra of (+)-fuscaxanthone I (19) 
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Figure 41. (3’S)-4-Hydroxy-3-(3’-hydroxy-3’,7’-dimethyloct-6’-enoyl)benzaldehyde 
 
 
Table 5. 1H NMR data of 21, 19 and 20 in acetone-d6 
Position 21 19 20 
1-OH 14.08 s 13.89 s 13.72 s 
4 6.35 s 6.34 s 6.23 s 
5 6.81 s 6.79 s 6.83 s 
11 3.45 d (8.0 Hz) 3.42 d (7.4 Hz) 3.22 & 3.12 dd (8.1 & 15.6 Hz) 
12 5.37 t (8.0 Hz) 5.35 t (7.4 Hz) 5.03 m 
14 4.20 s 4.28 s 3.96 & 3.57 d (9.6 Hz) 
15 1.73 s 1.71 s 1.19 s 
16 4.21 d (6.8 Hz) 3.42 overlap with H-11 4.12 d (6.6 Hz) 
17 5.06 t (6.8 Hz) 1.75 m 5.28 t (6.6 Hz) 
19 1.86 d (0.8 Hz) 1.28 s 1.82 s 
20 1.97 m 1.57 m 1.98 m 
21 2.05 m 2.18 m 2.05 m 
22 5.34 t (8.0 Hz) 5.17 t (7.2 Hz) 5.04 m 
24 1.57 s 1.66 s 1.55 s 
25 1.53 s 1.63 s 1.51 s 
7-OCH3  3.83 s 3.79 s 
 
600 MHz (J in Hz and  in ppm) at 298ºK. 
OH
CHO
O OH
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Table 6. 13C NMR data of 21, 19 and 20 in acetone-d6 
 
Position 21 19 20 
1 161.2 160.6 158.0 
2 109.7 109.7 108.5 
3 162.7 162.3 164.7 
4 93.3 92.5 88.2 
4a 155.9 154.9 157.4 
5 101.0 101.6 102.0 
6 153.6a 156.8a 157.4a 
7 141.7 143.5 144.2 
8 128.9 138.9 137.4 
8a 111.9 110.8 111.2 
9 183.0 181.7 182.2 
9a 103.0 102.5 103.7 
10a 152.6a 155.3a 155.6a 
11 21.7 20.7 26.1 
12 125.4 124.4 89.1 
13 135.7 134.7 73.6 
14 61.7 60.7 67.2 
15 22.0 21.0 20.2 
16 26.2 21.9 26.3 
17 124.4 42.5 124.4 
18 135.0 71.3 134.5 
19 16.6 26.4 16.1 
20 40.6 41.6 40.0 
21 27.4 22.4 26.8 
22 125.2 125.2 124.6 
23 131.4 130.3 131.0 
24 25.7 24.8 25.3 
25 17.6 16.7 17.2 
7-OCH3  60.5 60.8 
 
a Interchangeable in the same column, 150 MHz ( in ppm) at 298ºK 
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5.2.1.4. Compound 18 (fuscaxanthone L) 
 
 
 
 
 
 
 
 
Figure 42. Structure of fuscaxanthone L (18) 
 
Compound 18 was obtained as yellow oil. The 1H and 13C NMR spectrum (see 
Figure 45; Table 7) of this compound showed similarities to those of 19, 
corresponding to a 1,3,6-trihydroxy-7-methoxyxanthone nucleus [H 13.88 (1H, s, 1-
OH), 6.80 (1H, s, H-5), 6.36 (1H, s, H-4) and 3.78 (3H, s, 7-OCH3);  C 182.4 (C-9), 
163.5 (C-3), 161.5 (C-1), 157.6 (C-6), 156.9 (C-10a), 155.8 (C-4a), 145.0 (C-7), 139.9 
(C-8), 112.1 (C-8a), 110.0 (C-2), 103.5 (C-9a), 102.4 (C-5) and 93.5 (C-4)], a 4-
hydroxy-3-methylbut-2-enyl group at C-2 [H 5.36 (1H, t, J = 6.9 Hz, H-12), 4.29 (2H, 
s, H2-14), 3.44 (2H, d, J = 6.9 Hz, H2-11) and 1.72 (3H, s, H3-15); C 135.8 (C-13), 
125.3 (C-12), 61.8 (C-14), 22.0 (C-15) and 21.7 (C-11)]  and a C10 unit, in which the 
benzylic methylene protons at C-8 [H 3.40 and 3.26, 2H, dd, J = 6.6 and 13.2 Hz, H2-
16, C 25.9 (C-16)] were highly shielded. The absence of signals for two double-bonds 
indicated that the C10 unit is saturated. The molecular formula of 18 was determined as 
C29H34O8 by HRESIMS (m/z 511.2332 [M + H]
+), and the degrees of unsaturation are 
thirteen. Apart from eleven degrees of unsaturation in the xanthone nucleus and the 4-
hydroxy-3-methylbut-2-enyl group, the C10 unit certainly contained two degrees of 
unsaturation, i.e. there is a two-ring system in this unit.  
The shielded benzylic methylene protons (H 3.40 and 3.26) showed the HMBC 
correlations with an oxygenated quaternary carbon (C 87.5), a tertiary carbon (C 
58.0) and a quaternary carbon (C 46.6). On the other hand, these protons also 
exhibited the COSY interaction with the methine proton [H 1.86 (1H, t, J = 6.6 Hz)]. 
1
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Thus, the tertiary carbon is C-17, the quaternary carbon is C-18 and C-22 is the 
oxygenated quaternary carbon. The HMBC correlations of the protons of two methyl 
carbons (H 1.09 and 0.89; C 25.7 and 24.5) with C-17, C-18 and an oxygenated 
tertiary carbon [H 3.63 (1H, d, J = 5.4 Hz); C 86.4] revealed that these two methyl 
groups are bonded to C-18 and the oxygenated tertiary carbon is C-19. The COSY 
interactions between the methylene protons [H 1.82 and 1.51 (2H, m); C 26.5] with 
H-19 and the other methylene protons [H 1.42 and 1.24 (2H, m); C 40.1] showed that 
the secondary carbon at H 26.5 is C-20 and C-21 is the other carbon (C 40.1). The 
HMBC cross-peaks of the methyl protons [H 1.27 (3H, s); C 18.9] with C-17, C-21 
and C-22 confirmed the connectivity of C-21 with C-22 as well as the position of this 
methyl group at C-22. Hence the C10 unit was established as the 1,3,3-trimethyl-7-
oxabicyclo[2.2.1]hept-2-ylmethyl group comprising three chiral carbons at C-17, C-19 
and C-22. This was supported by comparison of the spectral data of 18 with those of 
parvixanthone I, which was previously isolated from G. parvifolia (Xu et al., 2001). 
This compound also contains a 1,3,3-trimethyl-7-oxabicyclo[2.2.1]hept-2-ylmethyl 
group at C-8 but the carbon C-2 is bonded with a proton instead of the 4-hydroxy-3-
methylbut-2-enyl side chain as in the case of 18. Due to the boat conformation of the 
7-oxabicyclo[2.2.1] system with the oxo-bridge, the direction of the proton H-19 and 
the methyl group at C-22 is required to be endo. In the NOESY spectrum, H-19 gave 
the interaction with the protons of the methyl group (H 1.09, H3-24) and a proton (H 
1.82) of H2-20, i.e. the direction of this methyl group and this proton is consequently 
exo (Figure 43). Meanwhile the direction of H-17 (H 1.86) and a proton (H 1.42) of 
H2-21 were determined as endo based on the NOESY interaction with the methyl 
protons H3-25 (see Figure 44) Furthermore, the HMBC cross-peaks of the benzylic 
methylene protons (H 3.40 and 3.26, C-16) with C-7 (C 145.0), C-8 (C 139.9) and 
C-8a (C 112.1) pointed out the location of the 1,3,3-trimethyl-7-
oxabicyclo[2.2.1]hept-2-ylmethyl group at C-8. Thus, compound 18 was identified as 
1,3,6-trihydroxy-2-(4-hydroxy-3-methylbut-2-enyl)-7-methoxy-8-(1,3,3-trimethyl-7-
oxabicyclo[2.2.1]hept-2-ylmethyl)xanthen-9-one and was given a trivial name 
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fuscaxanthone L. However the absolute configuration of the chiral carbons could not 
be determined. 
 
Figure 43. The NOESY interaction between H3-24, H-20 and H-19 
 
 
Figure 44. The NOESY interaction between H-21, H-17 and H3-25 
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Figure 45. 1H and 13C NMR spectra of fuscaxanthone L (18) 
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Table 7. 1H and 13C NMR data of 18 in acetone-d6 
Position H C 
1  161.5 
2  110.0 
3  163.5 
4 6.36 s 93.5 
4a  155.8 
5 6.80 s 102.4 
6  157.6a 
7  145.0 
8  139.9 
8a  112.1 
9  182.4 
9a  103.5 
10a  156.9a 
11 3.44 d (6.9 Hz) 21.7 
12 5.36 t (6.9 Hz) 125.3 
13  135.8 
14 4.29 s 61.8 
15 1.72 s 22.0 
16 3.40 dd (6.6 & 13.2 Hz) 25.9 
 3.26 dd (6.6 & 13.2 Hz)  
17 1.86 t (6.6 Hz) 58.0 
18  46.6 
19 3.63 d (5.4 Hz) 86.4 
20 1.82 m 
1.51 m 
26.5 
21 1.42 m 
1.24 m 
40.1 
22  87.5 
23   
24 1.09 s 24.5 
25 0.89 s 25.7 
26 1.27 s 18.9 
1-OH 13.88 s  
7-OCH3 3.78 s 60.5 
 
a Interchangeable, 600 MHz for 1H and 150 MHz for 13C (J in Hz and   in ppm) at 298ºK  
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5.2.1.5. Compound 22 (fuscaxanthone M) 
 
 
 
 
 
 
 
 
 
Figure 46. Structure of fuscaxanthone M (22)  
 
Compound 22 was isolated as yellow oil. The 1H and 13C NMR spectra (see Figure 
49 and Table 8) indicated that this compound contains two prenylated xanthone 
fragments. The fragment B is cowanol (Na Pattalung et al., 1994), comprising a 
hydrogen-bonded hydroxyl group [H 13.80 (1H, s, H-1’)] corresponding with a 
chelated carbonyl carbon [C 181.8 (C-8’)], two isolated aromatic protons [H 6.82 
(1H, s, H-5’) and 6.29 (1H, s, H-4’); C 101.6 (C-5’) and 93.7 (C-4’)], a methoxyl 
group [H 3.82 (3H, s, 7’-OCH3); C 62.1 (CH3O-7’)], a 4-hydroxy-3-methyl-but-2-
enyl group [H 5.36 (1H, t, J = 7.7 Hz, H-12’), 4.23 (1H, d, J = 10.8 Hz, HA-14’), 4.16 
(1H, d, J = 10.8 Hz, HB-14’), 3.66 (2H, d, J = 7.7 Hz, H2-11’) and 1.82 (3H, s, H-15’); 
C 131.9 (C-13’), 126.6 (C-12’), 61.8 (C-14’), 23.6 (C-15’) and 21.4 (C-11’)] and a 
geranyl group [H 5.27 (1H, t, J = 6.0 Hz, H-17’), 5.16 (1H, t, J = 7.2 Hz, H-22’), 4.10 
(2H, d, J = 6.0 Hz, H2-16’), 2.04 (2H, m, H2-21’), 1.99 (2H, m, H2-20’), 1.82 (3H, s, 
H3-19), 1.60 (3H, s, H3-24’) and 1.54 (3H, s, H3-25’); C 135.5 (C-18’), 131.3 (C-23’), 
124.3 (C-22’), 123.4 (C-17’), 39.8 (C-20’), 26.6 (C-16’), 26.5 (C-21’), 25.5 (C-24’), 
17.7 (C-25’) and 16.5 (C-19’)]. The fragment A resembled 19, including a hydroxyl 
group [H 13.92 (1H, s, H-1)] chelated with a conjugated carbonyl carbon [C 181.9 
(C-8)], two isolated aromatic protons [H 6.81 (1H, s, H-5) and 6.28 (1H, s, H-4); C 
101.8 (C-5) and 93.9 (C-4)], a methoxyl group [H 3.80 (3H, s, 7-OCH3); C 62.0 
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(CH3O-7)], a 4-hydroxy-3-methyl-but-2-enyl group [H 5.47 (1H, t, J = 6.8 Hz, H-12), 
4.36 (2H, s, H2-14), 3.52 (2H, d, J =  6.8 Hz, H-11) and 1.78 (3H, s, H-15); C 133.1 
(C-13), 127.0 (C-12), 63.0 (C-14), 21.6 (C-11) and 23.0 (C-15)] and a hydroxylated 
geranyl [H 5.02 (1H, t, J = 6.9 Hz, H-22), 3.42 (2H, m, H2-16), 2.15 (2H, m, H2-21), 
1.92 (1H, m, HA-20), 1.82 (1H, m, HA-17), 1.76 (1H, m, HB-17), 1.70 (3H, s, H3-24), 
1.67 (1H, m, HB-20), 1.64 (3H, s, H3-25) and 1.45 (3H, s, H3-19); C 131.6 (C-23), 
124.4 (C-22), 79.3 (C-18), 37.9 (C-20), 37.8 (C-17), 25.7 (C-24), 22.9 (C-19), 22.4 (C-
21), 21.9 (C-16) and 17.7 (C-25)].  
In the HMBC spectrum, the benzyl methylene protons H-16 (H 3.42) correlated 
with the secondary carbon C-17 and the oxygenated quaternary carbon C-18. The 
methylene protons H-17 gave cross-peaks with C-16 and C-18. These data together 
with the COSY interaction between H-16 and H-17 indicated that the double bond at 
C-17/C-18 of the geranyl group is hydroxylated. Furthermore the HMBC correlations 
of the proton H-16 with C-8, C-7 and C-8a, in addition to the NOESY interaction with 
the methoxyl protons 7-OCH3 allowed the placement of the hydroxylated geranyl 
group at C-8. The molecular formula of 22 was calculated to be C58H68O14 with 25 
degrees of unsaturation based on HRESIMS (m/z 1011.4503 [M + Na]+). Because the 
cowanol fragment has seven oxygen atoms, the fragment A therefore contains seven 
oxygen atoms. Due to six oxygenated aromatic carbons of the xanthone nucleus and an 
oxygenated methyl carbon of the 4-hydroxy-3-methyl-but-2-enyl group, the 
oxygenated quaternary carbon C-18 of the hydroxylated geranyl group has to be 
combined with the cowanol fragment by a C-O-C linkage. This was confirmed by the 
HMBC correlation of H-14’ with C-18 (Figure 47), in addition to the NOESY 
interaction between the vinyl methyl protons H3-15’ and the methylene protons H2-17, 
see Figure 48. Hence compound 22 was determined as 8-{3-[1’,3’,6’,-trihydroxy-2’-
(4-hydroxy-3-methylbut-2-enyl)-7’-methoxy-8’-(3,7-dimethylocta-2,6-dienyl)xanthen-
9-one-14’-oxyl]-3,7-dimethyloct-2,6-dienyl}-1,3,6-trihydroxy-2-(4-hydroxy-3-
methylbut-2-enyl)-7-methoxy-8-(3,7-dimethylocta-6-enyl)bixanthone and was given 
trivial name fuscaxanthone M. The configuration of the chiral carbon C-18 was 
suggested to be R by comparison of the optical rotation of 22 ([]22D + 54.6º ) with 
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that of (3’S)-4-hydroxy-3-(3’-hydroxy-3’,7’-dimethyloct-6’-enoyl)benzaldehyde 
([]25D – 12.0º) (Chakor et al., 2011).  
 
 
Figure 47. The HMBC correlation of H-14' with C-18 
 
 
Figure 48. The NOESY interaction between H-15' and H-17 
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Figure 49. 1H and 13C NMR spectra of fuscaxanthone M (22)
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Table 8. 1H and 13C NMR data of 22 in acetone-d6 
 Fragment A Fragment B 
H C  H C 
1  160.7 1'  160.4 
2  108.0 2'  107.6 
3  161.9 3'  163.0 
4 6.28 s 93.9 4' 6.29 s 93.7 
4a  155.3 4'a  155.1 
5 6.81 s 101.8 5' 6.82 s 101.6 
6  154.5a 6'  154.3a 
7  142.4 7'  142.6 
8  138.1 8'  137.0 
8a  112.3 8'a  112.2 
9  181.9 9'  181.8 
9a  103.2 9'a  103.0 
10a  155.8a 10'a  155.8a 
11 3.52 d (6.8 Hz) 21.6 11' 3.66 d (7.7 Hz) 21.4 
12 5.47 t (6.8 Hz) 127.0 12' 5.36 t (7.7 Hz) 126.6 
13  133.1 13'  131.9 
14 4.36 s 63.0 14' 4.23 d (10.8 Hz) 
4.16 d (10.8 Hz) 
61.8 
15 1.78 s 23.0 15' 1.82 s 23.5 
16 3.42 m 21.9 16' 4.10 d (6.0 Hz) 26.6 
17 1.82 m 
1.76 m 
37.8 17' 5.27 t (6.0 Hz) 123.4 
18  79.3 18'  135.5 
19 1.45 s 22.9 19' 1.82 s 16.5 
20 1.92 m 
1.67 m  
37.9 20' 1.99 m 39.8 
21 2.15 m 22.4 21' 2.04 m 26.5 
22 5.05 t (6.9 Hz) 124.4 22' 5.16 t (7.2 Hz) 124.3 
23  131.6 23'  131.3 
24 1.70 s 25.7 24' 1.60 s 25.5 
25 1.64 s 17.7 25' 1.54 s 17.7 
1-OH 13.92 s  1'-OH 13.88 s  
7-OCH3 3.80 s 62.0 7'-OCH3 3.78 s 62.1 
 
 
a Interexchangeable, 600 MHz for 1H and 150 MHz for 13C (J in Hz and   in ppm) at 298ºK 
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5.2.2. Structure identification of substances from the ethyl acetate extract 
Thin layer and column chromatography together with semi-preparative HPLC of the 
ethyl acetate extract led to the isolation of nine substances. Analysis of NMR spectra 
(see Appendix 18 – 23) and comparison with those of previous reports, the structures 
of six known compounds were elucidated as shown in Table 9. Meanwhile the 
structures of three new substances were identified by relying on data of UV, 1D and 
2D NMR, MS spectra and optical rotation. 
Generally, all three new compounds (24 - 26) reacted positively with FeCl3 in 
methanol, which indicated their phenolic feature. The UV spectra of these compounds 
are similar to those of 1,3,6,7-tetraoxygenated xanthones, comprising four maxima at 
208 - 213, 243 - 245, 315 - 317 and 355 - 360 nm (Iinuma et al., 1996; Nilar and 
Harrison, 2002). The 1H and 13C NMR spectra of these compounds resembled those of 
the new compounds from the n-hexane extract, which revealed that they were 
prenylated xanthone derivatives containing a hydrogen-bonded hydroxyl group at H 
13.88 – 13.99, a conjugated carbonyl carbon at C 182.8 – 183.1, two isolated aromatic 
protons at H 6.81 – 6.83 and 6.34 – 6.36 and a methoxyl group at H 3.77 – 3.79. 
Moreover the 1H and 13C NMR spectra also showed the presence of hydroxylated 
geranyl and isoprenyl groups.  
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Table 9. The structure of substances isolated from the ethyl acetate extract 
Isolated 
compounds 
Structure  
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11-Hydroxy-1-isomangostin (Sia et al., 1995) 
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Griffipavixanthone (Xu et al., 1998) 
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Morelloflavone (Waterman and Crichton, 1980) 
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Volkinflavone (Chen et al., 1975) 
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GB-1a (Jackson et al., 1971) 
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GB-2 (Jackson et al., 1971) 
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5.2.2.1. Compound 24 (fuscaxanthone N) 
 
 
 
 
 
 
 
 
 
Figure 50. Structure of fuscaxanthone N (24) 
 
Compound 24 was obtained as a yellow oil and the molecular formula was deduced 
to be C29H34O8 from the HRESIMS (m/z 509.2169 [M – H]
-). In the 1H and 13C NMR 
spectrum (see Figure 53 and Table 10), the presence of a hydrogen-bonded hydroxyl 
group [H 13.88 (1H, s, 1-OH)] corresponding with a chelated carbonyl carbon [C 
182.8 (C-9)], two separated aromatic protons [H 6.83 (1H, s, H-5) and 6.36 (1H, s, H-
4); C 102.8 (C-5) and 93.5 (C-4)], a methoxyl group [H 3.79 (3H, s, 7-OCH3); C 
61.4 (CH3O-7)] and a 4-hydroxy-3-methylbut-2-enyl group [H 5.34 (1H, t, J = 7.8 Hz, 
H-12),  4.29 (1H, s, H-14), 3.44 (2H, d, J = 7.8 Hz, H2-11) and 1.72 (3H, s, H3-15); C 
135.7 (C-13), 125.3 (C-12), 61.8 (C-14), 22.0 (C-15) and 21.7 (C-11)] were observed 
together with three vinyl protons [H 5.58 (1H, m, H-22), 5.55 (1H, m, H-21) and 5.35 
(1H, t, J = 6.9 Hz, H-17); C 136.9 (C-22), 128.6 (C-21) and 125.5 (C-17)], a benzylic 
methylene group [H 4.13 (2H, t, J = 6.9 Hz, H2-16); C 26.8 (C-16)], an vinyl 
methylene group [H 2.67 (2H, d, J = 6.0 Hz, H2-20), C 43.5 (C-20)] and three methyl 
groups [H 1.81 (3H, s, H3-19), 1.29 (3H, s, H3-24) and 1.21 (3H, s, H3-25); C 24.9 
(C-24 and C-25) and 16.5 (C-19)]. The 13C NMR spectrum also showed signals for six 
oxygenated aromatic carbons (C 144.5 – 163.2) and an oxygenated quaternary 
carbon [C 81.4 (C-23)]. These spectral data indicated that 24 is a prenylated 1,3,6,7-
tetrahydroxyxanthone like the new xanthones isolated from the n-hexane extract, 
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containing the 4-hydroxy-3-methylbut-2-enyl group and a C10 side chain with two 
double-bonds. These results were further supported by the data of the HMBC and 
COSY spectra. 
The HMBC correlations of the benzylic methylene protons (H 4.13) with a fully 
substituted olefinic carbon (C 134.1) and a protonated olefinic carbon (C 125.5) as 
well as the COSY interaction between these protons and the vinyl proton (C 5.35) 
showed that the fully substituted olefinic carbon is C-18 and the protonated olefinic 
carbon is C-17. The HMBC cross-peaks of the methyl protons at H 1.81 and the 
allylic protons (H 2.67) with C-17 and C-18 revealed that the methyl group and the 
vinyl methylene group are bonded to C-18. The protons H2-20 gave the HMBC 
correlations with two protonated olefinic carbons (C 136.9 and 128.6) and the COSY 
interaction with the vinyl proton (H 5.55). This indicated that the olefinic carbon (C 
128.6) is C-21 and the other one is C-22. Moreover the HMBC correlations of the 
vinyl proton (H 5.58) with the oxygenated quaternary carbon (C 81.4) and two 
methyl carbons (C 24.9) showed that the oxygenated quaternary carbon is C-23 and 
two methyl groups are attached to C-23. In the ROESY spectrum (see Figures 51 and 
52), the interactions of H-20/H-22 and H-21/H-24 showed that the configuration of the 
double bond at C-21/C-22 is trans. Thus, the C10 side chain is a 7-hydroxy-3,7-
dimethylocta-2,5-dienyl group. This was supported by comparison of the spectral data 
with those of 1,3,6-trihydroxy-8-(7-hydroxy-3,7-dimethyl-2,5-octadienyl)-7-
methoxyxanthone, which was previously reported from G. dioica (Iinuma et al., 1996). 
Furthermore the benzylic methylene protons of this side chain gave the resonance in a 
low field (H 4.13) together with the HMBC correlations with C-7 (C 144.5), C-8 
(137.9) and C-8a (111.9), i.e. they are deshielded by the adjacent carbonyl group and 
the C10 unit is located at C-8. On the other hand, the benzylic methylene protons (H 
5.34) of the 4-hydroxy-3-methylbut-2-enyl group exhibited the HMBC cross-peaks 
with two oxygenated aromatic carbons [C 163.2 (C-3) and 161.6 (C-1)] and the 
substituted aromatic carbon [C 110.1 (C-2)]. This allowed the placement of the group 
at C-2. Hence, compound 24 was determined as 1,3,6-trihydroxy-2-(4-hydroxy-3-
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methylbut-2-enyl)-8-(7-hydroxy-3,7-dimethylocta-2,5-dienyl)-7-methoxyxanthone and 
was given a trivial name fuscaxanthone N. 
 
Figure 51. The NOESY interaction between H-22 and H2-20 
 
 
 
Figure 52. The NOESY interaction between H-21 and H3-24 
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Figure 53. 1H and 13C NMR spectra of fuscaxanthone N (24) 
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5.2.2.2. Compound 25 (fuscaxanthone O) 
 
 
 
 
 
 
 
 
 
Figure 54. Structure of fuscaxanthone O (25) 
 
Compound 25 was isolated as a yellow oil and the molecular formula was 
established as C29H34O8 based on the HRESIMS (m/z 511.2322 [M + H]
+). The 1H and 
13C NMR spectra (Figure 56 and Table 10) were similar to those of compound 24, 
comprising the signals for a 1,3,6,7-tetrahydroxyxanthone nucleus [H 13.91 (1H, s, 1-
OH), 6.81 (1H, s, H-5), 6.35 (1H, s, H-4); C 181.8 (C-9), 163.3 (C-3), 161.6 (C-1), 
157.6 (C6/C-10a), 156.3 (C10a/C-6), 155.9 (C-4a), 144.6 (C-7), 138.1 (C-8), 111.8 (C-
8a), 110.1 (C-2), 103.5 (C-9a), 102.7 (C-5) and 93.5 (C-4)], a methoxyl group [H 3.79 
(3H, s, 7-OCH3); C 61.4 (CH3O-7)], a 4-hydroxy-3-methylbut-2-enyl group [H 5.35 
(1H, t, J = 7.8 Hz, H-12), 4.29 (2H, s, H2-14), 3.43 (2H, d, J = 7.8 Hz, H2-11) and 1.72 
(3H, s, H3-15); C 135.7 (C-13), 125.3 (C-12), 61.8 (C-14), 22.0 (C-15) and 21.7 (C-
11)] and a modified geranyl group [C 5.30 (1H, t, J = 6.6 Hz, H-17), 4.82 (1H, br s, 
HZ-24), 4.67 (1H, br s, HE-24), 4.13 (2H, d, J = 6.6 Hz, H2-16), 3.94 (1H, t, J = 6.6 Hz, 
H-22), 2.05 (1H, m, HA-20), 1.98 (1H, m, HB-20), 1.84 (3H, s, H3-19), 1.63 (3H, s, H3-
25) and 1.58 (2H, m, H2-21); C 149.2 (C-23), 135.2 (C-18), 124.7 (C-17), 110.3 (C-
24), 75.2 (C-22), 36.6 (C-20), 34.5 (C-21), 26.8 (C-16), 17.8 (C-25) and 16.7 (C-19)]. 
The benzylic methylene protons of the geranyl group gave the less shielded signal 
at H 4.13 and the HMBC correlations with C-7, C-8 and C-8a, i.e. this group is 
bonded to C-8. The COSY interaction between two allylic protons (H 2.05 and 1.98) 
and two methylene protons at H 1.58 indicated the connectivity of C-20 and C-21. 
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The protons H2-21 exhibited the HMBC cross-peaks with a fully substituted olefinic 
carbon (C 149.2) and an oxygenated tertiary carbon (C 75.2), in addition to the 
COSY interaction with the proton of the oxygenated tertiary carbon (H 3.94), which 
revealed that the oxygenated quaternary carbon is C-22 and C-23 is the fully 
substituted olefinic carbon. The proton H-22 gave the HMBC correlations to an 
unsubstituted olefinic carbon (C 110.3) and a vinyl methyl group (C 17.8), i.e. the 
unsubstituted olefinic carbon is C-24 and the methyl group is C-25. The vinyl proton 
(H 4.82) is HZ due to the NOESY interaction with the protons of the vinyl methyl 
group and the other one (H 4.67) is HE, corresponding to the NOESY interaction with 
the proton H-22 (see Figure 55). Hence the geranyl group is modified into the 6-
hydroxy-3,7-dimethyloct-2,7-dienyl group. This was further confirmed by comparison 
of the spectral data of this group with those of parvixanthone C, which was previously 
isolated from G. parvifolia (Xu et al., 2001). Compound 25 was therefore identified as 
1,3,6-trihydroxy-2-(4-hydroxy-3-methylbut-2-enyl)-8-(6-hydroxy-3,7-dimethyloct-
2,7-dienyl)-7-methoxyxanthen-9-one and was given a trivial name fuscaxanthone O. 
However the configuration of the chiral carbon C-22 could not be determined. 
 
 
Figure 55. The NOESY interaction between H2-24 and H-22 and H3-25
HE HZ 
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Figure 56. 1H and 13C NMR spectra of fuscaxanthone O (25) 
O
OHO
OH
H3CO
HO
OH
HO
HE
HZ
161.6
110.1
163.3
93.5102.7
103.5
155.9
181.8
157.6 156.3
144.6
138.1
111.8
61.4
135.721.7
125.3
61.8
22.0
149.2
135.2
124.7
110.3
75.2
36.6
34.5
17.8
16.7
26.8
O
OHO
OH
H3CO
HO
OH
HO
HE
HZ
6.356.81
3.79
3.43
5.35
4.29
1.72
5.30
3.94
2.05 & 1.98
1.58
1.63
1.84
4.13
13.91
4.82
4.67
Result and discussion  143 
 
Table 10. 1H and 13C NMR data of 24 and 25 in acetone-d6 
Position 24 25 
H C  H C 
1  161.6   161.6 
2  108.0   110.1 
3  163.2   163.3 
4 6.36 s 93.5  6.35 s 93.5 
4a  155.9   155.9 
5 6.83 s 102.8  6.81 s 102.7 
6  157.4a   157.6a 
7  144.5   144.6 
8  137.8   138.1 
8a  111.9   111.8 
9  182.8   181.8 
9a  103.6   103.5 
10a  156.2a   156.3a 
11 3.44 d (7.8 Hz) 21.7  3.43 d (7.8 Hz) 21.7 
12 5.34 t (7.8 Hz) 125.3  5.35 t (7.8 Hz) 125.3 
13  135.7   135.7 
14 4.29 s 61.8  4.29 s 61.8 
15 1.72 s 22.0  1.72 s 22.0 
16 4.13 t (6.9 Hz) 26.8  4.13 d (6.6 Hz) 26.8 
17 5.35 t (6.9 Hz) 125.5  5.30 t (6.6 Hz) 124.7 
18  134.1   135.2 
19 1.81 s 16.5  1.84 s 16.7 
20 2.67 d (6.0 Hz) 43.5  2.05 m 
1.98 m 
36.6 
21 5.55 m 128.6  1.58 m 34.5 
22 5.58 m 136.9  3.94 t (6.6 Hz) 75.2 
23  81.4   149.2 
24 1.29 s 24.9  4.82 brs HZ 
4.67 brs HE 
110.3 
25 1.21 s 24.9  1.63 s 17.8 
1-OH 13.88 s   13.91 s  
7-OCH3 3.79 s 61.4  3.79 s 62.1 
 
 
a Interexchangeable, 600 MHz for 1H and 150 MHz for 13C (J in Hz and   in ppm) at 298ºK 
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5.2.2.3. Compound 26 (fuscaxanthone P) 
 
 
 
 
 
 
 
 
Figure 57. Structure of fuscaxanthone P (26) 
 
Compound 26 was isolated as a yellow oil and was given the molecular formula as 
C29H34O8 with thirteen degrees of unsaturation on the basis of HRESIMS (m/z 
511.2330 [M + H]+). The 1H and 13C NMR spectra (see Figure 58 and Table 11) 
indicated that this compound is a 1,3,6,7-tetrahydroxyxanthone including a hydrogen-
bonded hydroxyl group [H 13.99 (1H, s, 1-OH)], two separated aromatic protons [H 
6.83 (1H, s, H-5) and 6.34 (1H, s, H-4); C 102.8 (C-5) and 93.5 (C-4)], a methoxyl 
group [H 3.77 (3H, s, 7-OCH3); C 60.3 (CH3O-7)] and a 4-hydroxy-3-methylbut-2-
enyl group [H 5.35 (1H, t, J = 7.6 Hz, H-12), 4.28 (2H, s, H2-14), 3.43 (2H, d, J = 7.6 
Hz, H2-11) and 1.72 (3H, s, H3-15); C 135.6 (C-13), 125.3 (C-12), 61.7 (C-14), 22.2 
(C-15) and 21.7 (C-11)]. The 1H and 13C spectra also displayed the resonances for a 
C10 side chain consisting of a benzylic methylene group [H 4.61 (1H, d, J = 15.6 Hz, 
HA-16) and 4.23 (1H, d, J = 15.6 Hz, HB-16); C 28.7 (C-16)], a oxygenated methine 
group [H 3.43 (1H, overlapped with H-11, H-22); C 76.0 (C-22)], an vinyl methylene 
group [H 2.00 (2H, overlapped, H2-20); C 32.8 (C-20)], another methylene group [H 
1.70 (2H, m, H2-21); C 27.9 (C-21)], a vinyl methyl group [H 1.33 (3H, s, H3-19); C 
20.7 (C-19)] and two other methyl groups [H 1.12 (3H, s, H3-24/25), 1.06 (3H, s, H3-
25/24); C 26.6 (C-24/25) and 21.8 (C-25/24)]. Due to thirteen degrees of unsaturation 
in the molecule, except for ten degrees of the xanthone nucleus and one of the 4-
hydroxy-3-methylbut-2-enyl group, the C10 side chain therefore has two degrees of 
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unsaturation, i.e. this group contains a double-bond and a ring, which was further 
confirmed by the HMBC and COSY spectra.  
The benzylic methylene protons (H 4.61) showed the HMBC correlations with two 
fully substituted olefinic carbons (C 135.8 and 125.6) and a quaternary carbon (C 
41.7). Besides the protons of two methyl groups (H 1.12 and 1.06) gave the HMBC 
cross-peaks to the fully substituted carbon (C 135.8) and the quaternary carbon as 
well as the ROESY interactions with the benzylic methylene protons. This revealed 
that the fully substituted carbon at C 135.8 is C-17, the other one is C-18, C-23 is the 
quaternary carbon and two methyl groups are attached to C-23. The HMBC 
correlations of the proton of the oxygenated methine group (H 3.43; C 76.0) with C-
23 and the two methyl groups pointed out the connectivity of this oxygenated methine 
group with C-23 and the oxygenated tertiary carbon is C-22. The COSY interaction 
between the methylene proton (H 1.70) and H-22 indicated that this methylene group 
is linked with C-22. The allylic protons (H 2.00) gave the HMBC correlations to C-
17, C-18, C-21 and C-22, which revealed that these protons are located at C-20. 
Moreover the vinyl methyl protons (H 1.33) exhibited the HMBC cross-peaks with C-
17, C-18 and C-20, i.e. this methyl group is bonded to C-18. Hence the C10 side chain 
was determined as the 5-hydroxy-2,6,6-trimethylcyclohexenylmethyl group. The 
HMBC correlation of H-16 with C-7 (C 145.7), C-8 (C 139.4) and C-8a (112.5), in 
addition to the ROESY interaction with the methoxyl protons (7-OCH3) allowed the 
placement of the 5-hydroxy-2,6,6-trimethylcyclohexenylmethyl group at C-8. 
Compound 26 was identified as 1,3,6-trihydroxy-2-(4-hydroxy-3-methylbut-2-enyl)-8-
(5-hydroxy-2,6,6-trimethylcyclohexenylmethyl)-7-methoxyxanthone and was given a 
trivial name fuscaxanthone P. However the configuration of the chiral carbon C-23 
could not be resolved. 
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Figure 58. 1H and 13C NMR spectra of fuscaxanthone P (26) 
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Table 11. 1H and 13C NMR data of 26 in acetone-d6 
Position H C 
1  161.4 
2  110.0 
3  163.7 
4 6.34 s 93.5 
4a  155.7 
5 6.83 s 102.8 
6  157.9a 
7  145.7 
8  139.4 
8a  112.5 
9  183.1 
9a  103.4 
10a  156.2a 
11 3.43 d (7.6 Hz) 21.7 
12 5.35 t (7.6 Hz) 125.3 
13  135.6 
14 4.28 s 61.7 
15 1.72 s 22.2 
16 4.61 d (15.6 Hz) 
4.23 d (15.6 Hz) 
28.7 
17  135.8 
18  125.6 
19 1.33 d (5.4 Hz) 20.7 
20 2.00 overlap with H-20 32.8 
21 1.70 m 27.9 
22 3.43 overlap with H-11 76.0 
23  41.7 
24 1.12a s 26.6 
25 1.06a s 21.8 
1-OH 13.99 s  
7-OCH3 3.77 s 60.3 
 
a Interchangeable, 600 MHz for 1H and 150 MHz for 13C (J in Hz and   in ppm) at 298ºK 
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5.3. Cytotoxicity of new substances 
Eight new xanthones, cowanol and griffpavixanthone were tested for the 
cytotoxicity on HeLa cells using a modified MTT assay according to Mosman (1983). 
As shown in Table 12, griffpavixanthone possessed relatively high activity with IC50 
value of 7.9  0.7 µM, whereas cowanol and (+)-fuscaxanthone I (19) showed 
moderate cytotoxicity with IC50 values of 19.1  1.0 and 19.9  0.9 µM, respectively. 
Five compounds fuscaxanthone L (18), fuscaxanthone J (21), fuscaxanthone N (24), 
fuscaxanthone O (25) and fuscaxanthone P (26) exhibited a weak inhibitory effect with 
the range of IC50 values of 32.5 – 45.9 µM. Meanwhile the remaining compounds 
fuscaxanthone K (20) and fuscaxanthone M (22) were not cytotoxic. The new 
xanthones possess the basic structure of cowanol with modification of the geranyl or 
4-hydroxy-3-methylbut-2-enyl group. Demethylation of the methoxyl group in 21 or 
modification of the double-bond at C-22/C-23 as in fuscaxanthone N and O (24 and 
25) or ring-closure of the geranyl group in fuscaxanthone L and P (18 and 26) resultes 
in a decrease of the activity compared to that of cowanol. The hydroxylation of the 
double-bond at C-17/C-18 in (+)-fuscaxanthone I (19) has no effect on the 
cytotoxicity, whereas the epoxylation of the double-bond at C-12/C-13 in 
fuscaxanthone K (20) brings about the losing of activity. Compound 22 is derived 
from two cowanol units through a C-O-C linkage. Though cowanol showed moderate 
activity, the C-O-C linkage in fuscaxanthone M (22) resultes in the loss of 
cytotoxicity.  
Griffipavixanthone is a dimeric xanthone which was previously isolated from three 
species of the Garcinia genus, G. griffithii, G. pavifolia and G.oblongifolia (Xu et al., 
1998; Shi et al., 2014). This xanthone was reported to exhibit a high in vitro 
cytotoxicity against three cancer cell lines P388, LL/2 and Wehil64 with ED50 values 
of 3.4, 6.8 and 4.6 µg/ml, respectively (Xu et al., 1998). In 2014, Shi et al. investigated 
the effect of griffipavixanthone on cell proliferation of several human non-small cell 
lung cancer cell lines (H520, H549, H1299 and A-549), human breast cancer cells 
(MCF-7 and MDA-231), human prostate cells (DU145, PC3 and LNcaP) and human 
colon cancer cells (HCT-116, HT-29 and SW-480). The investigation showed 
significant anti-proliferation activity of griffipavixanthone on all of these cells with the 
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IC50 values in the range of 3.03 – 29.33 µM. Furthermore this xanthone showed low 
cytotoxic effects on non-tumorigenic LO2 cells indicating that it may be selectively 
cytotoxic for human cancer cells (Shi et al., 2014). Because of such interesting 
biological properties, in the present work, griffipavixanthone was additionally tested 
for anti-angiogenic activity by in vitro proliferation assay on HMEC-1 cell line as 
described by Schmidt et al. (2012). It exhibited a very potent anti-proliferative effect 
on HMEC-1 cells with an IC50 value of 0.15  0.0085 µM after 72 h incubation. The 
result revealed that griffipavixanthone is a promising anti-angiogenic agent which 
should be further demonstrated in vivo. 
 
Table 12. Cytotoxicity of 18 – 22, 24 – 26, cowanol and griffipavixanthone against 
HeLa cells. 
Compound IC50  SD (µM)
a 
Cowanol 19.1  1.0 
Fuscaxanthone L (18) 41.5  0.4 
(+)-Fuscaxanthone I (19) 19.9  0.9 
Fuscaxanthone K (20) inactive 
Fuscaxanthone J (21) 32.5  2.8 
Fuscaxanthone M (22) inactive 
Fuscaxanthone N (24) 44.3  2.5 
Fuscaxanthone O (25) 35.4  1.7 
Fuscaxanthone P (26) 45.9  1.9 
Griffipavixanthone 7.9  0.4 
              
            a Mean of six measurements 
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 5.4. Proposed biosynthesis of the new xanthones in Garcinia fusca Pierre 
On the basis of the structure of eight new xanthones as well as the presence of 
rubraxanthone, norcowanin, cowanin and cowanol, a biosynthetic route (Scheme 25 
and 26) is suggested for the new xanthones from 1,3,7-trihydroxyxanthone, which 
together with 1,3,5-trihydroxyxanthone were shown as the precursors for most of 
xanthones in plants (see section 3.1, page 48). This xanthone is hydroxylated at C-6 by 
O2/NADPH to form 1,3,6,7-tetrahydroxyxanthone, which will be subsequently 
alkylated at C-8 by a geranyl diphosphate (GPP) to give 1,3,6,7-tetrahydroxy-8-
geranylxanthone. The hydroxyl group at C-7 of this xanthone can be methylated by 
SAM to give rubraxanthone. Meanwhile prenylation of this xanthone at C-2 by a 
dimethylallyl diphosphate (DMAPP) yielded norcowanin, which is further O-
methylated at 7-OH by SAM to produce cowanin. On the other hand, a vinyl methyl of 
isoprenyl group in norcowanin is hydroxylated by O2/NADPH to form fuscaxanthone 
J (21), which can be subsequently O-methylated at 7-OH by SAM to give cowanol. 
Epoxylation of the double-bond of the isoprenyl group in cowanol yield fuscaxanthone 
K (20), whilst hydroxylation of the double-bond at C-17/C-18 of the geranyl group 
will produce (+)-fuscaxanthone I (19). Moreover the double-bond at C-22/C-23 of the 
geranyl group in cowanol can be epoxylated by O2/NADPH and then the epoxy ring 
can be protonated and opened by a nucleophilic attack of water to generate a diol 
derivative which is dehydrated to form fuscaxanthone N and O (24 and 25). Besides 
the epoxy ring can be opened by the nucleophilic attack of the double-bond at C-17/C-
18 to yield the 5-hydroxy-2,6,6-trimethylcyclohexenylmethyl group as in 
fuscaxanthone P (26). The double-bond of the 5-hydroxy-2,6,6-
trimethylcyclohexenylmethyl group could further undergo the nucleophilic attack of 
the hydroxyl group to generate an oxo-bridge as in fuscaxanthone L (18). Similarly, 
compound 22 (fuscaxanthone M) is derived from two cowanol units via the C-O-C 
linkage, which can be formed either by the nucleophilic attack of the hydroxyl group 
of the 4-hydroxy-3-methylbut-2-enyl side chain to the double-bond at C-17/C-18 of 
the geranyl group or by condensation between cowanol and (+)-fuscaxanthone I (19). 
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Scheme 25. Proposed biosynthesis of the new xanthones in G. fusca 
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Scheme 26. Proposed biosynthesis of the new xanthones in G. fusca (continued) 
 
 
 
Scheme 26. Proposed biosynthesis of the new xanthones in G. fusca (continued) 
H2O
Epoxy-ring opening Dehydration
O
O OH
OH
H3CO
HO
OH
OH
O
H
OH
OH
O
O OH
OH
H3CO
HO
OH
OH
Dehydration
a
b
c
a and b
c
O
O OH
OH
H3CO
HO
OH
H
OH
- H
O
O OH
OH
H3CO
HO
OH
OH
O
O OH
OH
H3CO
HO
OH
O
Fuscaxanthone O (25)
Fuscaxanthone N (24)
Fuscaxanthone P (26) Fuscaxanthone L (18)  
OH
OH
OH
2 H3CO
HO
8
H3CO
HO O
O OH
OH
OH
O
O
H3CO
HO OH
OH
O
Fuscaxanthone M (22)
OH
OH
O
H
H
2 H3CO
HO
HO
8
- H2O
or
 
Conclusion   153 
 
6. CONCLUSION 
The phytochemical investigation of the n-hexane extract (GFH) and the ethyl 
acetate extract (GFE) of the bark of Garcinia fusca collected in south Vietnam resulted 
in the isolation of thirty one natural compounds using various chromatographic 
methods such as TLC, CC, FC, CPC, GPC and semi-preparative HPLC on silica gel, 
RP18 and Sephadex LH-20. The structures of isolated compounds were determined on 
the basis of spectral data such as UV, 1D and 2D NMR and MS spectra, as well as the 
optical rotation. These compounds include a tocotrienol, a benzaldehyde derivative, 
four biflavonoids and twenty five prenylated xanthones, nine of which have been first 
found in nature. The cytotoxicity of the new xanthones was tested on HeLa cells using 
MTT assay. The results indicated that five of them exhibited cytotoxic effect with the 
IC50 values in the range of 19.9 – 45.9 µM. Furthermore, the anti-angiogenic activity 
of a bixanthone, griffipavixanthone was evaluated in a proliferation assay using 
HMEC-1 cell line. This bixanthone showed strong anti-proliferation activity with the 
IC50 of 0.15  0.0085 µM, which revealed that it is a potential anti-angiogenic agent 
and should be further investigated in vivo. 
Because of the limited time, some fractions have not been studied yet. However the 
present work showed the difference of the chemical composition of the bark between 
this species and the species collected in Thailand (Ito et al., 2003; Nontakham et al., 
2014). For further work, the remaining fractions will be investigated to isolate more 
compounds and new compounds will be biologically studied for various properties 
such as anti-oxidant, antibacterial and anticancer activities. 
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Appendix 23. 1H and 13C NMR spectra of GB-2 (31) 
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